Magnusfu的个人主页 - 老虎社区

Magnusfu

Magnusfu

暂无个人介绍

IP属地：未知

31关注

2粉丝

5主题

0勋章

2021-07-13

Good news....

SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T

2021-06-28

Gene editing is the biggest winner on today market....well done.

Toplines Before US Market Open on Monday

2021-06-26

Yes...i do think BABA has huge upside potential to achieve.

Alibaba: Can BABA Get Back To $300? Yes, It Can

2021-06-23

Turbulence time ahead....

抱歉，原内容已删除

2021-06-21

This is the nature of bio- tech company, high risk and high reward at the same time, FDA approval is the key.

Orphazyme rose more than 6% in premarket trading

2021-06-20

Interesting....

Beware these risky tech stocks in your portfolio, strategist Parker warns

2021-06-19

What goes up will come down...

3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%

2021-06-19

Riding on the high of stock index...good luck to all.

U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week

2021-06-18

Oh dear...this is bad news from FDA.

Orphazyme shares tumbled more than 60% in pre-market trading

2021-06-17

It does not look good at all.

Musk-Touted CureVac Loses 49% of Value After Vaccine Setback

2021-06-16

Cathie is confident on draftkings future....

Cathie Wood buys $42 million in DraftKings on dip from short-seller report

2021-06-16

Hope history will guide the market....cheers

抱歉，原内容已删除

2021-06-16

Sensitive time period....on fed policies.

抱歉，原内容已删除

2021-06-11

Market sentiment is strong.....Fri will climb again.

S&P 500 climbs to a new record close, shrugging off inflation fears

2021-06-10

The confidence of the market is unshakable...at this point.

U.S. stocks gained in Thursday open. Chinese Education Stocks soared

2021-06-10

New phenomenon and new ways of trading....we all need to adapt.change is the only thing constant... indeed.

This robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and Amazon

2021-06-10

PLTR is complicated....to say the least.

Palantir Puzzle Pieces: SPACs, IBM And Healthcare

2021-06-10

Will pay close attention to them....

抱歉，原内容已删除

2021-06-08

Wow....this is significant

Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK

2021-06-04

$Nokia Oyj(NOK)$guys...dont treat nokia as a typical me me stock. It has strong fundamentals and has huge potential for long term growth.

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3578427892019378","uuid":"3578427892019378","gmtCreate":1615333868245,"gmtModify":1620018521337,"name":"Magnusfu","pinyin":"magnusfu","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":31,"tweetSize":38,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":5,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.14%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":142545606,"gmtCreate":1626164346005,"gmtModify":1631888120999,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Good news....","listText":"Good news....","text":"Good news....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/142545606","repostId":"1128533375","repostType":2,"repost":{"id":"1128533375","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626098621,"share":"https://www.laohu8.com/m/news/1128533375?lang=&edition=full","pubTime":"2021-07-12 22:03","market":"us","language":"en","title":"SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T","url":"https://stock-news.laohu8.com/highlight/detail?id=1128533375","media":"Tiger Newspress","summary":"SPI Energy stock jumps 17% on announcing the launch of next-generation electric pickup truck, EF1-T ","content":"<ul>\n <li>SPI Energy stock jumps 17% on&nbsp;announcing&nbsp;the launch of next-generation electric pickup truck, EF1-T by&nbsp;its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.</li>\n <li>The EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.</li>\n <li>\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman &amp; Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"</li>\n <li>Approximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/0bd67d49b5a0a872ac8d4bf5ef7788a7\" tg-width=\"1297\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSPI Energy stock jumps 17% on launching next generation electric pickup truck EF1-T\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-12 22:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>SPI Energy stock jumps 17% on&nbsp;announcing&nbsp;the launch of next-generation electric pickup truck, EF1-T by&nbsp;its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.</li>\n <li>The EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.</li>\n <li>\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman &amp; Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"</li>\n <li>Approximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.</li>\n</ul>\n<p><img src=\"https://static.tigerbbs.com/0bd67d49b5a0a872ac8d4bf5ef7788a7\" tg-width=\"1297\" tg-height=\"592\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPI":"阳光动力"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128533375","content_text":"SPI Energy stock jumps 17% on announcing the launch of next-generation electric pickup truck, EF1-T by its wholly owned EdisonFuture, Inc. and PhoenixMotor Inc. subsidiary.\nThe EF1-T standard model comes equipped with total power of 350 kilowatts, or 470 horsepower, while EdisonFuture's top of the line \"Super\" model offers 600kW, or 816HP.\n\"Our vision for EdisionFuture and Phoenix Motorcars is to be leaders in sustainable transportation with focus on energy efficiency and innovative design,\" stated Mr. Xiaofeng Peng, Chairman & Chief Executive Officer of SPI Energy. \"We have already filed multiple design and technology patents in the US related to the EF1-T and look forward to introducing this game-changing vehicle to the market in the coming months.\"\nApproximately 2.9M pickup trucks were sold in the US in 2020, +20% of the entire US auto market.","news_type":1},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150927820,"gmtCreate":1624883915760,"gmtModify":1631888121010,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Gene editing is the biggest winner on today market....well done.","listText":"Gene editing is the biggest winner on today market....well done.","text":"Gene editing is the biggest winner on today market....well done.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/150927820","repostId":"1149431635","repostType":4,"repost":{"id":"1149431635","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624882571,"share":"https://www.laohu8.com/m/news/1149431635?lang=&edition=full","pubTime":"2021-06-28 20:16","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1149431635","media":"Tiger Newspress","summary":"U.S. stock futures traded mixed in early pre-market trade\n\n\nVirgin Galactic stock surged another 6% ","content":"<ul>\n <li>U.S. stock futures traded mixed in early pre-market trade</li>\n</ul>\n<ul>\n <li>Virgin Galactic stock surged another 6% in premarket trading</li>\n</ul>\n<p>Futures tracking the S&amp;P 500 paused at an all-time high on Monday as investors stayed away from making big bets ahead of data on the health of a U.S. labor market recovery and corporate earnings later in the week.</p>\n<p>At 8:05 a.m. ET, Dow e-minis were down 33 points, or 0.1% and S&amp;P 500 e-minis were up 2.5 points, or 0.06%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a1d78faa2e0d7f393f800bb396bc1082\" tg-width=\"1080\" tg-height=\"425\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Nasdaq 100 e-minis were up 43.75 points, or 0.31% as megacap companies including Microsoft, Amazon&nbsp;and Facebook Inc&nbsp;edged higher in premarket trading.</p>\n<p>Crypto stocks follow the rise of Bitcoin in premarket trading.Marathon Digital,Riot Blockchain,Canaan&nbsp;and&nbsp;SOS Limited&nbsp;climbed between 1.8% and 6%.</p>\n<p>Quarterly results from Micron Technology, ConocoPhillips&nbsp;and Walgreens&nbsp;are slated for this week. On the economic front, attention will be on consumer confidence data, a private jobs report and a crucial monthly nonfarm payrolls report.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic&nbsp;(SPCE)</b>– Virgin Galactic shares surged another 6% in the premarket after geting the green light from the FAA to fly passengers to space.Virgin Galactic shares soared 38.87% to $55.91&nbsp;on last&nbsp;Friday in the regular session. The company’s shares have returned 135.6% on a year-to-date basis.</p>\n<p><b>Boeing&nbsp;(BA)</b> – Boeingis not likely to receive certification&nbsp;for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket.</p>\n<p><b>Baidu&nbsp;(BIDU)</b>&nbsp;–&nbsp;U.S-listed shares of Chinese tech giant Baidu rose 1.2% after its smart electric vehicle venture with automaker Geely [RIC:RIC:GEELY.UL], Jidu Auto, hired Frank Wu, formerly at Cadillac, to lead its design studio.</p>\n<p><b>Tesla&nbsp;(TSLA)</b> – Tesla&nbsp;is virtually recalling nearly 300,000 cars&nbsp;to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in order to receive the update.</p>\n<p><b>Nvidia&nbsp;(NVDA) </b>– Nvidia received support for its planned $40 billion takeover of ARM from some of the U.K. chip maker’s major customers, according to a report in the Sunday Times. The public display of support comes from&nbsp;Broadcom(AVGO),Marvell(MRVL) and MediaTek.</p>\n<p><b>Intellia Therapeutics&nbsp;(NTLA)</b> – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner&nbsp;Regeneron(REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with&nbsp;CRISPR Therapeutics(CRSP) soaring 13.5% and&nbsp;Editas Medicine(EDIT) jumping 17.1%.</p>\n<p><b>Perion Network&nbsp;(PERI)</b> – The advertising technology company’s shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast.</p>\n<p><b>Johnson &amp; Johnson&nbsp;(JNJ) </b>– Johnson &amp; Johnson will pay $263 million&nbsp;to resolve opioid-related claims&nbsp;in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&amp;J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday.</p>\n<p><b>Biogen&nbsp;(BIIB)</b> – House lawmakers announced an inquiry into the process that approved Biogen’s Alzheimer’s treatment as well as its pricing. Biogen told Reuters it would cooperate with any inquiries it received from lawmakers.</p>\n<p><b>MetLife&nbsp;(MET)</b> – MetLife received an offer from Netherlands-based insurer NN Group for some of MetLife’s European businesses, though NN did not say which businesses were involved or how much it had offered.</p>\n<p><b>MicroStrategy&nbsp;(MSTR)</b> – The business analytics company’s stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin. MicroStrategy has several billion dollars of the virtual currency on its books.</p>\n<p><b>Ocwen Financial&nbsp;(OCN),JOANN&nbsp;(JOAN)</b> – Both stocks will be included in the small-cap Russell 2000 index as of today. Ocwen is a mortgage origination and servicing company, while JOANN is an arts and crafts retailer.</p>\n<p><b>NRG Energy&nbsp;(NRG)</b> – The energy provider’s stock was added to the Conviction Buy list at Goldman Sachs, which also increased its price target on the stock to $57 per share from $46. The stock closed at $38.49 per share Friday, and gained 1.8% in premarket trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-28 20:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>U.S. stock futures traded mixed in early pre-market trade</li>\n</ul>\n<ul>\n <li>Virgin Galactic stock surged another 6% in premarket trading</li>\n</ul>\n<p>Futures tracking the S&amp;P 500 paused at an all-time high on Monday as investors stayed away from making big bets ahead of data on the health of a U.S. labor market recovery and corporate earnings later in the week.</p>\n<p>At 8:05 a.m. ET, Dow e-minis were down 33 points, or 0.1% and S&amp;P 500 e-minis were up 2.5 points, or 0.06%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a1d78faa2e0d7f393f800bb396bc1082\" tg-width=\"1080\" tg-height=\"425\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Nasdaq 100 e-minis were up 43.75 points, or 0.31% as megacap companies including Microsoft, Amazon&nbsp;and Facebook Inc&nbsp;edged higher in premarket trading.</p>\n<p>Crypto stocks follow the rise of Bitcoin in premarket trading.Marathon Digital,Riot Blockchain,Canaan&nbsp;and&nbsp;SOS Limited&nbsp;climbed between 1.8% and 6%.</p>\n<p>Quarterly results from Micron Technology, ConocoPhillips&nbsp;and Walgreens&nbsp;are slated for this week. On the economic front, attention will be on consumer confidence data, a private jobs report and a crucial monthly nonfarm payrolls report.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic&nbsp;(SPCE)</b>– Virgin Galactic shares surged another 6% in the premarket after geting the green light from the FAA to fly passengers to space.Virgin Galactic shares soared 38.87% to $55.91&nbsp;on last&nbsp;Friday in the regular session. The company’s shares have returned 135.6% on a year-to-date basis.</p>\n<p><b>Boeing&nbsp;(BA)</b> – Boeingis not likely to receive certification&nbsp;for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket.</p>\n<p><b>Baidu&nbsp;(BIDU)</b>&nbsp;–&nbsp;U.S-listed shares of Chinese tech giant Baidu rose 1.2% after its smart electric vehicle venture with automaker Geely [RIC:RIC:GEELY.UL], Jidu Auto, hired Frank Wu, formerly at Cadillac, to lead its design studio.</p>\n<p><b>Tesla&nbsp;(TSLA)</b> – Tesla&nbsp;is virtually recalling nearly 300,000 cars&nbsp;to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in order to receive the update.</p>\n<p><b>Nvidia&nbsp;(NVDA) </b>– Nvidia received support for its planned $40 billion takeover of ARM from some of the U.K. chip maker’s major customers, according to a report in the Sunday Times. The public display of support comes from&nbsp;Broadcom(AVGO),Marvell(MRVL) and MediaTek.</p>\n<p><b>Intellia Therapeutics&nbsp;(NTLA)</b> – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner&nbsp;Regeneron(REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with&nbsp;CRISPR Therapeutics(CRSP) soaring 13.5% and&nbsp;Editas Medicine(EDIT) jumping 17.1%.</p>\n<p><b>Perion Network&nbsp;(PERI)</b> – The advertising technology company’s shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast.</p>\n<p><b>Johnson &amp; Johnson&nbsp;(JNJ) </b>– Johnson &amp; Johnson will pay $263 million&nbsp;to resolve opioid-related claims&nbsp;in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&amp;J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday.</p>\n<p><b>Biogen&nbsp;(BIIB)</b> – House lawmakers announced an inquiry into the process that approved Biogen’s Alzheimer’s treatment as well as its pricing. Biogen told Reuters it would cooperate with any inquiries it received from lawmakers.</p>\n<p><b>MetLife&nbsp;(MET)</b> – MetLife received an offer from Netherlands-based insurer NN Group for some of MetLife’s European businesses, though NN did not say which businesses were involved or how much it had offered.</p>\n<p><b>MicroStrategy&nbsp;(MSTR)</b> – The business analytics company’s stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin. MicroStrategy has several billion dollars of the virtual currency on its books.</p>\n<p><b>Ocwen Financial&nbsp;(OCN),JOANN&nbsp;(JOAN)</b> – Both stocks will be included in the small-cap Russell 2000 index as of today. Ocwen is a mortgage origination and servicing company, while JOANN is an arts and crafts retailer.</p>\n<p><b>NRG Energy&nbsp;(NRG)</b> – The energy provider’s stock was added to the Conviction Buy list at Goldman Sachs, which also increased its price target on the stock to $57 per share from $46. The stock closed at $38.49 per share Friday, and gained 1.8% in premarket trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149431635","content_text":"U.S. stock futures traded mixed in early pre-market trade\n\n\nVirgin Galactic stock surged another 6% in premarket trading\n\nFutures tracking the S&P 500 paused at an all-time high on Monday as investors stayed away from making big bets ahead of data on the health of a U.S. labor market recovery and corporate earnings later in the week.\nAt 8:05 a.m. ET, Dow e-minis were down 33 points, or 0.1% and S&P 500 e-minis were up 2.5 points, or 0.06%.\n*Source From Tiger Trade, EST 08:05\nNasdaq 100 e-minis were up 43.75 points, or 0.31% as megacap companies including Microsoft, Amazon and Facebook Inc edged higher in premarket trading.\nCrypto stocks follow the rise of Bitcoin in premarket trading.Marathon Digital,Riot Blockchain,Canaan and SOS Limited climbed between 1.8% and 6%.\nQuarterly results from Micron Technology, ConocoPhillips and Walgreens are slated for this week. On the economic front, attention will be on consumer confidence data, a private jobs report and a crucial monthly nonfarm payrolls report.\nStocks making the biggest moves in the premarket:\nVirgin Galactic (SPCE)– Virgin Galactic shares surged another 6% in the premarket after geting the green light from the FAA to fly passengers to space.Virgin Galactic shares soared 38.87% to $55.91 on last Friday in the regular session. The company’s shares have returned 135.6% on a year-to-date basis.\nBoeing (BA) – Boeingis not likely to receive certification for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket.\nBaidu (BIDU) – U.S-listed shares of Chinese tech giant Baidu rose 1.2% after its smart electric vehicle venture with automaker Geely [RIC:RIC:GEELY.UL], Jidu Auto, hired Frank Wu, formerly at Cadillac, to lead its design studio.\nTesla (TSLA) – Tesla is virtually recalling nearly 300,000 cars to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in order to receive the update.\nNvidia (NVDA) – Nvidia received support for its planned $40 billion takeover of ARM from some of the U.K. chip maker’s major customers, according to a report in the Sunday Times. The public display of support comes from Broadcom(AVGO),Marvell(MRVL) and MediaTek.\nIntellia Therapeutics (NTLA) – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner Regeneron(REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with CRISPR Therapeutics(CRSP) soaring 13.5% and Editas Medicine(EDIT) jumping 17.1%.\nPerion Network (PERI) – The advertising technology company’s shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast.\nJohnson & Johnson (JNJ) – Johnson & Johnson will pay $263 million to resolve opioid-related claims in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday.\nBiogen (BIIB) – House lawmakers announced an inquiry into the process that approved Biogen’s Alzheimer’s treatment as well as its pricing. Biogen told Reuters it would cooperate with any inquiries it received from lawmakers.\nMetLife (MET) – MetLife received an offer from Netherlands-based insurer NN Group for some of MetLife’s European businesses, though NN did not say which businesses were involved or how much it had offered.\nMicroStrategy (MSTR) – The business analytics company’s stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin. MicroStrategy has several billion dollars of the virtual currency on its books.\nOcwen Financial (OCN),JOANN (JOAN) – Both stocks will be included in the small-cap Russell 2000 index as of today. Ocwen is a mortgage origination and servicing company, while JOANN is an arts and crafts retailer.\nNRG Energy (NRG) – The energy provider’s stock was added to the Conviction Buy list at Goldman Sachs, which also increased its price target on the stock to $57 per share from $46. The stock closed at $38.49 per share Friday, and gained 1.8% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":125473475,"gmtCreate":1624689362597,"gmtModify":1631888121022,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Yes...i do think BABA has huge upside potential to achieve.","listText":"Yes...i do think BABA has huge upside potential to achieve.","text":"Yes...i do think BABA has huge upside potential to achieve.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/125473475","repostId":"1164137597","repostType":4,"repost":{"id":"1164137597","pubTimestamp":1624671774,"share":"https://www.laohu8.com/m/news/1164137597?lang=&edition=full","pubTime":"2021-06-26 09:42","market":"us","language":"en","title":"Alibaba: Can BABA Get Back To $300? Yes, It Can","url":"https://stock-news.laohu8.com/highlight/detail?id=1164137597","media":"seekingalpha","summary":"The recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.The Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.Alibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.Alibaba is the dominant force in cloud services in China which could become a significant revenue g","content":"<p><b>Summary</b></p>\n<ul>\n <li>The recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.</li>\n <li>The Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.</li>\n <li>Alibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.</li>\n <li>Alibaba is the dominant force in cloud services in China which could become a significant revenue growth machine as the economy expands.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/814b0a9a0d17977f43665e2eba205b1e\" tg-width=\"1536\" tg-height=\"1024\"><span>Andrew Braun/iStock Editorial via Getty Images</span></p>\n<p>Alibaba(NYSE:BABA)operates a printing press that keeps spitting out tens of billions from total revenue down to net income. Many companies faced adversity throughout the pandemic, and some are still recovering, but not BABA. Through the worst economic environment for businesses to navigate in recent times, BABA generated over $100 billion in revenue and $20 billion in net income during their recent fiscal year. While BABA didn't get the memo about businesses facing challenges amidst the pandemic, the market must not have read BABA's earnings report or crunched the numbers.</p>\n<p>There are two Chinese companies I am bullish on, and BABA is my biggest conviction for appreciation. BABA smashed through the $300 share price level at the end of October 2020, but shareholders have been left confused and disappointed since then. It looked like BABA would turn the corner after a horrible end to 2020 as shares appreciated from $222.36 from the close of 2020 to $270.83 in the middle of February 2021. Still, the markets had other plans, and all shares of BABA have done is disappoint shareholders. If you missed the BABA train, it's time to grab your tickets and climb aboard, and if you purchased BABA during its run to $300 or early 2021 rebound, it might be time to add to your holdings. BABA is going to experience tremendous tailwinds from China's population and economic growth over the next several years, and their printing press is going to need more ink.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/86da7b532f25f563d08490ddc43cbede\" tg-width=\"640\" tg-height=\"337\"><span>(Source: Alibaba)</span></p>\n<p><b>The Alibaba printing press is open for business, and it spits out billions</b></p>\n<p>How many companies can say their annual revenue through the pandemic exceeded $100 billion? The $100 billion revenue mark is a prestigious club that companies such as&nbsp;Facebook (FB),PepsiCo (PEP),Procter &amp; Gamble (PG),Target (TGT), and&nbsp;Johnson &amp; Johnson (JNJ)&nbsp;are not part of. BABA, on the other hand, witnessed its revenue increase by 52.11% and smash through $100 billion as they generated $109.47 billion in their recent fiscal year. For the year ending March 2019, BABA's revenue increased by $16.25 billion (40.74%) to $56.15 billion, then for the March 2020 fiscal year, revenue increased another $15.82 billion (28.17%) to $71.97 billion. BABA is in the same boat as Alphabet(NASDAQ:GOOG)(GOOGL), FB, and Amazon (AMZN) as they watched the pandemic push more people to go digital which accelerated their businesses. For BABA, the forced transition to digital helped them achieve $37.5 billion (52.11%) in additional revenue as they finished their March 2021 fiscal year with $109.47 billion in revenue.</p>\n<p>Since 2013 BABA has not had a year where their annual revenue increase didn't exceed 25% Year over Year (YoY). When you think about that as a growth rate, it's remarkable for a company of BABA's size as this isn't a company chasing its first billion-dollar revenue year. Over the past 5 fiscal years, BABA's annual revenue has increased by $93.8 billion (408.08%) at an average annual rate of 48.25%. Smaller companies considered growth companies would be jealous of these rates, while many large caps are probably envious.</p>\n<p>BABA isn't a one-trick pony that can only generate tens of billions in revenue. BABA can convert right down to the bottom line. Each year BABA has increased its YoY gross profit by a minimum of 10% since 2013. In 2016 BABA generated $10.35 billion in gross profit and, over the next 5 fiscal years, increased its annual gross profit by $34.84 billion (336.68%). BABA has also never fallen below a 40% gross profit margin, Warren Buffett's magic number, as he indicates in<i>Warren Buffett and the Interpretation of Financial Statements. On page 34 of the Kindle edition,it says:</i></p>\n<blockquote>\n As a very general rule (and there are exceptions): Companies with gross profit margins of 40% or better tend to be companies with some sort of durable competitive advantage. Companies with gross profit margins below 40% tend to be companies in highly competitive industries, where competition is hurting overall profit margins (there are exceptions here, too).\n</blockquote>\n<p>The gross profit margin is important for investors to evaluate because it reveals how much of a company's revenue goes directly to producing it and if they have a moat around their business. BABA's numbers indicate they have a sufficient moat around their business that is hard to penetrate. With close to a decade of generating over 40% in gross profit margins, investors can expect that BABA's moat will protect its business operations for years to come.</p>\n<p>Moving to the bottom line BABA does a great job at generating profits. In their most recent fiscal year, BABA generated $22.98 billion in net income, converting more than 1/5th (20.99%) of their revenue to pure profits. Since 2013 BABA has only had 1 year where net income decreases YoY. With that track record, many options open up for BABA in the future as their cash stockpile continues to increase.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/41a5e036f023fa4ced7666e06aa1de6b\" tg-width=\"640\" tg-height=\"444\"><span>(Source: Alibaba)</span></p>\n<p><b>Alibaba will continue to experience tailwinds as China's population and economy expands</b></p>\n<p>Alibaba&nbsp;achieved one billion annual active consumers globally in the fiscal year that ended in March 2021. BABA has 891 million consumers across China's retail marketplace, local consumer services and digital media and entertainment platforms, and approximately 240 million consumers outside China. BABA's annual active consumers in the China retail marketplaces were 811 million as it grew by 85 million YoY. BABA will focus on developing a digital commerce infrastructure that offers an upgraded consumer experience by seamlessly integrating online and offline. Through BABA's infrastructure, countless retailers have digitally transformed their businesses and created multiple retail formats that have enabled new consumption experiences by leveraging consumer insights and technology. BABA's ecosystem, supply chain, and diversified fulfillment services have facilitated an immense digital transformation. By investing in its infrastructure, BABA's customers can now leverage a full range of high-frequency fulfillment services that include on-demand delivery, same-or-next day delivery, and next-day pick-up services for a full range of consumable and physical products.</p>\n<p>BABA will continue to be one of the cornerstones that supports growth within China's economy, which is benefiting from the acceleration of digitalization in all aspects of life and work. China is projected to be the world's largest economy by 2028. The per-capita income in China is expected to grow by roughly 50% from 2020 to 2025.China's average economic growth&nbsp;has been projected to increase at a rate of 5.7% from 2021 to 2025, then slow to 4.5% from 2026 to 2030. As a result,China&nbsp;is on track to join the top 1/3rd of nations and overtake 56 countries in the per capita income rankings by 2025. By the end of 2022, McKinsey&nbsp;predicts&nbsp;that the middle class could expand to 550 million people which is larger than the entire U.S population.</p>\n<p>If the projections for China are correct, this should mean a windfall of cash lining BABA's coffers. It's a simple recipe; when people make more money, they tend to spend more money to enhance their lives and increase their standard of living. As BABA is a dominant force in China's retail sector, they stand to benefit from a growing economy and a larger middle class. At the end of next year, if China has anywhere close to 550 million individuals in the middle class, I believe BABA's revenue and profits will increase significantly. This trend can provide tailwinds throughout the decade for BABA, and eventually, the market will reward shareholders based on BABA's value proposition.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/bbde4a092d19118a2d16daabf5c027d7\" tg-width=\"640\" tg-height=\"463\"><span>(Source: Blomberg)</span></p>\n<p><b>Alibaba has tremendous growth prospects in Cloud as China continues its digitization</b></p>\n<p>Cloud computing has been red hot in the U.S. as the transition from on-prem to cloud has increased the technological capabilities for many organizations. As digitization progresses across the business landscape, cloud providers continue to increase revenue generated from their cloud segments within their overall revenue mix. For example, AWS, the cloud computing division from&nbsp;AMZN, generated $45.37 billion in 2020. Cloud continues to be an exciting sector because the digital transformation is far from being over. Hence, the prospects of new customers are enormous while reoccurring revenue is generated after the transition occurs.</p>\n<p>In China, cloud infrastructure services are still in the early innings as the entire spend was around $15 billion in 2020. In Q1 of 2021, cloud infrastructure services in&nbsp;China&nbsp;grew by 55% YoY as it reached $6 billion. China was the 2nd largest market behind the U.S, accounting for 14% of global investment, up from 12% in Q1 of 2020. With cloud spending and digitization in China increasing, this serves as a major runway for growth in Alibaba Cloud.</p>\n<p>As China's economy expands, businesses will need to become more efficient to support both operations and customer demands. Chinese companies will need to implement infrastructure that can support a digital age of the workforce while supporting cloud services used by consumers for consumption. If China passes the U.S. as the world's largest economy in the second half of this decade, the amount of growth needed in cloud services will be immense. BABA is already the leader in cloud infrastructure services in China as their 39.8% market share accounted for $2.39 billion of the $6 billion spent in Q1 2021. Over the previous 6 quarters, cloud infrastructure spending has increased by roughly $2.3 billion (76.67%) in China. Based on cloud's current trajectory, quarterly revenue is on track to double over the next 2 years, putting Q1 2023 revenue at $10.6 billion. If BABA has a 35% market share, their Q1 2023 would be $3.71 billion, placing their 2023 revenue for cloud at $14.84 billion without factoring in any growth in 2023. From a cloud aspect, China's future spending is very exciting, and BABA will be one of the major benefactors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1759b81ce463d503a165d901e2e50d7c\" tg-width=\"640\" tg-height=\"728\"><span>(Source: Canalys)</span></p>\n<p><b>Alibaba has stellar financial metrics and is undervalued compared to the U.S. tech conglomerates</b></p>\n<p>For this comparison, I am going to use AMZN and GOOGL as they have been establishing their dominance in the U.S. for more than a decade. First, here are the raw numbers for AMZN, BABA, and GOOGL:</p>\n<ul>\n <li>AMZN</li>\n <li>BABA</li>\n <li>GOOGL</li>\n</ul>\n<p>The market currently places a multiple of 17.03x on AMZN's equity compared to its market cap, while its revenue multiple is 4.2x. GOOGL has a multiple of 7.17x on its equity and 8.39x on its revenue compared to market cap. AMZN and GOOGL's market caps exceed $1.5 trillion, while BABA's sits at $575.57 billion. The market is placing a 3.5x multiple on BABA's equity and 5.26x on its revenue compared to the market cap. Thus, the market is severely discounting BABA's equity and revenue generation. BABA's equity is worth 28.58% of its market cap, while AMZN's equity is equivalent to 5.87%, and GOOGL's is 13.94% of its market cap. The current discount placed on BABA's equity could create an additional tailwind for shareholders in the future.</p>\n<p><b>Conclusion</b></p>\n<p>It's hard to dismiss the growth opportunities some companies in China are presenting, especially after the recent decline in share prices. However, I believe shares of BABA are currently undervalued based on their current financial metrics and growth rates. China's economy and the amount of capital allocated to cloud service infrastructure are expected to grow substantially over the years. These will create powerful tailwinds for BABA throughout this decade. As a result, I think shareholders have been allowed to establish a BABA or dollar cost average position at a discounted price. I plan on continuing to add shares to my position while the market is discounting BABA.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba: Can BABA Get Back To $300? Yes, It Can</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba: Can BABA Get Back To $300? Yes, It Can\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-26 09:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nThe recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.\nThe Chinese economy is expected to become the world's largest economy by...</p>\n\n<a href=\"https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BABA":"阿里巴巴"},"source_url":"https://seekingalpha.com/article/4436373-alibaba-can-get-back-to-300","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164137597","content_text":"Summary\n\nThe recent downturn in Alibaba's share price has created an investment opportunity for long-term capital appreciation.\nThe Chinese economy is expected to become the world's largest economy by 2028 and more than 500 million people will be part of the middle class by end of 2023.\nAlibaba will experience tailwinds from individuals and businesses spending more money during this period of growth in China.\nAlibaba is the dominant force in cloud services in China which could become a significant revenue growth machine as the economy expands.\n\nAndrew Braun/iStock Editorial via Getty Images\nAlibaba(NYSE:BABA)operates a printing press that keeps spitting out tens of billions from total revenue down to net income. Many companies faced adversity throughout the pandemic, and some are still recovering, but not BABA. Through the worst economic environment for businesses to navigate in recent times, BABA generated over $100 billion in revenue and $20 billion in net income during their recent fiscal year. While BABA didn't get the memo about businesses facing challenges amidst the pandemic, the market must not have read BABA's earnings report or crunched the numbers.\nThere are two Chinese companies I am bullish on, and BABA is my biggest conviction for appreciation. BABA smashed through the $300 share price level at the end of October 2020, but shareholders have been left confused and disappointed since then. It looked like BABA would turn the corner after a horrible end to 2020 as shares appreciated from $222.36 from the close of 2020 to $270.83 in the middle of February 2021. Still, the markets had other plans, and all shares of BABA have done is disappoint shareholders. If you missed the BABA train, it's time to grab your tickets and climb aboard, and if you purchased BABA during its run to $300 or early 2021 rebound, it might be time to add to your holdings. BABA is going to experience tremendous tailwinds from China's population and economic growth over the next several years, and their printing press is going to need more ink.\n(Source: Alibaba)\nThe Alibaba printing press is open for business, and it spits out billions\nHow many companies can say their annual revenue through the pandemic exceeded $100 billion? The $100 billion revenue mark is a prestigious club that companies such as Facebook (FB),PepsiCo (PEP),Procter & Gamble (PG),Target (TGT), and Johnson & Johnson (JNJ) are not part of. BABA, on the other hand, witnessed its revenue increase by 52.11% and smash through $100 billion as they generated $109.47 billion in their recent fiscal year. For the year ending March 2019, BABA's revenue increased by $16.25 billion (40.74%) to $56.15 billion, then for the March 2020 fiscal year, revenue increased another $15.82 billion (28.17%) to $71.97 billion. BABA is in the same boat as Alphabet(NASDAQ:GOOG)(GOOGL), FB, and Amazon (AMZN) as they watched the pandemic push more people to go digital which accelerated their businesses. For BABA, the forced transition to digital helped them achieve $37.5 billion (52.11%) in additional revenue as they finished their March 2021 fiscal year with $109.47 billion in revenue.\nSince 2013 BABA has not had a year where their annual revenue increase didn't exceed 25% Year over Year (YoY). When you think about that as a growth rate, it's remarkable for a company of BABA's size as this isn't a company chasing its first billion-dollar revenue year. Over the past 5 fiscal years, BABA's annual revenue has increased by $93.8 billion (408.08%) at an average annual rate of 48.25%. Smaller companies considered growth companies would be jealous of these rates, while many large caps are probably envious.\nBABA isn't a one-trick pony that can only generate tens of billions in revenue. BABA can convert right down to the bottom line. Each year BABA has increased its YoY gross profit by a minimum of 10% since 2013. In 2016 BABA generated $10.35 billion in gross profit and, over the next 5 fiscal years, increased its annual gross profit by $34.84 billion (336.68%). BABA has also never fallen below a 40% gross profit margin, Warren Buffett's magic number, as he indicates inWarren Buffett and the Interpretation of Financial Statements. On page 34 of the Kindle edition,it says:\n\n As a very general rule (and there are exceptions): Companies with gross profit margins of 40% or better tend to be companies with some sort of durable competitive advantage. Companies with gross profit margins below 40% tend to be companies in highly competitive industries, where competition is hurting overall profit margins (there are exceptions here, too).\n\nThe gross profit margin is important for investors to evaluate because it reveals how much of a company's revenue goes directly to producing it and if they have a moat around their business. BABA's numbers indicate they have a sufficient moat around their business that is hard to penetrate. With close to a decade of generating over 40% in gross profit margins, investors can expect that BABA's moat will protect its business operations for years to come.\nMoving to the bottom line BABA does a great job at generating profits. In their most recent fiscal year, BABA generated $22.98 billion in net income, converting more than 1/5th (20.99%) of their revenue to pure profits. Since 2013 BABA has only had 1 year where net income decreases YoY. With that track record, many options open up for BABA in the future as their cash stockpile continues to increase.\n(Source: Alibaba)\nAlibaba will continue to experience tailwinds as China's population and economy expands\nAlibaba achieved one billion annual active consumers globally in the fiscal year that ended in March 2021. BABA has 891 million consumers across China's retail marketplace, local consumer services and digital media and entertainment platforms, and approximately 240 million consumers outside China. BABA's annual active consumers in the China retail marketplaces were 811 million as it grew by 85 million YoY. BABA will focus on developing a digital commerce infrastructure that offers an upgraded consumer experience by seamlessly integrating online and offline. Through BABA's infrastructure, countless retailers have digitally transformed their businesses and created multiple retail formats that have enabled new consumption experiences by leveraging consumer insights and technology. BABA's ecosystem, supply chain, and diversified fulfillment services have facilitated an immense digital transformation. By investing in its infrastructure, BABA's customers can now leverage a full range of high-frequency fulfillment services that include on-demand delivery, same-or-next day delivery, and next-day pick-up services for a full range of consumable and physical products.\nBABA will continue to be one of the cornerstones that supports growth within China's economy, which is benefiting from the acceleration of digitalization in all aspects of life and work. China is projected to be the world's largest economy by 2028. The per-capita income in China is expected to grow by roughly 50% from 2020 to 2025.China's average economic growth has been projected to increase at a rate of 5.7% from 2021 to 2025, then slow to 4.5% from 2026 to 2030. As a result,China is on track to join the top 1/3rd of nations and overtake 56 countries in the per capita income rankings by 2025. By the end of 2022, McKinsey predicts that the middle class could expand to 550 million people which is larger than the entire U.S population.\nIf the projections for China are correct, this should mean a windfall of cash lining BABA's coffers. It's a simple recipe; when people make more money, they tend to spend more money to enhance their lives and increase their standard of living. As BABA is a dominant force in China's retail sector, they stand to benefit from a growing economy and a larger middle class. At the end of next year, if China has anywhere close to 550 million individuals in the middle class, I believe BABA's revenue and profits will increase significantly. This trend can provide tailwinds throughout the decade for BABA, and eventually, the market will reward shareholders based on BABA's value proposition.\n(Source: Blomberg)\nAlibaba has tremendous growth prospects in Cloud as China continues its digitization\nCloud computing has been red hot in the U.S. as the transition from on-prem to cloud has increased the technological capabilities for many organizations. As digitization progresses across the business landscape, cloud providers continue to increase revenue generated from their cloud segments within their overall revenue mix. For example, AWS, the cloud computing division from AMZN, generated $45.37 billion in 2020. Cloud continues to be an exciting sector because the digital transformation is far from being over. Hence, the prospects of new customers are enormous while reoccurring revenue is generated after the transition occurs.\nIn China, cloud infrastructure services are still in the early innings as the entire spend was around $15 billion in 2020. In Q1 of 2021, cloud infrastructure services in China grew by 55% YoY as it reached $6 billion. China was the 2nd largest market behind the U.S, accounting for 14% of global investment, up from 12% in Q1 of 2020. With cloud spending and digitization in China increasing, this serves as a major runway for growth in Alibaba Cloud.\nAs China's economy expands, businesses will need to become more efficient to support both operations and customer demands. Chinese companies will need to implement infrastructure that can support a digital age of the workforce while supporting cloud services used by consumers for consumption. If China passes the U.S. as the world's largest economy in the second half of this decade, the amount of growth needed in cloud services will be immense. BABA is already the leader in cloud infrastructure services in China as their 39.8% market share accounted for $2.39 billion of the $6 billion spent in Q1 2021. Over the previous 6 quarters, cloud infrastructure spending has increased by roughly $2.3 billion (76.67%) in China. Based on cloud's current trajectory, quarterly revenue is on track to double over the next 2 years, putting Q1 2023 revenue at $10.6 billion. If BABA has a 35% market share, their Q1 2023 would be $3.71 billion, placing their 2023 revenue for cloud at $14.84 billion without factoring in any growth in 2023. From a cloud aspect, China's future spending is very exciting, and BABA will be one of the major benefactors.\n(Source: Canalys)\nAlibaba has stellar financial metrics and is undervalued compared to the U.S. tech conglomerates\nFor this comparison, I am going to use AMZN and GOOGL as they have been establishing their dominance in the U.S. for more than a decade. First, here are the raw numbers for AMZN, BABA, and GOOGL:\n\nAMZN\nBABA\nGOOGL\n\nThe market currently places a multiple of 17.03x on AMZN's equity compared to its market cap, while its revenue multiple is 4.2x. GOOGL has a multiple of 7.17x on its equity and 8.39x on its revenue compared to market cap. AMZN and GOOGL's market caps exceed $1.5 trillion, while BABA's sits at $575.57 billion. The market is placing a 3.5x multiple on BABA's equity and 5.26x on its revenue compared to the market cap. Thus, the market is severely discounting BABA's equity and revenue generation. BABA's equity is worth 28.58% of its market cap, while AMZN's equity is equivalent to 5.87%, and GOOGL's is 13.94% of its market cap. The current discount placed on BABA's equity could create an additional tailwind for shareholders in the future.\nConclusion\nIt's hard to dismiss the growth opportunities some companies in China are presenting, especially after the recent decline in share prices. However, I believe shares of BABA are currently undervalued based on their current financial metrics and growth rates. China's economy and the amount of capital allocated to cloud service infrastructure are expected to grow substantially over the years. These will create powerful tailwinds for BABA throughout this decade. As a result, I think shareholders have been allowed to establish a BABA or dollar cost average position at a discounted price. I plan on continuing to add shares to my position while the market is discounting BABA.","news_type":1},"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123088916,"gmtCreate":1624403655035,"gmtModify":1631888121034,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Turbulence time ahead....","listText":"Turbulence time ahead....","text":"Turbulence time ahead....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/123088916","repostId":"2145664330","repostType":4,"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167672128,"gmtCreate":1624267885964,"gmtModify":1631888121046,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"This is the nature of bio- tech company, high risk and high reward at the same time, FDA approval is the key.","listText":"This is the nature of bio- tech company, high risk and high reward at the same time, FDA approval is the key.","text":"This is the nature of bio- tech company, high risk and high reward at the same time, FDA approval is the key.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167672128","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohu8.com/m/news/1184501396?lang=&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1},"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164917488,"gmtCreate":1624165369044,"gmtModify":1631888121061,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Interesting....","listText":"Interesting....","text":"Interesting....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/164917488","repostId":"1183124175","repostType":4,"repost":{"id":"1183124175","pubTimestamp":1624151620,"share":"https://www.laohu8.com/m/news/1183124175?lang=&edition=full","pubTime":"2021-06-20 09:13","market":"us","language":"en","title":"Beware these risky tech stocks in your portfolio, strategist Parker warns","url":"https://stock-news.laohu8.com/highlight/detail?id=1183124175","media":"cnbc","summary":"As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.Growth stocks are shares of companies expected to grow at a faster rate than the rest of the market. However, these names are typically riskier and more volatile than the average stock.Adam Parker, former Morgan Stanley chief U.S. equity strategist and founder of Trivariate Research, said the time is right to buy growth shares, but investors should be cautious of a f","content":"<div>\n<p>As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.\nGrowth stocks are shares of companies expected to grow at a faster ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beware these risky tech stocks in your portfolio, strategist Parker warns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeware these risky tech stocks in your portfolio, strategist Parker warns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-20 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.\nGrowth stocks are shares of companies expected to grow at a faster ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWLO":"Twilio Inc","MCHP":"微芯科技","SQ":"Block","AAPL":"苹果","NVDA":"英伟达"},"source_url":"https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1183124175","content_text":"As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.\nGrowth stocks are shares of companies expected to grow at a faster rate than the rest of the market. However, these names are typically riskier and more volatile than the average stock.\nAdam Parker, former Morgan Stanley chief U.S. equity strategist and founder of Trivariate Research, said the time is right to buy growth shares, but investors should be cautious of a few.\n“We think that portfolio managers should be buying growth stocks again, focusing on positive free cash flow and margin expansion, not earnings-based valuation,” Parker said in a note released Wednesday.\nTrivariate Research used a number of criteria to identify risky stocks, including low or negative correlation to inflation, high correlation to the economic reopening and high levels of company insiders selling their shares. The research firm then identified the eight riskiest names based on those measures.\n“Our view is that these are among the riskiest stocks to own today, so investors who own these names should have disproportionate upside to their base cases to compensate them for these risks,” Parker said.\nTake a look at five of the riskiest technology stocks, according to Trivariate.\nRISKIEST TECH STOCKS, ACCORDING TO TRIVARIATE\n\n\n\nTICKER\nCOMPANY\nPRICE\n%CHANGE\n\n\n\n\nMCHP\nMicrochip Technology Inc\n145.62\n-3.0686\n\n\nTWLO\nTwilio Inc\n367.61\n1.84\n\n\nSQ\nSquare Inc\n237.05\n0.39\n\n\nNVDA\nNVIDIA Corp\n745.55\n-0.0992\n\n\nAAPL\nApple Inc\n130.46\n-1.0092\n\n\n\nApple is on Trivariate’s list of riskiest stocks. The research firm identifies Apple as one of the stocks with the most negative correlation to inflation. Trivariate predicts that if bond yields rise or if fears of inflation continue, shares of Apple will underperform the market.\nNvidiaalso makes the list of risky tech stocks. Trivariate found the semiconductor stock has one of the most asymmetric beta — meaning the stock is consistently more volatile than the broader market during a market pullback compared with typical times.\nTrivariate also named payments companySquare, cloud communications platformTwilioand semiconductor manufacturerMicrochip Technologyamong the riskiest technology stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165073846,"gmtCreate":1624083524785,"gmtModify":1631888121071,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"What goes up will come down...","listText":"What goes up will come down...","text":"What goes up will come down...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/165073846","repostId":"1166679093","repostType":4,"repost":{"id":"1166679093","pubTimestamp":1624065234,"share":"https://www.laohu8.com/m/news/1166679093?lang=&edition=full","pubTime":"2021-06-19 09:13","market":"us","language":"en","title":"3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166679093","media":"fool","summary":"Meme stocks have been all the rage so far this year. That's understandable, with several of them del","content":"<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.</p>\n<p>However, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.</p>\n<p>AMC Entertainment</p>\n<p><b>AMC Entertainment</b>(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.</p>\n<p>The consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.</p>\n<p>But isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.</p>\n<p>However, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.</p>\n<p>Clover Health Investments</p>\n<p>Only a few days ago, it looked like&nbsp;<b>Clover Health Investments</b>(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.</p>\n<p>Since the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.</p>\n<p>Clover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.</p>\n<p>Still, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.</p>\n<p>Sundial Growers</p>\n<p>At one point earlier this year,&nbsp;<b>Sundial Growers</b>(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.</p>\n<p>Analysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.</p>\n<p>There certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.</p>\n<p>Sundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.</p>\n<p>However, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the&nbsp;<b>Nasdaq</b>&nbsp;stock exchange.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","SNDL":"SNDL Inc.","CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166679093","content_text":"Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.\nAMC Entertainment\nAMC Entertainment(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.\nThe consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.\nBut isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.\nHowever, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.\nClover Health Investments\nOnly a few days ago, it looked like Clover Health Investments(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.\nSince the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.\nClover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.\nStill, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.\nSundial Growers\nAt one point earlier this year, Sundial Growers(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.\nAnalysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.\nThere certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.\nSundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.\nHowever, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the Nasdaq stock exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162545028,"gmtCreate":1624069377864,"gmtModify":1631888121080,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Riding on the high of stock index...good luck to all.","listText":"Riding on the high of stock index...good luck to all.","text":"Riding on the high of stock index...good luck to all.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/162545028","repostId":"1199331995","repostType":4,"repost":{"id":"1199331995","pubTimestamp":1624065374,"share":"https://www.laohu8.com/m/news/1199331995?lang=&edition=full","pubTime":"2021-06-19 09:16","market":"us","language":"en","title":"U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1199331995","media":"Renaissance","summary":"12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.Chinese freight platform Full Truck Alliance plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value , facilitating 22+ million fulfilled orders with GTV of nearly $8 billio","content":"<p>12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.</p>\n<p>Chinese freight platform&nbsp;<b>Full Truck Alliance</b>(YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21.</p>\n<p>Healthcare manager&nbsp;<b>Bright Health Group</b>(BHG) plans to raise $1.3 billion at a $15.4 billion market cap. Bright Health seeks to employ a more consumer-centric approach to healthcare to improve consumer experiences. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding.</p>\n<p>Data infrastructure provider&nbsp;<b>Confluent</b>(CFLT) plans to raise $713 million at a $10.0 billion market cap. Confluent data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company had more than 2,500 customers as of March 2021, with a dollar-based net retention rate of 117%.</p>\n<p>Car wash brand&nbsp;<b>Mister Car Wash</b>(MCW) plans to raise $600 million at a $5.3 billion market cap. Profitable with solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company offers a monthly subscription program called Unlimited Wash Club which had 1.4 million members as of 3/31/21, representing nearly two-thirds of total wash sales.</p>\n<p>Digital physicians network&nbsp;<b>Doximity</b>(DOCS) plans to raise $501 million at a $4.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. Fast growing and profitable, the company had over 1.8 million members as of 3/31/21, representing more than 80% of physicians across the country.</p>\n<p>Customer experience software provider&nbsp;<b>Sprinklr</b>(CXM) plans to raise $361 million at a $5.5 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has attracted more than 1,000 customers, including over 50% of the Fortune 100. Sprinklr has improved its gross margins, though cash flow swung negative in 1Q FY22.</p>\n<p>HR platform provider&nbsp;<b>First Advantage</b>(FA) plans to raise $298 million at a $2.1 billion market cap. First Advantage provides technology solutions for screening, verifications, safety, and compliance related to human capital. Profitable with positive cash flow, the company derives most of its revenues from pre-onboarding screening, performing over 75 million screens on behalf of more than 30,000 customers in 2020.</p>\n<p>Chinese social networking platform&nbsp;<b>Soulgate</b>(SSR) plans to raise $185 million at a $1.8 billion market cap. The company’s app Soul is a virtual social network created to address the drawbacks of current social media platforms. In March 2021, the company averaged 9.1 million DAUs, a 94% increase over the prior year period.</p>\n<p>Digital financial services provider&nbsp;<b>AMTD Digital</b>(HKD) plans to raise $120 million at a $1.4 billion market cap. AMTD Digital states that it is the \"fusion reactor\" at the core of the AMTD SpiderNet ecosystem, operating a comprehensive digital solutions platform in Asia. Profitable with explosive growth, the company primarily generates revenue from fees and commissions in two lines of business.</p>\n<p>Organ bioengineering company&nbsp;<b>Miromatrix Medical</b>(MIRO) plans to raise $32 million at a $162 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product.</p>\n<p>Kidney disease biotech&nbsp;<b>Unicycive Therapeutics</b>(UNCY) plans to raise $25 million at a $116 million market cap. The company’s candidates include Renazorb, which was in-licensed from Spectrum Pharmaceuticals, and UNI 494, which was in-licensed from Sphaera Pharmaceuticals. Unicycive began conducting preclinical trials on UNI 494 in 2020.</p>\n<p>Antibiotic biotech&nbsp;<b>Acurx Pharmaceuticals</b>(ACXP) plans to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year.</p>\n<table>\n <tbody>\n  <tr>\n   <th>U.S. IPO Calendar</th>\n  </tr>\n  <tr>\n   <th>Issuer Business</th>\n   <th>Deal Size Market Cap</th>\n   <th>Price Range Shares Filed</th>\n   <th>Top Bookrunners</th>\n  </tr>\n  <tr>\n   <td><p>Full Truck Alliance (YMM)</p><p>Guiyang, China</p></td>\n   <td>$1,485M$19,723M</td>\n   <td>$17 - $1982,500,000</td>\n   <td>Morgan StanleyCICC</td>\n  </tr>\n  <tr>\n   <td>Digital freight platform that connects shippers and truckers in China.</td>\n  </tr>\n  <tr>\n   <td><p>First Advantage (FA)</p><p>Atlanta, GA</p></td>\n   <td>$298M$2,097M</td>\n   <td>$13 - $1521,250,000</td>\n   <td>BarclaysBofA</td>\n  </tr>\n  <tr>\n   <td>Provides background checks and other services to corporate customers.</td>\n  </tr>\n  <tr>\n   <td><p>Sprinklr (CXM)</p><p>New York, NY</p></td>\n   <td>$361M$5,541M</td>\n   <td>$18 - $2019,000,000</td>\n   <td>Morgan StanleyJP Morgan</td>\n  </tr>\n  <tr>\n   <td>Provides customer experience management software for enterprises.</td>\n  </tr>\n  <tr>\n   <td><p>Bright Health Group (BHG)</p><p>Minneapolis, MN</p></td>\n   <td>$1,290M$15,385M</td>\n   <td>$20 - $2360,000,000</td>\n   <td>JP MorganGoldman</td>\n  </tr>\n  <tr>\n   <td>Provides health insurance and other healthcare services.</td>\n  </tr>\n  <tr>\n   <td><p>Confluent (CFLT)</p><p>Mountain View, CA</p></td>\n   <td>$713M$10,033M</td>\n   <td>$29 - $3323,000,000</td>\n   <td>Morgan StanleyJP Morgan</td>\n  </tr>\n  <tr>\n   <td>Provides an enterprise platform that collects and processes real-time data streams.</td>\n  </tr>\n  <tr>\n   <td><p>Doximity (DOCS)</p><p>San Francisco, CA</p></td>\n   <td>$501M$4,549M</td>\n   <td>$20 - $2323,300,000</td>\n   <td>Morgan StanleyGoldman</td>\n  </tr>\n  <tr>\n   <td>Professional network for physicians with telehealth and scheduling tools.</td>\n  </tr>\n  <tr>\n   <td><p>Soulgate (SSR)</p><p>Shanghai, China</p></td>\n   <td>$185M$1,824M</td>\n   <td>$13 - $1513,200,000</td>\n   <td>Morgan StanleyJefferies</td>\n  </tr>\n  <tr>\n   <td>Provides the gamified social networking app Soul in China.</td>\n  </tr>\n  <tr>\n   <td><p>Acurx Pharmaceuticals (ACXP)</p><p>Staten Island, NY</p></td>\n   <td>$15M$62M</td>\n   <td>$5 - $72,500,000</td>\n   <td>Alexander CapitalNetwork 1</td>\n  </tr>\n  <tr>\n   <td>Phase 2 biotech developing antibiotics for antibiotic-resistant pathogens.</td>\n  </tr>\n  <tr>\n   <td><p>Mister Car Wash (MCW)</p><p>Tucson, AZ</p></td>\n   <td>$600M$5,256M</td>\n   <td>$15 - $1737,500,000</td>\n   <td>BofAMorgan Stanley</td>\n  </tr>\n  <tr>\n   <td>Leading national car wash brand with 344 locations across the US.</td>\n  </tr>\n  <tr>\n   <td><p>AMTD Digital (HKD)</p><p>Hong Kong, China</p></td>\n   <td>$120M$1,388M</td>\n   <td>$6.80 - $8.2016,000,000</td>\n   <td>AMTD GlobalLoop Capital</td>\n  </tr>\n  <tr>\n   <td>Digital financial services provider being spun out of AMTD.</td>\n  </tr>\n  <tr>\n   <td><p>Miromatrix Medical (MIRO)</p><p>Eden Prairie, MN</p></td>\n   <td>$32M$162M</td>\n   <td>$7 - $94,000,000</td>\n   <td>Craig-Hallum</td>\n  </tr>\n  <tr>\n   <td>Developing novel bioengineering technology for organ transplants.</td>\n  </tr>\n  <tr>\n   <td><p>Unicycive Therapeutics (UNCY)</p><p>Los Altos, CA</p></td>\n   <td>$25M$116M</td>\n   <td>$8.50 - $10.502,635,000</td>\n   <td>Roth Cap.</td>\n  </tr>\n  <tr>\n   <td>Early-stage biotech developing in-licensed therapies for kidney disease.</td>\n  </tr>\n </tbody>\n</table>\n<p>Street research is expected for seven companies, and lock-up periods will be expiring for up to two companies.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. IPO Week Ahead: Billion-Dollar Deals Come To Market In A 12 IPO Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week><strong>Renaissance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.\nChinese freight platform Full Truck Alliance(YMM) plans to raise $1.5 billion at a $19.7 billion market ...</p>\n\n<a href=\"https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FA":"First Advantage Corp.","CXM":"Sprinklr, Inc.","DOCS":"Doximity, Inc.","MCW":"Mister Car Wash, Inc.","CFLT":"Confluent, Inc.","YMM":"满帮"},"source_url":"https://seekingalpha.com/article/4435613-us-ipo-week-ahead-billion-dollar-deals-come-to-market-in-a-12-ipo-week","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1199331995","content_text":"12 IPOs are scheduled to raise $5.6 billion in the week ahead led by two billion-dollar deals.\nChinese freight platform Full Truck Alliance(YMM) plans to raise $1.5 billion at a $19.7 billion market cap. The company’s platform connects shippers with truckers to facilitate shipments across distance ranges, cargo weights, and types. Full Truck states that it is the world's largest digital freight platform by gross transaction value (GTV), facilitating 22+ million fulfilled orders with GTV of nearly $8 billion in the 1Q21.\nHealthcare manager Bright Health Group(BHG) plans to raise $1.3 billion at a $15.4 billion market cap. Bright Health seeks to employ a more consumer-centric approach to healthcare to improve consumer experiences. Through a multi-pronged organic and inorganic growth strategy, the company’s core business has grown to serve roughly 623,000 patients in 14 states since its founding.\nData infrastructure provider Confluent(CFLT) plans to raise $713 million at a $10.0 billion market cap. Confluent data infrastructure offering is designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. The company had more than 2,500 customers as of March 2021, with a dollar-based net retention rate of 117%.\nCar wash brand Mister Car Wash(MCW) plans to raise $600 million at a $5.3 billion market cap. Profitable with solid cash flow, Mister Car Wash is the largest national car wash brand in the US, with 344 locations in 21 states. The company offers a monthly subscription program called Unlimited Wash Club which had 1.4 million members as of 3/31/21, representing nearly two-thirds of total wash sales.\nDigital physicians network Doximity(DOCS) plans to raise $501 million at a $4.5 billion market cap. Doximity claims that it is the leading digital platform for US medical professionals, allowing collaboration with colleagues and secure coordination of patient care, among other features. Fast growing and profitable, the company had over 1.8 million members as of 3/31/21, representing more than 80% of physicians across the country.\nCustomer experience software provider Sprinklr(CXM) plans to raise $361 million at a $5.5 billion market cap. Sprinklr provides a software platform that helps enterprises create a persistent, unified view of each customer at scale. The company has attracted more than 1,000 customers, including over 50% of the Fortune 100. Sprinklr has improved its gross margins, though cash flow swung negative in 1Q FY22.\nHR platform provider First Advantage(FA) plans to raise $298 million at a $2.1 billion market cap. First Advantage provides technology solutions for screening, verifications, safety, and compliance related to human capital. Profitable with positive cash flow, the company derives most of its revenues from pre-onboarding screening, performing over 75 million screens on behalf of more than 30,000 customers in 2020.\nChinese social networking platform Soulgate(SSR) plans to raise $185 million at a $1.8 billion market cap. The company’s app Soul is a virtual social network created to address the drawbacks of current social media platforms. In March 2021, the company averaged 9.1 million DAUs, a 94% increase over the prior year period.\nDigital financial services provider AMTD Digital(HKD) plans to raise $120 million at a $1.4 billion market cap. AMTD Digital states that it is the \"fusion reactor\" at the core of the AMTD SpiderNet ecosystem, operating a comprehensive digital solutions platform in Asia. Profitable with explosive growth, the company primarily generates revenue from fees and commissions in two lines of business.\nOrgan bioengineering company Miromatrix Medical(MIRO) plans to raise $32 million at a $162 million market cap. Miromatrix is developing a novel technology for bioengineering fully transplantable human organs, initially focused on livers and kidneys. The company has demonstrated functional vasculature and important organ function in preclinical studies, and hopes to initiate a Phase 1 trial in late 2022 with its External Liver Assist Product.\nKidney disease biotech Unicycive Therapeutics(UNCY) plans to raise $25 million at a $116 million market cap. The company’s candidates include Renazorb, which was in-licensed from Spectrum Pharmaceuticals, and UNI 494, which was in-licensed from Sphaera Pharmaceuticals. Unicycive began conducting preclinical trials on UNI 494 in 2020.\nAntibiotic biotech Acurx Pharmaceuticals(ACXP) plans to raise $15 million at a $62 million market cap. The company is developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the WHO, CDC, and USDA. Its lead candidate recently completed a Phase 2a trial in patients with C. difficile infections, and is expected to begin a Phase 2b trial this year.\n\n\n\nU.S. IPO Calendar\n\n\nIssuer Business\nDeal Size Market Cap\nPrice Range Shares Filed\nTop Bookrunners\n\n\nFull Truck Alliance (YMM)Guiyang, China\n$1,485M$19,723M\n$17 - $1982,500,000\nMorgan StanleyCICC\n\n\nDigital freight platform that connects shippers and truckers in China.\n\n\nFirst Advantage (FA)Atlanta, GA\n$298M$2,097M\n$13 - $1521,250,000\nBarclaysBofA\n\n\nProvides background checks and other services to corporate customers.\n\n\nSprinklr (CXM)New York, NY\n$361M$5,541M\n$18 - $2019,000,000\nMorgan StanleyJP Morgan\n\n\nProvides customer experience management software for enterprises.\n\n\nBright Health Group (BHG)Minneapolis, MN\n$1,290M$15,385M\n$20 - $2360,000,000\nJP MorganGoldman\n\n\nProvides health insurance and other healthcare services.\n\n\nConfluent (CFLT)Mountain View, CA\n$713M$10,033M\n$29 - $3323,000,000\nMorgan StanleyJP Morgan\n\n\nProvides an enterprise platform that collects and processes real-time data streams.\n\n\nDoximity (DOCS)San Francisco, CA\n$501M$4,549M\n$20 - $2323,300,000\nMorgan StanleyGoldman\n\n\nProfessional network for physicians with telehealth and scheduling tools.\n\n\nSoulgate (SSR)Shanghai, China\n$185M$1,824M\n$13 - $1513,200,000\nMorgan StanleyJefferies\n\n\nProvides the gamified social networking app Soul in China.\n\n\nAcurx Pharmaceuticals (ACXP)Staten Island, NY\n$15M$62M\n$5 - $72,500,000\nAlexander CapitalNetwork 1\n\n\nPhase 2 biotech developing antibiotics for antibiotic-resistant pathogens.\n\n\nMister Car Wash (MCW)Tucson, AZ\n$600M$5,256M\n$15 - $1737,500,000\nBofAMorgan Stanley\n\n\nLeading national car wash brand with 344 locations across the US.\n\n\nAMTD Digital (HKD)Hong Kong, China\n$120M$1,388M\n$6.80 - $8.2016,000,000\nAMTD GlobalLoop Capital\n\n\nDigital financial services provider being spun out of AMTD.\n\n\nMiromatrix Medical (MIRO)Eden Prairie, MN\n$32M$162M\n$7 - $94,000,000\nCraig-Hallum\n\n\nDeveloping novel bioengineering technology for organ transplants.\n\n\nUnicycive Therapeutics (UNCY)Los Altos, CA\n$25M$116M\n$8.50 - $10.502,635,000\nRoth Cap.\n\n\nEarly-stage biotech developing in-licensed therapies for kidney disease.\n\n\n\nStreet research is expected for seven companies, and lock-up periods will be expiring for up to two companies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166603163,"gmtCreate":1624004486352,"gmtModify":1631888121095,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Oh dear...this is bad news from FDA.","listText":"Oh dear...this is bad news from FDA.","text":"Oh dear...this is bad news from FDA.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166603163","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://www.laohu8.com/m/news/1142916683?lang=&edition=full","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163236069,"gmtCreate":1623885775951,"gmtModify":1631888121107,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"It does not look good at all.","listText":"It does not look good at all.","text":"It does not look good at all.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163236069","repostId":"1199737134","repostType":4,"repost":{"id":"1199737134","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623885157,"share":"https://www.laohu8.com/m/news/1199737134?lang=&edition=full","pubTime":"2021-06-17 07:12","market":"us","language":"en","title":"Musk-Touted CureVac Loses 49% of Value After Vaccine Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=1199737134","media":"Tiger Newspress","summary":"Company plunges After Covid Shot Falls Short With 47% Efficacy\nEffectiveness is far below that seen ","content":"<ul>\n <li>Company plunges After Covid Shot Falls Short With 47% Efficacy</li>\n <li>Effectiveness is far below that seen with other mRNA vaccines</li>\n</ul>\n<p>CureVac NV&nbsp;shares plunged after a preliminary analysis of a large study muddied by the spread of virus variants found its Covid-19 vaccine was 47% effective, well short of the high bar set by other messenger RNA shots.</p>\n<p>The interim analysis of data from about 40,000 volunteers included 134 Covid cases, the German company said in a statement. CureVac declined to say how many who got the shot got sick or how many received a placebo. But the results suggest the vaccine works less well for older people than in a younger population, Chief Technology Officer Mariola Fotin-Mleczek said in an interview Wednesday.</p>\n<p>Though preliminary, the results throw the future of the vaccine into question as wealthy nations around the world move swiftly to inoculate their populations with shots already available. Still, CureVac will finish its trial and plans to gain approval, Chief Executive Officer Franz-Werner Haas said.</p>\n<p>“There is a huge need for vaccine, and I think we can still make a contribution,” Haas said.</p>\n<p>The company’s shares fell more than 49% in post-market trading after being up 17% this year through Wednesday’s close.</p>\n<p><img src=\"https://static.tigerbbs.com/d6ec3f2e05cfbc6c7d87c3fa174f459c\" tg-width=\"1302\" tg-height=\"663\"></p>\n<p>In April, Elon Musk tweeted about CureVac, which&nbsp;Tesla Inc.&nbsp;has&nbsp;partnered with&nbsp;on a vaccine printer,saying&nbsp;it “sounds like they’re a few months away from regulatory approval.” He added that “a tidal wave of vaccine is coming this summer.” He later deleted the tweet.</p>\n<p>The shot could be a boost in the developing world, since it doesn’t require the deep freezing needed for other Covid shots. Partly owned by the German government, CureVac has forged partnerships with&nbsp;Bayer AG,GlaxoSmithKline Plc&nbsp;and the&nbsp;U.K. government&nbsp;aimed at speeding production of its shot and future versions that will target mutated strains.</p>\n<p>The data comes as the world is at something of a crossroads in the Covid fight, with global infections falling even as outbreaks in places with less access to vaccines serve as a reminder that the pandemic is far from over. The wealthiest countries have taken an outsize share of the&nbsp;more than 2.4 billion shots&nbsp;administered so far.</p>\n<p>The proliferation of variants in the CureVac trial is testimony to how the pandemic has changed since the first large vaccine clinical trials were run last year.</p>\n<p><b>Genetic Sequencing</b></p>\n<p>CureVac’s researchers genetically sequenced 124 of the 134 cases they included in their analysis. Just one of the sequenced cases was due to the original SARS-CoV-2 virus first identified in Wuhan, China. The rest came from a range of variants, including 21% of cases attributable to a new variant called lambda that was first identified in Peru.</p>\n<p>TheWorld Health Organization&nbsp;added lambda to its&nbsp;watchlist&nbsp;as a variant of interest on Monday.</p>\n<p>Some 57% of the Covid cases in the study were due to so-called variants of concern, the four variants that the World Health Organization has deemed the most worrying. Most of these -- about 41% of all the cases -- were due to the alpha variant first observed in the U.K., CureVac said.</p>\n<p>That variant is now the most common in the U.S., and other vaccines, including shots from&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;as well as&nbsp;Novavax Inc., have shown themselves effective against it. CureVac didn’t release detailed data about how its shot performed against each of the variants.</p>\n<p><b>Final Readout</b></p>\n<p>More details will emerge in the final readout of the study, which will include more than 200 Covid cases and could come within two or three weeks, CureVac said.</p>\n<p>Like the shots from&nbsp;Moderna Inc.&nbsp;and the Pfizer-BioNtech alliance, CureVac’s vaccine relies on mRNA, enlisting the body’s own cells as vaccine factories. Unproven until last year, the technology has now catapulted to the forefront of the global fight against Covid.</p>\n<p>CureVac’s shot, though, is subtly different than its competitors, because it uses an unmodified form of mRNA.</p>\n<p>CureVac has said it plans to supply 300 million vaccine doses this year, enough to immunize 150 million people. Together with partners, it has said it will supply more than 1 billion doses in 2022.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk-Touted CureVac Loses 49% of Value After Vaccine Setback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk-Touted CureVac Loses 49% of Value After Vaccine Setback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-17 07:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Company plunges After Covid Shot Falls Short With 47% Efficacy</li>\n <li>Effectiveness is far below that seen with other mRNA vaccines</li>\n</ul>\n<p>CureVac NV&nbsp;shares plunged after a preliminary analysis of a large study muddied by the spread of virus variants found its Covid-19 vaccine was 47% effective, well short of the high bar set by other messenger RNA shots.</p>\n<p>The interim analysis of data from about 40,000 volunteers included 134 Covid cases, the German company said in a statement. CureVac declined to say how many who got the shot got sick or how many received a placebo. But the results suggest the vaccine works less well for older people than in a younger population, Chief Technology Officer Mariola Fotin-Mleczek said in an interview Wednesday.</p>\n<p>Though preliminary, the results throw the future of the vaccine into question as wealthy nations around the world move swiftly to inoculate their populations with shots already available. Still, CureVac will finish its trial and plans to gain approval, Chief Executive Officer Franz-Werner Haas said.</p>\n<p>“There is a huge need for vaccine, and I think we can still make a contribution,” Haas said.</p>\n<p>The company’s shares fell more than 49% in post-market trading after being up 17% this year through Wednesday’s close.</p>\n<p><img src=\"https://static.tigerbbs.com/d6ec3f2e05cfbc6c7d87c3fa174f459c\" tg-width=\"1302\" tg-height=\"663\"></p>\n<p>In April, Elon Musk tweeted about CureVac, which&nbsp;Tesla Inc.&nbsp;has&nbsp;partnered with&nbsp;on a vaccine printer,saying&nbsp;it “sounds like they’re a few months away from regulatory approval.” He added that “a tidal wave of vaccine is coming this summer.” He later deleted the tweet.</p>\n<p>The shot could be a boost in the developing world, since it doesn’t require the deep freezing needed for other Covid shots. Partly owned by the German government, CureVac has forged partnerships with&nbsp;Bayer AG,GlaxoSmithKline Plc&nbsp;and the&nbsp;U.K. government&nbsp;aimed at speeding production of its shot and future versions that will target mutated strains.</p>\n<p>The data comes as the world is at something of a crossroads in the Covid fight, with global infections falling even as outbreaks in places with less access to vaccines serve as a reminder that the pandemic is far from over. The wealthiest countries have taken an outsize share of the&nbsp;more than 2.4 billion shots&nbsp;administered so far.</p>\n<p>The proliferation of variants in the CureVac trial is testimony to how the pandemic has changed since the first large vaccine clinical trials were run last year.</p>\n<p><b>Genetic Sequencing</b></p>\n<p>CureVac’s researchers genetically sequenced 124 of the 134 cases they included in their analysis. Just one of the sequenced cases was due to the original SARS-CoV-2 virus first identified in Wuhan, China. The rest came from a range of variants, including 21% of cases attributable to a new variant called lambda that was first identified in Peru.</p>\n<p>TheWorld Health Organization&nbsp;added lambda to its&nbsp;watchlist&nbsp;as a variant of interest on Monday.</p>\n<p>Some 57% of the Covid cases in the study were due to so-called variants of concern, the four variants that the World Health Organization has deemed the most worrying. Most of these -- about 41% of all the cases -- were due to the alpha variant first observed in the U.K., CureVac said.</p>\n<p>That variant is now the most common in the U.S., and other vaccines, including shots from&nbsp;Pfizer Inc.&nbsp;and&nbsp;BioNTech SE&nbsp;as well as&nbsp;Novavax Inc., have shown themselves effective against it. CureVac didn’t release detailed data about how its shot performed against each of the variants.</p>\n<p><b>Final Readout</b></p>\n<p>More details will emerge in the final readout of the study, which will include more than 200 Covid cases and could come within two or three weeks, CureVac said.</p>\n<p>Like the shots from&nbsp;Moderna Inc.&nbsp;and the Pfizer-BioNtech alliance, CureVac’s vaccine relies on mRNA, enlisting the body’s own cells as vaccine factories. Unproven until last year, the technology has now catapulted to the forefront of the global fight against Covid.</p>\n<p>CureVac’s shot, though, is subtly different than its competitors, because it uses an unmodified form of mRNA.</p>\n<p>CureVac has said it plans to supply 300 million vaccine doses this year, enough to immunize 150 million people. Together with partners, it has said it will supply more than 1 billion doses in 2022.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CVAC":"CureVac B.V."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1199737134","content_text":"Company plunges After Covid Shot Falls Short With 47% Efficacy\nEffectiveness is far below that seen with other mRNA vaccines\n\nCureVac NV shares plunged after a preliminary analysis of a large study muddied by the spread of virus variants found its Covid-19 vaccine was 47% effective, well short of the high bar set by other messenger RNA shots.\nThe interim analysis of data from about 40,000 volunteers included 134 Covid cases, the German company said in a statement. CureVac declined to say how many who got the shot got sick or how many received a placebo. But the results suggest the vaccine works less well for older people than in a younger population, Chief Technology Officer Mariola Fotin-Mleczek said in an interview Wednesday.\nThough preliminary, the results throw the future of the vaccine into question as wealthy nations around the world move swiftly to inoculate their populations with shots already available. Still, CureVac will finish its trial and plans to gain approval, Chief Executive Officer Franz-Werner Haas said.\n“There is a huge need for vaccine, and I think we can still make a contribution,” Haas said.\nThe company’s shares fell more than 49% in post-market trading after being up 17% this year through Wednesday’s close.\n\nIn April, Elon Musk tweeted about CureVac, which Tesla Inc. has partnered with on a vaccine printer,saying it “sounds like they’re a few months away from regulatory approval.” He added that “a tidal wave of vaccine is coming this summer.” He later deleted the tweet.\nThe shot could be a boost in the developing world, since it doesn’t require the deep freezing needed for other Covid shots. Partly owned by the German government, CureVac has forged partnerships with Bayer AG,GlaxoSmithKline Plc and the U.K. government aimed at speeding production of its shot and future versions that will target mutated strains.\nThe data comes as the world is at something of a crossroads in the Covid fight, with global infections falling even as outbreaks in places with less access to vaccines serve as a reminder that the pandemic is far from over. The wealthiest countries have taken an outsize share of the more than 2.4 billion shots administered so far.\nThe proliferation of variants in the CureVac trial is testimony to how the pandemic has changed since the first large vaccine clinical trials were run last year.\nGenetic Sequencing\nCureVac’s researchers genetically sequenced 124 of the 134 cases they included in their analysis. Just one of the sequenced cases was due to the original SARS-CoV-2 virus first identified in Wuhan, China. The rest came from a range of variants, including 21% of cases attributable to a new variant called lambda that was first identified in Peru.\nTheWorld Health Organization added lambda to its watchlist as a variant of interest on Monday.\nSome 57% of the Covid cases in the study were due to so-called variants of concern, the four variants that the World Health Organization has deemed the most worrying. Most of these -- about 41% of all the cases -- were due to the alpha variant first observed in the U.K., CureVac said.\nThat variant is now the most common in the U.S., and other vaccines, including shots from Pfizer Inc. and BioNTech SE as well as Novavax Inc., have shown themselves effective against it. CureVac didn’t release detailed data about how its shot performed against each of the variants.\nFinal Readout\nMore details will emerge in the final readout of the study, which will include more than 200 Covid cases and could come within two or three weeks, CureVac said.\nLike the shots from Moderna Inc. and the Pfizer-BioNtech alliance, CureVac’s vaccine relies on mRNA, enlisting the body’s own cells as vaccine factories. Unproven until last year, the technology has now catapulted to the forefront of the global fight against Covid.\nCureVac’s shot, though, is subtly different than its competitors, because it uses an unmodified form of mRNA.\nCureVac has said it plans to supply 300 million vaccine doses this year, enough to immunize 150 million people. Together with partners, it has said it will supply more than 1 billion doses in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":312,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163032019,"gmtCreate":1623853005231,"gmtModify":1631890212449,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Cathie is confident on draftkings future....","listText":"Cathie is confident on draftkings future....","text":"Cathie is confident on draftkings future....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/163032019","repostId":"1100405031","repostType":4,"repost":{"id":"1100405031","pubTimestamp":1623848550,"share":"https://www.laohu8.com/m/news/1100405031?lang=&edition=full","pubTime":"2021-06-16 21:02","market":"us","language":"en","title":"Cathie Wood buys $42 million in DraftKings on dip from short-seller report","url":"https://stock-news.laohu8.com/highlight/detail?id=1100405031","media":"cnbc","summary":"Ark Invest CEO Cathie Wood on Tuesday bought the dip in DraftKings, as the sports-betting company fa","content":"<div>\n<p>Ark Invest CEO Cathie Wood on Tuesday bought the dip in DraftKings, as the sports-betting company faltered on news that Hindenburg Research hadtaken a short positionagainst the stock.\nWood purchased ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/cathie-wood-buys-42-million-in-draftkings-on-dip-from-short-seller-report.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood buys $42 million in DraftKings on dip from short-seller report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood buys $42 million in DraftKings on dip from short-seller report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 21:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/16/cathie-wood-buys-42-million-in-draftkings-on-dip-from-short-seller-report.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ark Invest CEO Cathie Wood on Tuesday bought the dip in DraftKings, as the sports-betting company faltered on news that Hindenburg Research hadtaken a short positionagainst the stock.\nWood purchased ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/16/cathie-wood-buys-42-million-in-draftkings-on-dip-from-short-seller-report.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DKNG":"DraftKings Inc."},"source_url":"https://www.cnbc.com/2021/06/16/cathie-wood-buys-42-million-in-draftkings-on-dip-from-short-seller-report.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1100405031","content_text":"Ark Invest CEO Cathie Wood on Tuesday bought the dip in DraftKings, as the sports-betting company faltered on news that Hindenburg Research hadtaken a short positionagainst the stock.\nWood purchased 870,299 shares ofDraftKingsin her various funds. That position is worth roughly $42.2 million based on the stock’s Tuesday closing price of $48.51.\nAbout 688,700 of the shares were purchased in Wood’s flagship fund,ARK Innovation. DraftKings is now the 17th largest holding in the exchange traded fund, representing about 1.94% of its allocation. Meanwhile, nearly 181,600 shares were purchased inARK Next General Internet ETF.\nShares of DraftKings rose more than 1% in premarket trading on Wednesday.\n\nShares of DraftKings fell about 4.2% on Tuesday after Hindenburgannouncedit was betting the stock would fall. The short-selling firm questioned the company’s promotional spending and future success in the highly competitive sports-gambling landscape.\nThe report also alleges that SBTech, a European technology company that merged with DraftKings as part of a SPAC deal, generates significant revenue from questionable gambling practices in overseas markets, particularly in some Asian markets.\nDraftKings and Diamond Eagle Acquisition Corp. first announced their merger deal in December 2019 and completed the combination in April 2020. Shares of DraftKings are up more than 4% for the year as investors rotated out of growth stocks.\nAfter rising 6% last week, shares of the Ark Innovation ETF are down less than 1% this week.","news_type":1},"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163002685,"gmtCreate":1623852550747,"gmtModify":1631884324558,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Hope history will guide the market....cheers","listText":"Hope history will guide the market....cheers","text":"Hope history will guide the market....cheers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163002685","repostId":"2143179480","repostType":4,"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169512318,"gmtCreate":1623842610634,"gmtModify":1631890212463,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Sensitive time period....on fed policies.","listText":"Sensitive time period....on fed policies.","text":"Sensitive time period....on fed policies.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169512318","repostId":"1185142374","repostType":4,"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":181063286,"gmtCreate":1623367653245,"gmtModify":1631890212475,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Market sentiment is strong.....Fri will climb again.","listText":"Market sentiment is strong.....Fri will climb again.","text":"Market sentiment is strong.....Fri will climb again.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/181063286","repostId":"1184070773","repostType":4,"repost":{"id":"1184070773","pubTimestamp":1623367038,"share":"https://www.laohu8.com/m/news/1184070773?lang=&edition=full","pubTime":"2021-06-11 07:17","market":"us","language":"en","title":"S&P 500 climbs to a new record close, shrugging off inflation fears","url":"https://stock-news.laohu8.com/highlight/detail?id=1184070773","media":"cnbc","summary":"The S&P 500 rose to an all-time high on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.The broad equity benchmark climbed nearly 0.5% to a record closing high of 4,239.18. The S&P 500 also hit an intraday record of 4,249.74, overtaking its May 7 high after the market traded sideways for a month. The Dow Jones Industrial Average advanced 19.10 points, or less than 0.1%, to 34,466.24, while the Nasdaq Composite gained about ","content":"<div>\n<p>The S&P 500 rose to an all-time high on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.\nThe broad equity benchmark climbed ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/09/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 climbs to a new record close, shrugging off inflation fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 climbs to a new record close, shrugging off inflation fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 07:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/09/stock-market-open-to-close-news.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P 500 rose to an all-time high on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.\nThe broad equity benchmark climbed ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/09/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","GME":"游戏驿站","UPS":"联合包裹",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/06/09/stock-market-open-to-close-news.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1184070773","content_text":"The S&P 500 rose to an all-time high on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.\nThe broad equity benchmark climbed nearly 0.5% to a record closing high of 4,239.18. The S&P 500 also hit an intraday record of 4,249.74, overtaking its May 7 high after the market traded sideways for a month. The Dow Jones Industrial Average advanced 19.10 points, or less than 0.1%, to 34,466.24, while the Nasdaq Composite gained about 0.8% to 14,020.33.\nConsumer prices for May accelerated at their fastest pace since the summer of 2008 amid the economic recovery from the pandemic-triggered recession,the Labor Department reported Thursday.\nThe consumer price index, which represents a basket including food, energy, groceries and prices across a spectrum of goods, rose 5% from a year ago. Economists surveyed by Dow Jones had been expecting a gain of 4.7%.\n\"I think there were a lot of people who held back, who wanted to see the hotter inflation number,\" CNBC's Jim Cramer said on \"Squawk on the Street.\" \"Now they've said, 'OK, now that's over with. Let's do some buying.' Because they've been on the sideline and they want to get in. I don't think that's actually usual these days because there's still so much buying power out there. People want in.\"\nFears of spiking inflation have weighed on the stock market in the last month, with investors worried the jump in prices will raise costs for companies, spark a move higher in interest rates and cause the Federal Reserve to remove its easy money policies.\n\"This CPI isn't likely to change the narrative dramatically, and there are still indications that inflation momentum is set to abate in the coming months,\" Adam Crisafulli, founder of Vital Knowledge, said in a note Thursday.\nMany economists also said the surge in used car costs for the month could have skewed the inflation reading. Used car and truck prices jumped more than 7%, accounting for one-third of the total increase for the month, according to the Bureau of Labor Statistics. The jump in used car prices likely reflects a temporary phenomenon related to the pandemic and auto supply.\nA separate report released Thursday showed that jobless claims for the week ended June 5 came in at 376,000, versus a Dow Jones estimate of 370,000. The total still marked the lowest of the pandemic era.\nUPS shares rose about 1% afteran upgrade from JPMorgan. Shares of Boeing were higher, but Delta Air Lines slipped.\nVideo-game retailer and meme stock GameStop fell 27% even after the company tapped former Amazon executive Matt Furlong to be its next CEO and said that sales rose 25% last quarter. The company also said it may sell up to 5 million additional shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":190,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183256525,"gmtCreate":1623333701367,"gmtModify":1631890212488,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"The confidence of the market is unshakable...at this point.","listText":"The confidence of the market is unshakable...at this point.","text":"The confidence of the market is unshakable...at this point.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/183256525","repostId":"1180064020","repostType":4,"repost":{"id":"1180064020","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623331902,"share":"https://www.laohu8.com/m/news/1180064020?lang=&edition=full","pubTime":"2021-06-10 21:31","market":"us","language":"en","title":"U.S. stocks gained in Thursday open. Chinese Education Stocks soared","url":"https://stock-news.laohu8.com/highlight/detail?id=1180064020","media":"Tiger Newspress","summary":"(June 10) U.S. stocks gained in Thursday open. Chinese Education Stocks soared.\nAirline stocks rally","content":"<p>(June 10)&nbsp;U.S. stocks gained in Thursday open.&nbsp;Chinese Education Stocks soared.</p>\n<p><img src=\"https://static.tigerbbs.com/3319d3b4d9de022c9ba1cf2e2452ee50\" tg-width=\"307\" tg-height=\"241\" referrerpolicy=\"no-referrer\">Airline stocks rally.</p>\n<p><img src=\"https://static.tigerbbs.com/918397d0861786d9643834f404915b8f\" tg-width=\"303\" tg-height=\"364\" referrerpolicy=\"no-referrer\"></p>\n<p>Video-game retailer and meme stock GameStop fell over 6%&nbsp;in morning trading even after the company tapped formerAmazon executive Matt Furlong to be its next CEOand said that sales rose 25% last quarter. The company also said it may sell up to 5 million additional shares.</p>\n<p><img src=\"https://static.tigerbbs.com/5437e23fe0b63fa6886cf840ceac1e81\" tg-width=\"700\" tg-height=\"584\" referrerpolicy=\"no-referrer\">U.S. stocks climbed on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.</p>\n<p>The Dow Jones Industrial Average rose 200 points, while theS&amp;P 500edged 0.4% higher. The Nasdaq Composite traded 0.2% higher even with bond yields rising.</p>\n<p>Consumer prices for May accelerated at their fastest pace since the summer of 2008 amid the economic recovery from the pandemic-triggered recession,the Labor Department reported Thursday.</p>\n<p>The consumer price index, which represents a basket including food, energy, groceries across a spectrum of goods, rose 5% from a year ago. Economists surveyed by Dow Jones had been expecting a gain of 4.7%.</p>\n<p>Fears of spiking inflation have weighed on the stock market in the last month, with investors worried the jump in prices will raise costs for companies, spark a move higher in interest rates and cause the Federal Reserve to remove its easy money policies.</p>\n<p>“This CPI isn’t likely to change the narrative dramatically and there are still indications that inflation momentum is set to abate in the coming months,” Adam Crisafulli, founder of Vital Knowledge, said in a note Thursday.</p>\n<p>Many economists also said the surge in used car costs for the month could have skewed the inflation reading. Used car and truck prices jumped more than 7%, accounting for one-third of the total increase for the month, according to the BLS. The jump in used car prices likely reflects a temporary phenomenon related to the pandemic and auto supply.</p>\n<p>UPS shares rose about 1% in premarket trading afteran upgrade from JPMorgan. Shares of Boeing and Delta Air Lines were also higher in premarket trading.</p>\n<p>U.S. markets continued to trade within a tight range on Wednesday, with all three major indexes ending the day within 0.5% of Tuesday’s closing levels. The Dow, S&amp;P 500 and Nasdaq Composite all fell during regular trading, ending the session further away from their respective all-time highs.</p>\n<p>The S&amp;P 500 remains closest to its benchmark and is just 0.44% away from a new all-time high. The Dow and Nasdaq are roughly 2% away from records.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title> U.S. stocks gained in Thursday open. Chinese Education Stocks soared</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n U.S. stocks gained in Thursday open. Chinese Education Stocks soared\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-10 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 10)&nbsp;U.S. stocks gained in Thursday open.&nbsp;Chinese Education Stocks soared.</p>\n<p><img src=\"https://static.tigerbbs.com/3319d3b4d9de022c9ba1cf2e2452ee50\" tg-width=\"307\" tg-height=\"241\" referrerpolicy=\"no-referrer\">Airline stocks rally.</p>\n<p><img src=\"https://static.tigerbbs.com/918397d0861786d9643834f404915b8f\" tg-width=\"303\" tg-height=\"364\" referrerpolicy=\"no-referrer\"></p>\n<p>Video-game retailer and meme stock GameStop fell over 6%&nbsp;in morning trading even after the company tapped formerAmazon executive Matt Furlong to be its next CEOand said that sales rose 25% last quarter. The company also said it may sell up to 5 million additional shares.</p>\n<p><img src=\"https://static.tigerbbs.com/5437e23fe0b63fa6886cf840ceac1e81\" tg-width=\"700\" tg-height=\"584\" referrerpolicy=\"no-referrer\">U.S. stocks climbed on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.</p>\n<p>The Dow Jones Industrial Average rose 200 points, while theS&amp;P 500edged 0.4% higher. The Nasdaq Composite traded 0.2% higher even with bond yields rising.</p>\n<p>Consumer prices for May accelerated at their fastest pace since the summer of 2008 amid the economic recovery from the pandemic-triggered recession,the Labor Department reported Thursday.</p>\n<p>The consumer price index, which represents a basket including food, energy, groceries across a spectrum of goods, rose 5% from a year ago. Economists surveyed by Dow Jones had been expecting a gain of 4.7%.</p>\n<p>Fears of spiking inflation have weighed on the stock market in the last month, with investors worried the jump in prices will raise costs for companies, spark a move higher in interest rates and cause the Federal Reserve to remove its easy money policies.</p>\n<p>“This CPI isn’t likely to change the narrative dramatically and there are still indications that inflation momentum is set to abate in the coming months,” Adam Crisafulli, founder of Vital Knowledge, said in a note Thursday.</p>\n<p>Many economists also said the surge in used car costs for the month could have skewed the inflation reading. Used car and truck prices jumped more than 7%, accounting for one-third of the total increase for the month, according to the BLS. The jump in used car prices likely reflects a temporary phenomenon related to the pandemic and auto supply.</p>\n<p>UPS shares rose about 1% in premarket trading afteran upgrade from JPMorgan. Shares of Boeing and Delta Air Lines were also higher in premarket trading.</p>\n<p>U.S. markets continued to trade within a tight range on Wednesday, with all three major indexes ending the day within 0.5% of Tuesday’s closing levels. The Dow, S&amp;P 500 and Nasdaq Composite all fell during regular trading, ending the session further away from their respective all-time highs.</p>\n<p>The S&amp;P 500 remains closest to its benchmark and is just 0.44% away from a new all-time high. The Dow and Nasdaq are roughly 2% away from records.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180064020","content_text":"(June 10) U.S. stocks gained in Thursday open. Chinese Education Stocks soared.\nAirline stocks rally.\n\nVideo-game retailer and meme stock GameStop fell over 6% in morning trading even after the company tapped formerAmazon executive Matt Furlong to be its next CEOand said that sales rose 25% last quarter. The company also said it may sell up to 5 million additional shares.\nU.S. stocks climbed on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.\nThe Dow Jones Industrial Average rose 200 points, while theS&P 500edged 0.4% higher. The Nasdaq Composite traded 0.2% higher even with bond yields rising.\nConsumer prices for May accelerated at their fastest pace since the summer of 2008 amid the economic recovery from the pandemic-triggered recession,the Labor Department reported Thursday.\nThe consumer price index, which represents a basket including food, energy, groceries across a spectrum of goods, rose 5% from a year ago. Economists surveyed by Dow Jones had been expecting a gain of 4.7%.\nFears of spiking inflation have weighed on the stock market in the last month, with investors worried the jump in prices will raise costs for companies, spark a move higher in interest rates and cause the Federal Reserve to remove its easy money policies.\n“This CPI isn’t likely to change the narrative dramatically and there are still indications that inflation momentum is set to abate in the coming months,” Adam Crisafulli, founder of Vital Knowledge, said in a note Thursday.\nMany economists also said the surge in used car costs for the month could have skewed the inflation reading. Used car and truck prices jumped more than 7%, accounting for one-third of the total increase for the month, according to the BLS. The jump in used car prices likely reflects a temporary phenomenon related to the pandemic and auto supply.\nUPS shares rose about 1% in premarket trading afteran upgrade from JPMorgan. Shares of Boeing and Delta Air Lines were also higher in premarket trading.\nU.S. markets continued to trade within a tight range on Wednesday, with all three major indexes ending the day within 0.5% of Tuesday’s closing levels. The Dow, S&P 500 and Nasdaq Composite all fell during regular trading, ending the session further away from their respective all-time highs.\nThe S&P 500 remains closest to its benchmark and is just 0.44% away from a new all-time high. The Dow and Nasdaq are roughly 2% away from records.","news_type":1},"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183966826,"gmtCreate":1623301106465,"gmtModify":1631884082634,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"New phenomenon and new ways of trading....we all need to adapt.change is the only thing constant... indeed.","listText":"New phenomenon and new ways of trading....we all need to adapt.change is the only thing constant... indeed.","text":"New phenomenon and new ways of trading....we all need to adapt.change is the only thing constant... indeed.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/183966826","repostId":"2142210925","repostType":4,"repost":{"id":"2142210925","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623289980,"share":"https://www.laohu8.com/m/news/2142210925?lang=&edition=full","pubTime":"2021-06-10 09:53","market":"us","language":"en","title":"This robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and Amazon","url":"https://stock-news.laohu8.com/highlight/detail?id=2142210925","media":"Dow Jones","summary":"Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the","content":"<p>Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the AMOM fund on June 2</p>\n<p>An exchange-traded fund driven by artificial intelligence booted Tesla and Amazon from its portfolio in June, instead choosing to load up on shares of companies including Qualcomm, Snap and GameStop.</p>\n<p>The Qraft AI-Enhanced U.S. Large Cap Momentum ETF, trading as AMOM <a href=\"https://laohu8.com/S/AMOM\">$(AMOM)$</a> on the New York Stock Exchange, removed major technology companies from its portfolio this month, as it shifted to favor retailers and other post-pandemic trades.</p>\n<p>Electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> represented two of the fund's three largest holdings in May, but were completely removed in the latest rebalancing on June 2, along with graphics microchip maker Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, which was its sixth-largest holding. The artificial-intelligence program controlling the fund believes these stocks will see price declines across the coming month.</p>\n<p>The standout among the stocks added in June was GameStop <a href=\"https://laohu8.com/S/GME\">$(GME)$</a>, the videogame retailer that epitomized the \"meme stock\" trading frenzy that began in late January.</p>\n<p>This was when a flock of investors, largely organized on social media platform Reddit, helped squeeze hedge funds' short positions on companies including GameStop, cinema chain AMC <a href=\"https://laohu8.com/S/AMC\">$(AMC)$</a>, and tech group BlackBerry (BB.T) earlier this year. The trading frenzy caused multibillion-dollar losses for hedge funds, unbelievable gains for individuals that timed it right, and ushered in a new era of internet-inspired trading.</p>\n<p>GameStop's stock price rose almost 10-fold from Jan. 15 to Jan. 27, from $35 per share to nearly $350. The stock is currently trading around $300 and makes up around 1% of AMOM. And now the AI calling the shots thinks it will move even higher in June, and the shares have already gained more than 6% since the stock was added to the fund for the first time.</p>\n<p>\"Few fund managers would take the risk of adding a meme stock to their portfolios, but Qraft's AI model has no such prejudices,\" said Geeseok Oh, a managing director at Qraft and the head of its Asia-Pacific business.</p>\n<p>The top five stocks by portfolio weight added to AMOM in June include semiconductor group Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>, Big Tobacco company Philip Morris <a href=\"https://laohu8.com/S/PM\">$(PM)$</a>, social-media player Snap <a href=\"https://laohu8.com/S/SNAP\">$(SNAP)$</a>, medical technology specialists Edwards Lifesciences <a href=\"https://laohu8.com/S/EW\">$(EW)$</a>, and orthodontics group Align Technology <a href=\"https://laohu8.com/S/ALGN\">$(ALGN)$</a>.</p>\n<p>After the fund was rebalanced, AMOM's top five largest holdings by portfolio weight were tech giant <a href=\"https://laohu8.com/S/FB\">Facebook</a> (FB), retailers Walmart <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a> and Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, software company Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, and semiconductor manufacturing company Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>.</p>\n<p>\"This month, AMOM's portfolio appears to be shifting towards post-pandemic trades, a bit more diversified of a portfolio from the previous month's big tech-heavy strategy,\" said Oh.</p>\n<p>AMOM's decision to remove Tesla from its portfolio came after a bullish bet failed to pay off. The fund bought around $1.4 million worth of shares in the electric-vehicle company in May after avoiding the stock for months, and shares in Tesla fell 7% before the AI ditched it from the fund. This mistake with Tesla was a rare occurrence for the robot controlling AMOM, which otherwise has a strong record of predicting moves in the company's share price .</p>\n<p>AMOM has been listed in New York since May 2019, and has delivered total returns of 11% so far in 2021 and 53% in the past year -- outpacing its benchmark, the S&amp;P 500 Momentum index , which has climbed a comparable 26% in the past year.</p>\n<p>AMOM is an actively managed portfolio driven by artificial intelligence, tracking 50 large-cap U.S. stocks and reweighting its holdings each month. It is based on a momentum strategy, with the AI behind its stock picks capitalizing on the movements of existing market trends to inform the decision to add, remove, or reweight holdings. The artificial intelligence scans the market and uses its predictive power to analyze a wide set of patterns that show stock-market momentum.</p>\n<p>The fund is a product of Qraft, a Seoul, South Korea-based fintech group leveraging AI across its investment products, which include three other AI-picked versions of major indexes: a U.S. large cap index <a href=\"https://laohu8.com/S/QRFT\">$(QRFT)$</a>; a U.S. large cap dividend index <a href=\"https://laohu8.com/S/HDIV.UK\">$(HDIV.UK)$</a>; and a U.S. value index <a href=\"https://laohu8.com/S/NVQ\">$(NVQ)$</a>.</p>\n<p>The entrance of AI-run funds onto Wall Street promised a new high-tech future for investing, though it hasn't quite lived up to the hype yet. Theoretically, researchers have shown that AI investing strategies can beat the market by up to 40% on an annualized basis , when tested against historical data.</p>\n<p>But Vasant Dhar, a professor at New York University's Stern School of Business and the founder of machine-learning-based hedge fund SCT Capital Management, argued on MarketWatch in June 2020 that AI-run funds won't \"crack\" the code of the stock market.</p>\n<p>Advocating caution, Dhar said that it was difficult for funds underpinned by machine learning to maintain a sustainable edge over markets, which have \"a nonstationary and adversarial nature.\" He advised investors considering an AI system to ask tough questions, including how likely it is that the AI's \"edge\" will persist into the future, and what the inherent uncertainties and range of performance outcomes for the fund are.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and Amazon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and Amazon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-10 09:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the AMOM fund on June 2</p>\n<p>An exchange-traded fund driven by artificial intelligence booted Tesla and Amazon from its portfolio in June, instead choosing to load up on shares of companies including Qualcomm, Snap and GameStop.</p>\n<p>The Qraft AI-Enhanced U.S. Large Cap Momentum ETF, trading as AMOM <a href=\"https://laohu8.com/S/AMOM\">$(AMOM)$</a> on the New York Stock Exchange, removed major technology companies from its portfolio this month, as it shifted to favor retailers and other post-pandemic trades.</p>\n<p>Electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> represented two of the fund's three largest holdings in May, but were completely removed in the latest rebalancing on June 2, along with graphics microchip maker Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, which was its sixth-largest holding. The artificial-intelligence program controlling the fund believes these stocks will see price declines across the coming month.</p>\n<p>The standout among the stocks added in June was GameStop <a href=\"https://laohu8.com/S/GME\">$(GME)$</a>, the videogame retailer that epitomized the \"meme stock\" trading frenzy that began in late January.</p>\n<p>This was when a flock of investors, largely organized on social media platform Reddit, helped squeeze hedge funds' short positions on companies including GameStop, cinema chain AMC <a href=\"https://laohu8.com/S/AMC\">$(AMC)$</a>, and tech group BlackBerry (BB.T) earlier this year. The trading frenzy caused multibillion-dollar losses for hedge funds, unbelievable gains for individuals that timed it right, and ushered in a new era of internet-inspired trading.</p>\n<p>GameStop's stock price rose almost 10-fold from Jan. 15 to Jan. 27, from $35 per share to nearly $350. The stock is currently trading around $300 and makes up around 1% of AMOM. And now the AI calling the shots thinks it will move even higher in June, and the shares have already gained more than 6% since the stock was added to the fund for the first time.</p>\n<p>\"Few fund managers would take the risk of adding a meme stock to their portfolios, but Qraft's AI model has no such prejudices,\" said Geeseok Oh, a managing director at Qraft and the head of its Asia-Pacific business.</p>\n<p>The top five stocks by portfolio weight added to AMOM in June include semiconductor group Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>, Big Tobacco company Philip Morris <a href=\"https://laohu8.com/S/PM\">$(PM)$</a>, social-media player Snap <a href=\"https://laohu8.com/S/SNAP\">$(SNAP)$</a>, medical technology specialists Edwards Lifesciences <a href=\"https://laohu8.com/S/EW\">$(EW)$</a>, and orthodontics group Align Technology <a href=\"https://laohu8.com/S/ALGN\">$(ALGN)$</a>.</p>\n<p>After the fund was rebalanced, AMOM's top five largest holdings by portfolio weight were tech giant <a href=\"https://laohu8.com/S/FB\">Facebook</a> (FB), retailers Walmart <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a> and Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, software company Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, and semiconductor manufacturing company Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>.</p>\n<p>\"This month, AMOM's portfolio appears to be shifting towards post-pandemic trades, a bit more diversified of a portfolio from the previous month's big tech-heavy strategy,\" said Oh.</p>\n<p>AMOM's decision to remove Tesla from its portfolio came after a bullish bet failed to pay off. The fund bought around $1.4 million worth of shares in the electric-vehicle company in May after avoiding the stock for months, and shares in Tesla fell 7% before the AI ditched it from the fund. This mistake with Tesla was a rare occurrence for the robot controlling AMOM, which otherwise has a strong record of predicting moves in the company's share price .</p>\n<p>AMOM has been listed in New York since May 2019, and has delivered total returns of 11% so far in 2021 and 53% in the past year -- outpacing its benchmark, the S&amp;P 500 Momentum index , which has climbed a comparable 26% in the past year.</p>\n<p>AMOM is an actively managed portfolio driven by artificial intelligence, tracking 50 large-cap U.S. stocks and reweighting its holdings each month. It is based on a momentum strategy, with the AI behind its stock picks capitalizing on the movements of existing market trends to inform the decision to add, remove, or reweight holdings. The artificial intelligence scans the market and uses its predictive power to analyze a wide set of patterns that show stock-market momentum.</p>\n<p>The fund is a product of Qraft, a Seoul, South Korea-based fintech group leveraging AI across its investment products, which include three other AI-picked versions of major indexes: a U.S. large cap index <a href=\"https://laohu8.com/S/QRFT\">$(QRFT)$</a>; a U.S. large cap dividend index <a href=\"https://laohu8.com/S/HDIV.UK\">$(HDIV.UK)$</a>; and a U.S. value index <a href=\"https://laohu8.com/S/NVQ\">$(NVQ)$</a>.</p>\n<p>The entrance of AI-run funds onto Wall Street promised a new high-tech future for investing, though it hasn't quite lived up to the hype yet. Theoretically, researchers have shown that AI investing strategies can beat the market by up to 40% on an annualized basis , when tested against historical data.</p>\n<p>But Vasant Dhar, a professor at New York University's Stern School of Business and the founder of machine-learning-based hedge fund SCT Capital Management, argued on MarketWatch in June 2020 that AI-run funds won't \"crack\" the code of the stock market.</p>\n<p>Advocating caution, Dhar said that it was difficult for funds underpinned by machine learning to maintain a sustainable edge over markets, which have \"a nonstationary and adversarial nature.\" He advised investors considering an AI system to ask tough questions, including how likely it is that the AI's \"edge\" will persist into the future, and what the inherent uncertainties and range of performance outcomes for the fund are.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMOM":"QRAFT AI-Enhanced U.S. Large Cap Momentum ETF","TXN":"德州仪器","EW":"爱德华兹","TSLA":"特斯拉","PM":"菲利普莫里斯","QCOM":"高通","QNETCN":"纳斯达克中美互联网老虎指数","NVDA":"英伟达","AMZN":"亚马逊","GME":"游戏驿站","ALGN":"艾利科技","WMT":"沃尔玛","09086":"华夏纳指-U","SNAP":"Snap Inc","HD":"家得宝","ADBE":"Adobe","03086":"华夏纳指"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142210925","content_text":"Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the AMOM fund on June 2\nAn exchange-traded fund driven by artificial intelligence booted Tesla and Amazon from its portfolio in June, instead choosing to load up on shares of companies including Qualcomm, Snap and GameStop.\nThe Qraft AI-Enhanced U.S. Large Cap Momentum ETF, trading as AMOM $(AMOM)$ on the New York Stock Exchange, removed major technology companies from its portfolio this month, as it shifted to favor retailers and other post-pandemic trades.\nElectric-car maker Tesla $(TSLA)$ and online retailer Amazon $(AMZN)$ represented two of the fund's three largest holdings in May, but were completely removed in the latest rebalancing on June 2, along with graphics microchip maker Nvidia $(NVDA)$, which was its sixth-largest holding. The artificial-intelligence program controlling the fund believes these stocks will see price declines across the coming month.\nThe standout among the stocks added in June was GameStop $(GME)$, the videogame retailer that epitomized the \"meme stock\" trading frenzy that began in late January.\nThis was when a flock of investors, largely organized on social media platform Reddit, helped squeeze hedge funds' short positions on companies including GameStop, cinema chain AMC $(AMC)$, and tech group BlackBerry (BB.T) earlier this year. The trading frenzy caused multibillion-dollar losses for hedge funds, unbelievable gains for individuals that timed it right, and ushered in a new era of internet-inspired trading.\nGameStop's stock price rose almost 10-fold from Jan. 15 to Jan. 27, from $35 per share to nearly $350. The stock is currently trading around $300 and makes up around 1% of AMOM. And now the AI calling the shots thinks it will move even higher in June, and the shares have already gained more than 6% since the stock was added to the fund for the first time.\n\"Few fund managers would take the risk of adding a meme stock to their portfolios, but Qraft's AI model has no such prejudices,\" said Geeseok Oh, a managing director at Qraft and the head of its Asia-Pacific business.\nThe top five stocks by portfolio weight added to AMOM in June include semiconductor group Qualcomm $(QCOM)$, Big Tobacco company Philip Morris $(PM)$, social-media player Snap $(SNAP)$, medical technology specialists Edwards Lifesciences $(EW)$, and orthodontics group Align Technology $(ALGN)$.\nAfter the fund was rebalanced, AMOM's top five largest holdings by portfolio weight were tech giant Facebook (FB), retailers Walmart $(WMT)$ and Home Depot $(HD)$, software company Adobe $(ADBE)$, and semiconductor manufacturing company Texas Instruments $(TXN)$.\n\"This month, AMOM's portfolio appears to be shifting towards post-pandemic trades, a bit more diversified of a portfolio from the previous month's big tech-heavy strategy,\" said Oh.\nAMOM's decision to remove Tesla from its portfolio came after a bullish bet failed to pay off. The fund bought around $1.4 million worth of shares in the electric-vehicle company in May after avoiding the stock for months, and shares in Tesla fell 7% before the AI ditched it from the fund. This mistake with Tesla was a rare occurrence for the robot controlling AMOM, which otherwise has a strong record of predicting moves in the company's share price .\nAMOM has been listed in New York since May 2019, and has delivered total returns of 11% so far in 2021 and 53% in the past year -- outpacing its benchmark, the S&P 500 Momentum index , which has climbed a comparable 26% in the past year.\nAMOM is an actively managed portfolio driven by artificial intelligence, tracking 50 large-cap U.S. stocks and reweighting its holdings each month. It is based on a momentum strategy, with the AI behind its stock picks capitalizing on the movements of existing market trends to inform the decision to add, remove, or reweight holdings. The artificial intelligence scans the market and uses its predictive power to analyze a wide set of patterns that show stock-market momentum.\nThe fund is a product of Qraft, a Seoul, South Korea-based fintech group leveraging AI across its investment products, which include three other AI-picked versions of major indexes: a U.S. large cap index $(QRFT)$; a U.S. large cap dividend index $(HDIV.UK)$; and a U.S. value index $(NVQ)$.\nThe entrance of AI-run funds onto Wall Street promised a new high-tech future for investing, though it hasn't quite lived up to the hype yet. Theoretically, researchers have shown that AI investing strategies can beat the market by up to 40% on an annualized basis , when tested against historical data.\nBut Vasant Dhar, a professor at New York University's Stern School of Business and the founder of machine-learning-based hedge fund SCT Capital Management, argued on MarketWatch in June 2020 that AI-run funds won't \"crack\" the code of the stock market.\nAdvocating caution, Dhar said that it was difficult for funds underpinned by machine learning to maintain a sustainable edge over markets, which have \"a nonstationary and adversarial nature.\" He advised investors considering an AI system to ask tough questions, including how likely it is that the AI's \"edge\" will persist into the future, and what the inherent uncertainties and range of performance outcomes for the fund are.","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189288278,"gmtCreate":1623276185694,"gmtModify":1631890212501,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"PLTR is complicated....to say the least.","listText":"PLTR is complicated....to say the least.","text":"PLTR is complicated....to say the least.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/189288278","repostId":"1154764167","repostType":4,"repost":{"id":"1154764167","pubTimestamp":1623253346,"share":"https://www.laohu8.com/m/news/1154764167?lang=&edition=full","pubTime":"2021-06-09 23:42","market":"us","language":"en","title":"Palantir Puzzle Pieces: SPACs, IBM And Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=1154764167","media":"seekingalpha","summary":"Summary\n\nI discuss Palantir's (PLTR) history of acquisitions from 2013 to 2016.\nThen I explain PLTR'","content":"<p><b>Summary</b></p>\n<ul>\n <li>I discuss Palantir's (PLTR) history of acquisitions from 2013 to 2016.</li>\n <li>Then I explain PLTR's six recent SPAC investments; insights provided.</li>\n <li>Lastly, I reveal ideas related to IBM but also healthcare opportunities.</li>\n</ul>\n<p><b>Quick Agenda</b></p>\n<p>First, I discuss Palantir's (PLTR) history of acquisitions from 2013 to 2016. It's about talent and brainpower. Second, I explain PLTR's six recent SPAC investments. I show that there's a shift in strategy and purpose. Third, I reveal ideas related to IBM (IBM) but also healthcare, which is rather exciting. I'm especially thrilled that all of these things relate to each other. It's like pieces of a puzzle are really starting to click into place; very satisfying.</p>\n<p><b>History</b></p>\n<p>It might surprise you to learn that PLTR has been actively buying companies for many years. Here's a quick look:</p>\n<ul>\n <li>Voicegem(Acquired: Feb 16, 2013) is a web and iOS based voice messaging platform.</li>\n <li>Poptip(Acquired: Jul 29, 2014) analyzes and synthesizes social conversations in real-time to enable brands to understand people's opinions.</li>\n <li>Propeller(Acquired: Jul 31, 2014) is a web platform for creating and updating applications using a drag-and-drop interface.</li>\n <li>FT Tech(Acquired: Feb 6th, 2015) provides retailers the ability to compete in today’s omnichannel world and make their brick-and-mortar operations more efficient.</li>\n <li>Kimono Labs(Acquired: Feb 15, 2016) is an online platform that allows its users to convert their websites into APIs.</li>\n <li>Silk(Acquired: Aug 10, 2016) is a cloud-based application that enables users to visualize their data online by the way of interactive web pages.</li>\n</ul>\n<p>What I find surprising is that there isn't really a single area of focus. This buying activity isn't all connected to data visualization, security, or some set of specific tools and technology. It feels all over the place. However, I did findthese clues:</p>\n<blockquote>\n Last year, Propeller raised $1.25 million in funding from Andreessen Horowitz, ffAngel, and, in the words of my boss Alexia Tsotsis, “everyone good basically.” One big connection with Palantir:Peter Thielis both a co-founder at Palantir and a partner at Founders Fund (ffAngel is the firm’s seed investment arm).\n</blockquote>\n<p>And then this from the same source:</p>\n<blockquote>\n We have great respect for the people and the work accomplished at Palantir, and getting to know them over the past few months made it clear just how well our teams are aligned. Having tackled many technical challenges facing mobile app creation, we’re eager to solve important problems at Palantir on a global scale.\n</blockquote>\n<p>So, at least for Propeller, the central idea was very much about people, both in terms of their social networks vis-à-vis Peter Thiel but also the brainpower.</p>\n<p>TheVoicegem acquisitionalso tells a similar story of grabbing talent:</p>\n<blockquote>\n The acqhire [sic] is another example of how top-tier accelerators are becoming talent feeders for big tech companies. The exhaustive process of building a startup gives young entrepreneurs valuable skills that are attractive even if their first companies don’t pan out. Eventually, you have to decide if you want to ride out your own focused business idea, or play a small part in something bigger. It seems Voicegem chose impact over control.\n</blockquote>\n<p>For even more clarity, when PLTR bought Voicegem they didn't keep the product, or even the data. It also stopped accepting new users and they shut down the service entirely.</p>\n<p>And, finally, because I want to beat a dead horse,it was the same for Silk.</p>\n<blockquote>\n The transaction appears to be an acqui-hire, with members of the Silk team directly joining Palantir in new roles.\n</blockquote>\n<p>Plus...</p>\n<blockquote>\n The Silk team noted that it was willing to transition to work on “even bigger and more important data problems,” signaling that the deal is likely not indicative of any new consumer pivot for Palantir.\n</blockquote>\n<p>Taking this all together, from 2013 to 2016, PLTR was hunting for talent. They were on the prowl for engineers, designers, developers and much more. It appears they found some of that talent inside small start-up companies, often with strong connections in the VC community and of course via Peter Thiel.</p>\n<p>I want to be very clear here before moving on. This is not a set of desperate actions. I feel that this acquisition activity was good because not only did PLTR get strong talent, but they also tapped into people with good energy and knowledge. I'm specifically talking about the experience that comes from being inside of a start-up company. That's the kind of entrepreneurial spirit that can drive and sustain culture.</p>\n<p><b>Pivot To SPACs</b></p>\n<p>It's likely that you're familiar with SPACS but if not here's aquick overview:</p>\n<blockquote>\n Otherwise known as a special purpose acquisition company or a blank check company, a SPAC is a publicly traded entity that exists solely to raise money and acquire an existing private company.\n</blockquote>\n<p>And, why does this matter?</p>\n<blockquote>\n A company might choose to go public through a SPAC versus an IPO because the process can be accomplished more quickly, with fewer associated costs and extensive financial disclosure requirements than an outright IPO.\n</blockquote>\n<p>In my opinion, these \"blank check\" companies give investors a fast and easy way to channel money into opportunities. With so much easy money sloshing around, it's pretty easy to see why SPACs have become so popular.</p>\n<p>In any event, PLTR has aggressively entered the space. They've now agreed to no less thansix SPAC deals in less than three months. Here's a usefuloverviewif you really want to dig deep. And, for faster reference:</p>\n<ul>\n <li>Sarcos (market: robotics)</li>\n <li>Lilium (market: high speed air transportation)</li>\n <li>Wejo (market: automotive sensors and data)</li>\n <li>Celularity (market: biotechnology)</li>\n <li>Roivant (market: healthcare and drug development)</li>\n <li>Babylon (market: healthcare)</li>\n</ul>\n<p>First, I have to admit that on the surface, I think this activity is weird. That's because PLTR just recently went public via a \"DPO\" (Direct Public Offering) afterwaiting about 17 years. Furthermore, they are ingrowth modeso it's strange they would be looking to invest into other companies at this point.</p>\n<p>That being said, there is definitely afinancial incentive here:</p>\n<blockquote>\n By participating in the PIPE, or private investment in public equity, Palantir is guaranteed ownership of a certain amount of stock once the transaction closes and the shares in the operating company start trading.\n</blockquote>\n<p>PIPEis simply an acronym. It means you've got private investment in public equity and the purpose is to allow the issuer of the stock to raise capital for the public company. The main point is that PLTR is getting real skin in the game and can be rewarded if the SPAC works out. In other words, there is an opportunity to place a bet and possibly win big. Not a bad thing, of course, but you have to admit it's odd given PTLR's situation.</p>\n<p>Then again, maybe this is a brilliant maneuver. Unlike its early acquisitions, via SPACs, PLTR is able totap into many large companies with great speed.</p>\n<blockquote>\n While many tech companies like Google, Salesforce and Intel have large venture groups that back start-ups at various stages, Palantir’s focus on SPACs is unique among strategic investors. It means Palantir is betting on more mature companies that are often already valued in the billions of dollars.\n</blockquote>\n<p>Big companies can use SPACs to tap into smaller companies. However, while PLTR is \"big\" it's certainly no Google (GOOG)(GOOGL), for example. Therefore, this is an opportunity to tap into bigger fish. Yet, that still doesn't fully explain what they are doing.</p>\n<p>I think what's happening is relatively simple. In effect, PLTR is strategically buying its way into large organizations. Similarly, they are getting cozy with these companies, their leadership and their customers. It's a classic \"foot in the door\" marketing technique, with the unique twist of a financial kicker. That is, if the SPAC is homerun, they also get that leverage.</p>\n<p>What's wonderful is that this isn't some theory that I concocted. We merely have tolisten to PLTRto hear the truth:</p>\n<blockquote>\n “We’re seeing an opportunity to back really good management teams with big visions,” said Kevin Kawasaki, Palantir’s head of business development. The company can partner and “allow them to have our data operating systems platform that we’ve put 15 years and billions of R&amp;D dollars into,” he said.\n</blockquote>\n<p><b>The \"IBM Echo\"</b></p>\n<p>This reminds me of what IBM did years ago with the Weather Channel. Sure, weather affects nearly everyone and everything,but consider this:</p>\n<blockquote>\n Now instead of having to lease the Weather Company’s data and related data sifting technology, IBM can simply own it and do what it wants. Presumably, that means IBM will sell companies access to the information as well as related weather forecasting services.\n</blockquote>\n<p>IBM wanted unlimited access to the data so they just bought what they needed. Imagine how they are able to feed their artificial intelligence systems, and what that means for real-world, real-time training.</p>\n<p>I'm confident PLTR is looking to gain similar access to data. Three SPACs are involved in healthcare and two SPACs are in automotive, so there's also a more narrow focus than their early days where they focused on engineering talent, and related brainpower. Now they're turning to systems integration, market intelligence (i.e., large, real-time data pools) and strategic marketing.</p>\n<p><b>Healthcare, Oh My!</b></p>\n<p>It's becoming clear to me that PLTR is landing troops on the healthcare beach for a full assault. In addition to Celularity, Roivant and Babylon SPACS, go ahead andfeast your eyes on this:</p>\n<blockquote>\n Palantir Technologies (NYSE:PLTR) announces hiring Dr William J. Kassler, MD, MPH, as the company's first U.S. Government Chief Medical Officer. Dr. Kassler, who joins Palantir from IBM Watson Health, will lead the Public Health and Life Sciences teams across the USG and international business.\n</blockquote>\n<p>I also want to reinforceyet another concept here. Weaving this all together is extremely important to understand the long-term PLTR bullish thesis:</p>\n<blockquote>\n IBM and Palantir Technologies today announced a new partnership consisting of IBM's hybrid cloud data platform designed to deliver AI for business, with Palantir's next generation operations platform for building applications. The product is expected to simplify how businesses build and deploy AI-infused applications with IBM Watson and help users access, analyze, and take action on the vast amounts of data that is scattered across hybrid cloud environments – without the need for deep technical skills. The new product, Palantir for IBM Cloud Pak for Data, is planned for general availability in March of 2021.\n</blockquote>\n<p>I didn't mention IBM and the Weather Channel earlier by accident. While I initially thought that PLTR was getting close to IBM for the sake of IBM's sales team, I've shifted my view. I'll come back to that in a moment, first justconsider the value to PLTR:</p>\n<blockquote>\n Reselling Palantir’s software to augment the data and AI tools that IBM already offers and make them easier for more people to use was “a natural” fit, said Rob Thomas, IBM’s senior vice president of software, cloud and data. “We’re going to sell it to 180 countries and thousands of customers.”\n</blockquote>\n<p>But, as I pointed out, I think this is merely one small part of the bigger picture. PLTR and IBM are far more than simple business partners, whereby PLTR gets greater reach. Strategically, PLTR is getting deep exposure to healthcare opportunities via relationships, sales teams, technical integration, data sets, and far more.</p>\n<p>In fact, I think the IBM partnership and the three healthcare SPACs all point to an incredible long-term opportunity in that market. Sure, Dr. Kassler is tied to government healthcare, and yes, PLTR is known more for government work. However, it's not the military or defense. Furthermore,this news just broke:</p>\n<blockquote>\n Palantir Technologies wasawardeda $7.4M one-year contract renewal with the U.S. Centers for Disease Control and Prevention(NASDAQ:CDC)to continue to provide an outbreak response and disease surveillance solution for the Data Collation and Integration for Public Health Event Response, or DCIPHER, Program.\n</blockquote>\n<p>PLTR is far deeper into healthcare than most investors realize and obviously the TAM (total addressable market) is absolutely monstrous. We have the IBM connection combined with Dr. Kessler. Now, we have the SPAC activity, plus the news about the new CDC contract. In other words, PLTR might become a true powerhouse in healthcare in the coming years. The opportunities are legion and it makes my head spin.</p>\n<p><b>Wrap Up and Insights</b></p>\n<p>PLTR's early acquisitions were all about talent and brainpower. Nothing mysterious or deep. That is, the products didn't matter, the markets didn't matter and the technology didn't even matter much at all.</p>\n<p>Then, nothing much happened between 2017 and 2020. I suspect that PLTR was setting up for their public launch. Instead of bringing on more talent, they probably decided to buckle down and get all their systems tidied up, fully integrated, and more. Their house was messy and they cleaned up.</p>\n<p>Recently, they've gone a bit crazy buying into SPACs. As I've outlined, this activity is really about buying into leadership, new customers, and new data. These SPACs could certainly provide financial rewards in the short term, but I think strategically PLTR is getting set up for long-term benefits, even customers that can feed them money, opportunities and even more data. Tactically, I applaud this seemingly odd activity and strategically I'm willing to give PLTR the benefit of the doubt. It's not random in my view.</p>\n<p>And lastly, my eyes have been more widely opened up to PLTR's deep and nuanced connections with IBM. More importantly, I'm now seeing much larger opportunities for PLTR in healthcare based on their SPAC activity, IBM connections and of course the recent contract news regarding the CDC. Of course, it probably goes without saying that I remain bullish on PLTR.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Puzzle Pieces: SPACs, IBM And Healthcare</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Puzzle Pieces: SPACs, IBM And Healthcare\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-09 23:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4433828-palantir-puzzle-pieces-spacs-ibm-and-healthcare><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nI discuss Palantir's (PLTR) history of acquisitions from 2013 to 2016.\nThen I explain PLTR's six recent SPAC investments; insights provided.\nLastly, I reveal ideas related to IBM but also ...</p>\n\n<a href=\"https://seekingalpha.com/article/4433828-palantir-puzzle-pieces-spacs-ibm-and-healthcare\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4433828-palantir-puzzle-pieces-spacs-ibm-and-healthcare","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1154764167","content_text":"Summary\n\nI discuss Palantir's (PLTR) history of acquisitions from 2013 to 2016.\nThen I explain PLTR's six recent SPAC investments; insights provided.\nLastly, I reveal ideas related to IBM but also healthcare opportunities.\n\nQuick Agenda\nFirst, I discuss Palantir's (PLTR) history of acquisitions from 2013 to 2016. It's about talent and brainpower. Second, I explain PLTR's six recent SPAC investments. I show that there's a shift in strategy and purpose. Third, I reveal ideas related to IBM (IBM) but also healthcare, which is rather exciting. I'm especially thrilled that all of these things relate to each other. It's like pieces of a puzzle are really starting to click into place; very satisfying.\nHistory\nIt might surprise you to learn that PLTR has been actively buying companies for many years. Here's a quick look:\n\nVoicegem(Acquired: Feb 16, 2013) is a web and iOS based voice messaging platform.\nPoptip(Acquired: Jul 29, 2014) analyzes and synthesizes social conversations in real-time to enable brands to understand people's opinions.\nPropeller(Acquired: Jul 31, 2014) is a web platform for creating and updating applications using a drag-and-drop interface.\nFT Tech(Acquired: Feb 6th, 2015) provides retailers the ability to compete in today’s omnichannel world and make their brick-and-mortar operations more efficient.\nKimono Labs(Acquired: Feb 15, 2016) is an online platform that allows its users to convert their websites into APIs.\nSilk(Acquired: Aug 10, 2016) is a cloud-based application that enables users to visualize their data online by the way of interactive web pages.\n\nWhat I find surprising is that there isn't really a single area of focus. This buying activity isn't all connected to data visualization, security, or some set of specific tools and technology. It feels all over the place. However, I did findthese clues:\n\n Last year, Propeller raised $1.25 million in funding from Andreessen Horowitz, ffAngel, and, in the words of my boss Alexia Tsotsis, “everyone good basically.” One big connection with Palantir:Peter Thielis both a co-founder at Palantir and a partner at Founders Fund (ffAngel is the firm’s seed investment arm).\n\nAnd then this from the same source:\n\n We have great respect for the people and the work accomplished at Palantir, and getting to know them over the past few months made it clear just how well our teams are aligned. Having tackled many technical challenges facing mobile app creation, we’re eager to solve important problems at Palantir on a global scale.\n\nSo, at least for Propeller, the central idea was very much about people, both in terms of their social networks vis-à-vis Peter Thiel but also the brainpower.\nTheVoicegem acquisitionalso tells a similar story of grabbing talent:\n\n The acqhire [sic] is another example of how top-tier accelerators are becoming talent feeders for big tech companies. The exhaustive process of building a startup gives young entrepreneurs valuable skills that are attractive even if their first companies don’t pan out. Eventually, you have to decide if you want to ride out your own focused business idea, or play a small part in something bigger. It seems Voicegem chose impact over control.\n\nFor even more clarity, when PLTR bought Voicegem they didn't keep the product, or even the data. It also stopped accepting new users and they shut down the service entirely.\nAnd, finally, because I want to beat a dead horse,it was the same for Silk.\n\n The transaction appears to be an acqui-hire, with members of the Silk team directly joining Palantir in new roles.\n\nPlus...\n\n The Silk team noted that it was willing to transition to work on “even bigger and more important data problems,” signaling that the deal is likely not indicative of any new consumer pivot for Palantir.\n\nTaking this all together, from 2013 to 2016, PLTR was hunting for talent. They were on the prowl for engineers, designers, developers and much more. It appears they found some of that talent inside small start-up companies, often with strong connections in the VC community and of course via Peter Thiel.\nI want to be very clear here before moving on. This is not a set of desperate actions. I feel that this acquisition activity was good because not only did PLTR get strong talent, but they also tapped into people with good energy and knowledge. I'm specifically talking about the experience that comes from being inside of a start-up company. That's the kind of entrepreneurial spirit that can drive and sustain culture.\nPivot To SPACs\nIt's likely that you're familiar with SPACS but if not here's aquick overview:\n\n Otherwise known as a special purpose acquisition company or a blank check company, a SPAC is a publicly traded entity that exists solely to raise money and acquire an existing private company.\n\nAnd, why does this matter?\n\n A company might choose to go public through a SPAC versus an IPO because the process can be accomplished more quickly, with fewer associated costs and extensive financial disclosure requirements than an outright IPO.\n\nIn my opinion, these \"blank check\" companies give investors a fast and easy way to channel money into opportunities. With so much easy money sloshing around, it's pretty easy to see why SPACs have become so popular.\nIn any event, PLTR has aggressively entered the space. They've now agreed to no less thansix SPAC deals in less than three months. Here's a usefuloverviewif you really want to dig deep. And, for faster reference:\n\nSarcos (market: robotics)\nLilium (market: high speed air transportation)\nWejo (market: automotive sensors and data)\nCelularity (market: biotechnology)\nRoivant (market: healthcare and drug development)\nBabylon (market: healthcare)\n\nFirst, I have to admit that on the surface, I think this activity is weird. That's because PLTR just recently went public via a \"DPO\" (Direct Public Offering) afterwaiting about 17 years. Furthermore, they are ingrowth modeso it's strange they would be looking to invest into other companies at this point.\nThat being said, there is definitely afinancial incentive here:\n\n By participating in the PIPE, or private investment in public equity, Palantir is guaranteed ownership of a certain amount of stock once the transaction closes and the shares in the operating company start trading.\n\nPIPEis simply an acronym. It means you've got private investment in public equity and the purpose is to allow the issuer of the stock to raise capital for the public company. The main point is that PLTR is getting real skin in the game and can be rewarded if the SPAC works out. In other words, there is an opportunity to place a bet and possibly win big. Not a bad thing, of course, but you have to admit it's odd given PTLR's situation.\nThen again, maybe this is a brilliant maneuver. Unlike its early acquisitions, via SPACs, PLTR is able totap into many large companies with great speed.\n\n While many tech companies like Google, Salesforce and Intel have large venture groups that back start-ups at various stages, Palantir’s focus on SPACs is unique among strategic investors. It means Palantir is betting on more mature companies that are often already valued in the billions of dollars.\n\nBig companies can use SPACs to tap into smaller companies. However, while PLTR is \"big\" it's certainly no Google (GOOG)(GOOGL), for example. Therefore, this is an opportunity to tap into bigger fish. Yet, that still doesn't fully explain what they are doing.\nI think what's happening is relatively simple. In effect, PLTR is strategically buying its way into large organizations. Similarly, they are getting cozy with these companies, their leadership and their customers. It's a classic \"foot in the door\" marketing technique, with the unique twist of a financial kicker. That is, if the SPAC is homerun, they also get that leverage.\nWhat's wonderful is that this isn't some theory that I concocted. We merely have tolisten to PLTRto hear the truth:\n\n “We’re seeing an opportunity to back really good management teams with big visions,” said Kevin Kawasaki, Palantir’s head of business development. The company can partner and “allow them to have our data operating systems platform that we’ve put 15 years and billions of R&D dollars into,” he said.\n\nThe \"IBM Echo\"\nThis reminds me of what IBM did years ago with the Weather Channel. Sure, weather affects nearly everyone and everything,but consider this:\n\n Now instead of having to lease the Weather Company’s data and related data sifting technology, IBM can simply own it and do what it wants. Presumably, that means IBM will sell companies access to the information as well as related weather forecasting services.\n\nIBM wanted unlimited access to the data so they just bought what they needed. Imagine how they are able to feed their artificial intelligence systems, and what that means for real-world, real-time training.\nI'm confident PLTR is looking to gain similar access to data. Three SPACs are involved in healthcare and two SPACs are in automotive, so there's also a more narrow focus than their early days where they focused on engineering talent, and related brainpower. Now they're turning to systems integration, market intelligence (i.e., large, real-time data pools) and strategic marketing.\nHealthcare, Oh My!\nIt's becoming clear to me that PLTR is landing troops on the healthcare beach for a full assault. In addition to Celularity, Roivant and Babylon SPACS, go ahead andfeast your eyes on this:\n\n Palantir Technologies (NYSE:PLTR) announces hiring Dr William J. Kassler, MD, MPH, as the company's first U.S. Government Chief Medical Officer. Dr. Kassler, who joins Palantir from IBM Watson Health, will lead the Public Health and Life Sciences teams across the USG and international business.\n\nI also want to reinforceyet another concept here. Weaving this all together is extremely important to understand the long-term PLTR bullish thesis:\n\n IBM and Palantir Technologies today announced a new partnership consisting of IBM's hybrid cloud data platform designed to deliver AI for business, with Palantir's next generation operations platform for building applications. The product is expected to simplify how businesses build and deploy AI-infused applications with IBM Watson and help users access, analyze, and take action on the vast amounts of data that is scattered across hybrid cloud environments – without the need for deep technical skills. The new product, Palantir for IBM Cloud Pak for Data, is planned for general availability in March of 2021.\n\nI didn't mention IBM and the Weather Channel earlier by accident. While I initially thought that PLTR was getting close to IBM for the sake of IBM's sales team, I've shifted my view. I'll come back to that in a moment, first justconsider the value to PLTR:\n\n Reselling Palantir’s software to augment the data and AI tools that IBM already offers and make them easier for more people to use was “a natural” fit, said Rob Thomas, IBM’s senior vice president of software, cloud and data. “We’re going to sell it to 180 countries and thousands of customers.”\n\nBut, as I pointed out, I think this is merely one small part of the bigger picture. PLTR and IBM are far more than simple business partners, whereby PLTR gets greater reach. Strategically, PLTR is getting deep exposure to healthcare opportunities via relationships, sales teams, technical integration, data sets, and far more.\nIn fact, I think the IBM partnership and the three healthcare SPACs all point to an incredible long-term opportunity in that market. Sure, Dr. Kassler is tied to government healthcare, and yes, PLTR is known more for government work. However, it's not the military or defense. Furthermore,this news just broke:\n\n Palantir Technologies wasawardeda $7.4M one-year contract renewal with the U.S. Centers for Disease Control and Prevention(NASDAQ:CDC)to continue to provide an outbreak response and disease surveillance solution for the Data Collation and Integration for Public Health Event Response, or DCIPHER, Program.\n\nPLTR is far deeper into healthcare than most investors realize and obviously the TAM (total addressable market) is absolutely monstrous. We have the IBM connection combined with Dr. Kessler. Now, we have the SPAC activity, plus the news about the new CDC contract. In other words, PLTR might become a true powerhouse in healthcare in the coming years. The opportunities are legion and it makes my head spin.\nWrap Up and Insights\nPLTR's early acquisitions were all about talent and brainpower. Nothing mysterious or deep. That is, the products didn't matter, the markets didn't matter and the technology didn't even matter much at all.\nThen, nothing much happened between 2017 and 2020. I suspect that PLTR was setting up for their public launch. Instead of bringing on more talent, they probably decided to buckle down and get all their systems tidied up, fully integrated, and more. Their house was messy and they cleaned up.\nRecently, they've gone a bit crazy buying into SPACs. As I've outlined, this activity is really about buying into leadership, new customers, and new data. These SPACs could certainly provide financial rewards in the short term, but I think strategically PLTR is getting set up for long-term benefits, even customers that can feed them money, opportunities and even more data. Tactically, I applaud this seemingly odd activity and strategically I'm willing to give PLTR the benefit of the doubt. It's not random in my view.\nAnd lastly, my eyes have been more widely opened up to PLTR's deep and nuanced connections with IBM. More importantly, I'm now seeing much larger opportunities for PLTR in healthcare based on their SPAC activity, IBM connections and of course the recent contract news regarding the CDC. Of course, it probably goes without saying that I remain bullish on PLTR.","news_type":1},"isVote":1,"tweetType":1,"viewCount":69,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189280302,"gmtCreate":1623275624206,"gmtModify":1631890212514,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Will pay close attention to them....","listText":"Will pay close attention to them....","text":"Will pay close attention to them....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/189280302","repostId":"1141925795","repostType":4,"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117098146,"gmtCreate":1623109160485,"gmtModify":1631890212525,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Wow....this is significant","listText":"Wow....this is significant","text":"Wow....this is significant","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/117098146","repostId":"2141453253","repostType":4,"repost":{"id":"2141453253","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623096780,"share":"https://www.laohu8.com/m/news/2141453253?lang=&edition=full","pubTime":"2021-06-08 04:13","market":"us","language":"en","title":"Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK","url":"https://stock-news.laohu8.com/highlight/detail?id=2141453253","media":"Dow Jones","summary":"Shares rally to second -biggest one-day percentage gain since they went public 30 years agoShares of","content":"<p>Shares rally to second -biggest <a href=\"https://laohu8.com/S/AONE\">one</a>-day percentage gain since they went public 30 years ago</p><p>Shares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.</p><p>The stock <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> blasted $109.71, or 38.3% higher, to $395.85, the highest close since April 2015. The stock had been halted twice for volatility  during Monday's session, once at 10:44 a.m. Eastern and a second time at 1:37 p.m.</p><p>Trading volume spiked up to 17.7 million shares, compared with the full-day average over the past 30 days of about 1.0 million shares, according to FactSet.</p><p>Earlier Friday, the FDA approved Biogen's Aduhelm , also known as aducanumab, to treat Alzheimer's, the first drug to be approved that promises to actually slow the disease rather than just treat the symptoms.</p><p>Biogen investors were treated to the stock's biggest-ever <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day price gain, and second-biggest one-day percentage gain since it went public in September 1991. The stock had shot up $108.62, or 44.0%, on Nov. 4, 2020, after the FDA said there was \"substantial evidence\"</p><p>\"Currently available options only treat symptoms of the disease; this treatment option is the first therapy to target and affect the underlying disease process of Alzheimer's,\" said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research. \"As we have learned from the fight against cancer, the accelerated approval pathway can bring therapies to patients faster while spurring more research an innovation.\"</p><p>As the FDA described, accelerated approval can be based on the drug's effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients, with \"a required post-approval trial\" to verify the drug provides that expected clinical benefit.</p><p>Bernstein analyst Aaron Gal said approval under accelerated pathway is a distinction without a difference. \"The pathway allows for approval based on surrogate market, rather than completed efficacy endpoint data,\" Gal wrote in a note to clients. \"As long as Biogen does not challenge the use of the path, which they obviously would not, the approval holds.\"</p><p>Evercore ISI's Umer Raffat noted that the option of Accelerated Approval was not discussed by the FDA's advisory committee. And as the drug has \"clearly shown\" in all trials to substantially reduce amyloid beta plaques, the \"reduction in plaques is reasonably likely to result in clinical benefit.\"</p><p>Regarding labeling, Bernstein's Gal said it is \"almost shockingly broad,\" as the label just said Aduhelm is indicated for the treatment of Alzheimer's disease.</p><p>\"Thus, the approved population is broader than the tested population (mild-moderate Alzheimer's patients),\" Gal wrote. \"There is also no restriction on treatment duration suggesting that patients can stay on treatment until either all plaque is removed or the patient progresses.\"</p><p>Evercore's Raffat concurred, saying the label reads very very broad. He indicated that investors could be relieved, as there was some concern that the target population might be limited, and/or require very frequent monitoring.</p><p>Although pricing is still unknown, the Institute of Clinical and Economic Review (ICER) said that due to the relatively small overall health gains demonstrated in Phase 3 clinical trials, the drug should be price no higher than $8,400 a year, as MarketWatch's Jaimy Lee reported .</p><p>Some analysts say Biogen could price the drug higher than that, even though that might potentially trigger a regulatory response.</p><p>Evercore's Raffat said his financial estimates on Biogen include an estimate of $10,000, while Bernstein's Gal said the pricing could end up \"much higher,\" possibly as high as more than $30,000.</p><p>Gal said Biogen has a long history of pricing drugs in the \"specialty\" range, and is less likely to fear a backlash. \"Biogen would justify the price by arguing the total system impact would be modest upfront and that it will use the money to provide substantial services to [Alzheimer's disease] patients,\" Gal wrote.</p><p>Biogen and Eisai Inc., the U.S. subsidiary of Japan-based Eisai Co. Ltd. (4523.TO), announced after Aduhelm's approval programs intended to support access for all qualified patients, including those from traditionally underserved populations.</p><p>Eisai's U.S.-listed shares skyrocketed 68.9% in afternoon trading, on track for a record close and the biggest one-day gain since it started trading in the U.S. in December 1995.</p><p>\"We are committed to access and health equity as top priorities and will continue working with multiple stakeholders with the goal of helping patients who may benefit from treatment obtain care as quickly as possible,\" said Alisha Alaimo, president of Biogen U.S.</p><p>Biogen's stock has now run up 61.7% year to date, while SPDR Health Care Select Sector exchange-traded fund <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has gained 8.0% and the S&amp;P 500 index  has advanced 12.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-08 04:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares rally to second -biggest <a href=\"https://laohu8.com/S/AONE\">one</a>-day percentage gain since they went public 30 years ago</p><p>Shares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.</p><p>The stock <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> blasted $109.71, or 38.3% higher, to $395.85, the highest close since April 2015. The stock had been halted twice for volatility  during Monday's session, once at 10:44 a.m. Eastern and a second time at 1:37 p.m.</p><p>Trading volume spiked up to 17.7 million shares, compared with the full-day average over the past 30 days of about 1.0 million shares, according to FactSet.</p><p>Earlier Friday, the FDA approved Biogen's Aduhelm , also known as aducanumab, to treat Alzheimer's, the first drug to be approved that promises to actually slow the disease rather than just treat the symptoms.</p><p>Biogen investors were treated to the stock's biggest-ever <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day price gain, and second-biggest one-day percentage gain since it went public in September 1991. The stock had shot up $108.62, or 44.0%, on Nov. 4, 2020, after the FDA said there was \"substantial evidence\"</p><p>\"Currently available options only treat symptoms of the disease; this treatment option is the first therapy to target and affect the underlying disease process of Alzheimer's,\" said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research. \"As we have learned from the fight against cancer, the accelerated approval pathway can bring therapies to patients faster while spurring more research an innovation.\"</p><p>As the FDA described, accelerated approval can be based on the drug's effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients, with \"a required post-approval trial\" to verify the drug provides that expected clinical benefit.</p><p>Bernstein analyst Aaron Gal said approval under accelerated pathway is a distinction without a difference. \"The pathway allows for approval based on surrogate market, rather than completed efficacy endpoint data,\" Gal wrote in a note to clients. \"As long as Biogen does not challenge the use of the path, which they obviously would not, the approval holds.\"</p><p>Evercore ISI's Umer Raffat noted that the option of Accelerated Approval was not discussed by the FDA's advisory committee. And as the drug has \"clearly shown\" in all trials to substantially reduce amyloid beta plaques, the \"reduction in plaques is reasonably likely to result in clinical benefit.\"</p><p>Regarding labeling, Bernstein's Gal said it is \"almost shockingly broad,\" as the label just said Aduhelm is indicated for the treatment of Alzheimer's disease.</p><p>\"Thus, the approved population is broader than the tested population (mild-moderate Alzheimer's patients),\" Gal wrote. \"There is also no restriction on treatment duration suggesting that patients can stay on treatment until either all plaque is removed or the patient progresses.\"</p><p>Evercore's Raffat concurred, saying the label reads very very broad. He indicated that investors could be relieved, as there was some concern that the target population might be limited, and/or require very frequent monitoring.</p><p>Although pricing is still unknown, the Institute of Clinical and Economic Review (ICER) said that due to the relatively small overall health gains demonstrated in Phase 3 clinical trials, the drug should be price no higher than $8,400 a year, as MarketWatch's Jaimy Lee reported .</p><p>Some analysts say Biogen could price the drug higher than that, even though that might potentially trigger a regulatory response.</p><p>Evercore's Raffat said his financial estimates on Biogen include an estimate of $10,000, while Bernstein's Gal said the pricing could end up \"much higher,\" possibly as high as more than $30,000.</p><p>Gal said Biogen has a long history of pricing drugs in the \"specialty\" range, and is less likely to fear a backlash. \"Biogen would justify the price by arguing the total system impact would be modest upfront and that it will use the money to provide substantial services to [Alzheimer's disease] patients,\" Gal wrote.</p><p>Biogen and Eisai Inc., the U.S. subsidiary of Japan-based Eisai Co. Ltd. (4523.TO), announced after Aduhelm's approval programs intended to support access for all qualified patients, including those from traditionally underserved populations.</p><p>Eisai's U.S.-listed shares skyrocketed 68.9% in afternoon trading, on track for a record close and the biggest one-day gain since it started trading in the U.S. in December 1995.</p><p>\"We are committed to access and health equity as top priorities and will continue working with multiple stakeholders with the goal of helping patients who may benefit from treatment obtain care as quickly as possible,\" said Alisha Alaimo, president of Biogen U.S.</p><p>Biogen's stock has now run up 61.7% year to date, while SPDR Health Care Select Sector exchange-traded fund <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has gained 8.0% and the S&amp;P 500 index  has advanced 12.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141453253","content_text":"Shares rally to second -biggest one-day percentage gain since they went public 30 years agoShares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.The stock $(BIIB)$ blasted $109.71, or 38.3% higher, to $395.85, the highest close since April 2015. The stock had been halted twice for volatility  during Monday's session, once at 10:44 a.m. Eastern and a second time at 1:37 p.m.Trading volume spiked up to 17.7 million shares, compared with the full-day average over the past 30 days of about 1.0 million shares, according to FactSet.Earlier Friday, the FDA approved Biogen's Aduhelm , also known as aducanumab, to treat Alzheimer's, the first drug to be approved that promises to actually slow the disease rather than just treat the symptoms.Biogen investors were treated to the stock's biggest-ever one-day price gain, and second-biggest one-day percentage gain since it went public in September 1991. The stock had shot up $108.62, or 44.0%, on Nov. 4, 2020, after the FDA said there was \"substantial evidence\"\"Currently available options only treat symptoms of the disease; this treatment option is the first therapy to target and affect the underlying disease process of Alzheimer's,\" said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research. \"As we have learned from the fight against cancer, the accelerated approval pathway can bring therapies to patients faster while spurring more research an innovation.\"As the FDA described, accelerated approval can be based on the drug's effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients, with \"a required post-approval trial\" to verify the drug provides that expected clinical benefit.Bernstein analyst Aaron Gal said approval under accelerated pathway is a distinction without a difference. \"The pathway allows for approval based on surrogate market, rather than completed efficacy endpoint data,\" Gal wrote in a note to clients. \"As long as Biogen does not challenge the use of the path, which they obviously would not, the approval holds.\"Evercore ISI's Umer Raffat noted that the option of Accelerated Approval was not discussed by the FDA's advisory committee. And as the drug has \"clearly shown\" in all trials to substantially reduce amyloid beta plaques, the \"reduction in plaques is reasonably likely to result in clinical benefit.\"Regarding labeling, Bernstein's Gal said it is \"almost shockingly broad,\" as the label just said Aduhelm is indicated for the treatment of Alzheimer's disease.\"Thus, the approved population is broader than the tested population (mild-moderate Alzheimer's patients),\" Gal wrote. \"There is also no restriction on treatment duration suggesting that patients can stay on treatment until either all plaque is removed or the patient progresses.\"Evercore's Raffat concurred, saying the label reads very very broad. He indicated that investors could be relieved, as there was some concern that the target population might be limited, and/or require very frequent monitoring.Although pricing is still unknown, the Institute of Clinical and Economic Review (ICER) said that due to the relatively small overall health gains demonstrated in Phase 3 clinical trials, the drug should be price no higher than $8,400 a year, as MarketWatch's Jaimy Lee reported .Some analysts say Biogen could price the drug higher than that, even though that might potentially trigger a regulatory response.Evercore's Raffat said his financial estimates on Biogen include an estimate of $10,000, while Bernstein's Gal said the pricing could end up \"much higher,\" possibly as high as more than $30,000.Gal said Biogen has a long history of pricing drugs in the \"specialty\" range, and is less likely to fear a backlash. \"Biogen would justify the price by arguing the total system impact would be modest upfront and that it will use the money to provide substantial services to [Alzheimer's disease] patients,\" Gal wrote.Biogen and Eisai Inc., the U.S. subsidiary of Japan-based Eisai Co. Ltd. (4523.TO), announced after Aduhelm's approval programs intended to support access for all qualified patients, including those from traditionally underserved populations.Eisai's U.S.-listed shares skyrocketed 68.9% in afternoon trading, on track for a record close and the biggest one-day gain since it started trading in the U.S. in December 1995.\"We are committed to access and health equity as top priorities and will continue working with multiple stakeholders with the goal of helping patients who may benefit from treatment obtain care as quickly as possible,\" said Alisha Alaimo, president of Biogen U.S.Biogen's stock has now run up 61.7% year to date, while SPDR Health Care Select Sector exchange-traded fund $(XLV)$ has gained 8.0% and the S&P 500 index  has advanced 12.5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":116195083,"gmtCreate":1622779060142,"gmtModify":1631887021800,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NOK\">$Nokia Oyj(NOK)$</a>guys...dont treat nokia as a typical me me stock. It has strong fundamentals and has huge potential for long term growth.&nbsp;","listText":"<a href=\"https://laohu8.com/S/NOK\">$Nokia Oyj(NOK)$</a>guys...dont treat nokia as a typical me me stock. It has strong fundamentals and has huge potential for long term growth.&nbsp;","text":"$Nokia Oyj(NOK)$guys...dont treat nokia as a typical me me stock. It has strong fundamentals and has huge potential for long term growth.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/116195083","isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":116195083,"gmtCreate":1622779060142,"gmtModify":1631887021800,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NOK\">$Nokia Oyj(NOK)$</a>guys...dont treat nokia as a typical me me stock. It has strong fundamentals and has huge potential for long term growth.&nbsp;","listText":"<a href=\"https://laohu8.com/S/NOK\">$Nokia Oyj(NOK)$</a>guys...dont treat nokia as a typical me me stock. It has strong fundamentals and has huge potential for long term growth.&nbsp;","text":"$Nokia Oyj(NOK)$guys...dont treat nokia as a typical me me stock. It has strong fundamentals and has huge potential for long term growth.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/116195083","isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183256525,"gmtCreate":1623333701367,"gmtModify":1631890212488,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"The confidence of the market is unshakable...at this point.","listText":"The confidence of the market is unshakable...at this point.","text":"The confidence of the market is unshakable...at this point.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/183256525","repostId":"1180064020","repostType":4,"repost":{"id":"1180064020","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623331902,"share":"https://www.laohu8.com/m/news/1180064020?lang=&edition=full","pubTime":"2021-06-10 21:31","market":"us","language":"en","title":"U.S. stocks gained in Thursday open. Chinese Education Stocks soared","url":"https://stock-news.laohu8.com/highlight/detail?id=1180064020","media":"Tiger Newspress","summary":"(June 10) U.S. stocks gained in Thursday open. Chinese Education Stocks soared.\nAirline stocks rally","content":"<p>(June 10)&nbsp;U.S. stocks gained in Thursday open.&nbsp;Chinese Education Stocks soared.</p>\n<p><img src=\"https://static.tigerbbs.com/3319d3b4d9de022c9ba1cf2e2452ee50\" tg-width=\"307\" tg-height=\"241\" referrerpolicy=\"no-referrer\">Airline stocks rally.</p>\n<p><img src=\"https://static.tigerbbs.com/918397d0861786d9643834f404915b8f\" tg-width=\"303\" tg-height=\"364\" referrerpolicy=\"no-referrer\"></p>\n<p>Video-game retailer and meme stock GameStop fell over 6%&nbsp;in morning trading even after the company tapped formerAmazon executive Matt Furlong to be its next CEOand said that sales rose 25% last quarter. The company also said it may sell up to 5 million additional shares.</p>\n<p><img src=\"https://static.tigerbbs.com/5437e23fe0b63fa6886cf840ceac1e81\" tg-width=\"700\" tg-height=\"584\" referrerpolicy=\"no-referrer\">U.S. stocks climbed on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.</p>\n<p>The Dow Jones Industrial Average rose 200 points, while theS&amp;P 500edged 0.4% higher. The Nasdaq Composite traded 0.2% higher even with bond yields rising.</p>\n<p>Consumer prices for May accelerated at their fastest pace since the summer of 2008 amid the economic recovery from the pandemic-triggered recession,the Labor Department reported Thursday.</p>\n<p>The consumer price index, which represents a basket including food, energy, groceries across a spectrum of goods, rose 5% from a year ago. Economists surveyed by Dow Jones had been expecting a gain of 4.7%.</p>\n<p>Fears of spiking inflation have weighed on the stock market in the last month, with investors worried the jump in prices will raise costs for companies, spark a move higher in interest rates and cause the Federal Reserve to remove its easy money policies.</p>\n<p>“This CPI isn’t likely to change the narrative dramatically and there are still indications that inflation momentum is set to abate in the coming months,” Adam Crisafulli, founder of Vital Knowledge, said in a note Thursday.</p>\n<p>Many economists also said the surge in used car costs for the month could have skewed the inflation reading. Used car and truck prices jumped more than 7%, accounting for one-third of the total increase for the month, according to the BLS. The jump in used car prices likely reflects a temporary phenomenon related to the pandemic and auto supply.</p>\n<p>UPS shares rose about 1% in premarket trading afteran upgrade from JPMorgan. Shares of Boeing and Delta Air Lines were also higher in premarket trading.</p>\n<p>U.S. markets continued to trade within a tight range on Wednesday, with all three major indexes ending the day within 0.5% of Tuesday’s closing levels. The Dow, S&amp;P 500 and Nasdaq Composite all fell during regular trading, ending the session further away from their respective all-time highs.</p>\n<p>The S&amp;P 500 remains closest to its benchmark and is just 0.44% away from a new all-time high. The Dow and Nasdaq are roughly 2% away from records.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title> U.S. stocks gained in Thursday open. Chinese Education Stocks soared</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n U.S. stocks gained in Thursday open. Chinese Education Stocks soared\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-10 21:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 10)&nbsp;U.S. stocks gained in Thursday open.&nbsp;Chinese Education Stocks soared.</p>\n<p><img src=\"https://static.tigerbbs.com/3319d3b4d9de022c9ba1cf2e2452ee50\" tg-width=\"307\" tg-height=\"241\" referrerpolicy=\"no-referrer\">Airline stocks rally.</p>\n<p><img src=\"https://static.tigerbbs.com/918397d0861786d9643834f404915b8f\" tg-width=\"303\" tg-height=\"364\" referrerpolicy=\"no-referrer\"></p>\n<p>Video-game retailer and meme stock GameStop fell over 6%&nbsp;in morning trading even after the company tapped formerAmazon executive Matt Furlong to be its next CEOand said that sales rose 25% last quarter. The company also said it may sell up to 5 million additional shares.</p>\n<p><img src=\"https://static.tigerbbs.com/5437e23fe0b63fa6886cf840ceac1e81\" tg-width=\"700\" tg-height=\"584\" referrerpolicy=\"no-referrer\">U.S. stocks climbed on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.</p>\n<p>The Dow Jones Industrial Average rose 200 points, while theS&amp;P 500edged 0.4% higher. The Nasdaq Composite traded 0.2% higher even with bond yields rising.</p>\n<p>Consumer prices for May accelerated at their fastest pace since the summer of 2008 amid the economic recovery from the pandemic-triggered recession,the Labor Department reported Thursday.</p>\n<p>The consumer price index, which represents a basket including food, energy, groceries across a spectrum of goods, rose 5% from a year ago. Economists surveyed by Dow Jones had been expecting a gain of 4.7%.</p>\n<p>Fears of spiking inflation have weighed on the stock market in the last month, with investors worried the jump in prices will raise costs for companies, spark a move higher in interest rates and cause the Federal Reserve to remove its easy money policies.</p>\n<p>“This CPI isn’t likely to change the narrative dramatically and there are still indications that inflation momentum is set to abate in the coming months,” Adam Crisafulli, founder of Vital Knowledge, said in a note Thursday.</p>\n<p>Many economists also said the surge in used car costs for the month could have skewed the inflation reading. Used car and truck prices jumped more than 7%, accounting for one-third of the total increase for the month, according to the BLS. The jump in used car prices likely reflects a temporary phenomenon related to the pandemic and auto supply.</p>\n<p>UPS shares rose about 1% in premarket trading afteran upgrade from JPMorgan. Shares of Boeing and Delta Air Lines were also higher in premarket trading.</p>\n<p>U.S. markets continued to trade within a tight range on Wednesday, with all three major indexes ending the day within 0.5% of Tuesday’s closing levels. The Dow, S&amp;P 500 and Nasdaq Composite all fell during regular trading, ending the session further away from their respective all-time highs.</p>\n<p>The S&amp;P 500 remains closest to its benchmark and is just 0.44% away from a new all-time high. The Dow and Nasdaq are roughly 2% away from records.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯","SPY":"标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180064020","content_text":"(June 10) U.S. stocks gained in Thursday open. Chinese Education Stocks soared.\nAirline stocks rally.\n\nVideo-game retailer and meme stock GameStop fell over 6% in morning trading even after the company tapped formerAmazon executive Matt Furlong to be its next CEOand said that sales rose 25% last quarter. The company also said it may sell up to 5 million additional shares.\nU.S. stocks climbed on Thursday as investors shrugged off a key inflation report that showed a bigger-than-expected increase in price pressures.\nThe Dow Jones Industrial Average rose 200 points, while theS&P 500edged 0.4% higher. The Nasdaq Composite traded 0.2% higher even with bond yields rising.\nConsumer prices for May accelerated at their fastest pace since the summer of 2008 amid the economic recovery from the pandemic-triggered recession,the Labor Department reported Thursday.\nThe consumer price index, which represents a basket including food, energy, groceries across a spectrum of goods, rose 5% from a year ago. Economists surveyed by Dow Jones had been expecting a gain of 4.7%.\nFears of spiking inflation have weighed on the stock market in the last month, with investors worried the jump in prices will raise costs for companies, spark a move higher in interest rates and cause the Federal Reserve to remove its easy money policies.\n“This CPI isn’t likely to change the narrative dramatically and there are still indications that inflation momentum is set to abate in the coming months,” Adam Crisafulli, founder of Vital Knowledge, said in a note Thursday.\nMany economists also said the surge in used car costs for the month could have skewed the inflation reading. Used car and truck prices jumped more than 7%, accounting for one-third of the total increase for the month, according to the BLS. The jump in used car prices likely reflects a temporary phenomenon related to the pandemic and auto supply.\nUPS shares rose about 1% in premarket trading afteran upgrade from JPMorgan. Shares of Boeing and Delta Air Lines were also higher in premarket trading.\nU.S. markets continued to trade within a tight range on Wednesday, with all three major indexes ending the day within 0.5% of Tuesday’s closing levels. The Dow, S&P 500 and Nasdaq Composite all fell during regular trading, ending the session further away from their respective all-time highs.\nThe S&P 500 remains closest to its benchmark and is just 0.44% away from a new all-time high. The Dow and Nasdaq are roughly 2% away from records.","news_type":1},"isVote":1,"tweetType":1,"viewCount":170,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":164917488,"gmtCreate":1624165369044,"gmtModify":1631888121061,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Interesting....","listText":"Interesting....","text":"Interesting....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/164917488","repostId":"1183124175","repostType":4,"repost":{"id":"1183124175","pubTimestamp":1624151620,"share":"https://www.laohu8.com/m/news/1183124175?lang=&edition=full","pubTime":"2021-06-20 09:13","market":"us","language":"en","title":"Beware these risky tech stocks in your portfolio, strategist Parker warns","url":"https://stock-news.laohu8.com/highlight/detail?id=1183124175","media":"cnbc","summary":"As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.Growth stocks are shares of companies expected to grow at a faster rate than the rest of the market. However, these names are typically riskier and more volatile than the average stock.Adam Parker, former Morgan Stanley chief U.S. equity strategist and founder of Trivariate Research, said the time is right to buy growth shares, but investors should be cautious of a f","content":"<div>\n<p>As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.\nGrowth stocks are shares of companies expected to grow at a faster ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beware these risky tech stocks in your portfolio, strategist Parker warns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeware these risky tech stocks in your portfolio, strategist Parker warns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-20 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.\nGrowth stocks are shares of companies expected to grow at a faster ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TWLO":"Twilio Inc","MCHP":"微芯科技","SQ":"Block","AAPL":"苹果","NVDA":"英伟达"},"source_url":"https://www.cnbc.com/2021/06/19/tech-stocks-strategist-warns-of-risky-names.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1183124175","content_text":"As investors cycle back into growth stocks, one market strategist warns against certain technology names he believes are high risk.\nGrowth stocks are shares of companies expected to grow at a faster rate than the rest of the market. However, these names are typically riskier and more volatile than the average stock.\nAdam Parker, former Morgan Stanley chief U.S. equity strategist and founder of Trivariate Research, said the time is right to buy growth shares, but investors should be cautious of a few.\n“We think that portfolio managers should be buying growth stocks again, focusing on positive free cash flow and margin expansion, not earnings-based valuation,” Parker said in a note released Wednesday.\nTrivariate Research used a number of criteria to identify risky stocks, including low or negative correlation to inflation, high correlation to the economic reopening and high levels of company insiders selling their shares. The research firm then identified the eight riskiest names based on those measures.\n“Our view is that these are among the riskiest stocks to own today, so investors who own these names should have disproportionate upside to their base cases to compensate them for these risks,” Parker said.\nTake a look at five of the riskiest technology stocks, according to Trivariate.\nRISKIEST TECH STOCKS, ACCORDING TO TRIVARIATE\n\n\n\nTICKER\nCOMPANY\nPRICE\n%CHANGE\n\n\n\n\nMCHP\nMicrochip Technology Inc\n145.62\n-3.0686\n\n\nTWLO\nTwilio Inc\n367.61\n1.84\n\n\nSQ\nSquare Inc\n237.05\n0.39\n\n\nNVDA\nNVIDIA Corp\n745.55\n-0.0992\n\n\nAAPL\nApple Inc\n130.46\n-1.0092\n\n\n\nApple is on Trivariate’s list of riskiest stocks. The research firm identifies Apple as one of the stocks with the most negative correlation to inflation. Trivariate predicts that if bond yields rise or if fears of inflation continue, shares of Apple will underperform the market.\nNvidiaalso makes the list of risky tech stocks. Trivariate found the semiconductor stock has one of the most asymmetric beta — meaning the stock is consistently more volatile than the broader market during a market pullback compared with typical times.\nTrivariate also named payments companySquare, cloud communications platformTwilioand semiconductor manufacturerMicrochip Technologyamong the riskiest technology stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103510547,"gmtCreate":1619792856889,"gmtModify":1631892448461,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Happy to know chew, a singaporean, will be head of Tiktok...lovely. cheers","listText":"Happy to know chew, a singaporean, will be head of Tiktok...lovely. cheers","text":"Happy to know chew, a singaporean, will be head of Tiktok...lovely. cheers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/103510547","repostId":"1152594140","repostType":4,"repost":{"id":"1152594140","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1619791880,"share":"https://www.laohu8.com/m/news/1152594140?lang=&edition=full","pubTime":"2021-04-30 22:11","market":"us","language":"en","title":"TikTok names ByteDance CFO Shouzi Chew as new CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=1152594140","media":"Reuters","summary":"TikTok appointed Shouzi Chew, a Singaporean national, as the new Chief Executive Officer of the hot ","content":"<p>TikTok appointed Shouzi Chew, a Singaporean national, as the new Chief Executive Officer of the hot video-sharing platform, the company said on Friday.</p>\n<p>Chew, who is based in Singapore and was named CFO of TikTok parent company ByteDance in March this year, will continue in that role.</p>\n<p>TikTok’s interim head Vanessa Pappas, based in Los Angeles, will be the new Chief Operating Officer.</p>\n<p>Chew had served as Xiaomi’s chief financial officer from 2015 to 2020, and ran its international business for a year.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TikTok names ByteDance CFO Shouzi Chew as new CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTikTok names ByteDance CFO Shouzi Chew as new CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-30 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TikTok appointed Shouzi Chew, a Singaporean national, as the new Chief Executive Officer of the hot video-sharing platform, the company said on Friday.</p>\n<p>Chew, who is based in Singapore and was named CFO of TikTok parent company ByteDance in March this year, will continue in that role.</p>\n<p>TikTok’s interim head Vanessa Pappas, based in Los Angeles, will be the new Chief Operating Officer.</p>\n<p>Chew had served as Xiaomi’s chief financial officer from 2015 to 2020, and ran its international business for a year.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1152594140","content_text":"TikTok appointed Shouzi Chew, a Singaporean national, as the new Chief Executive Officer of the hot video-sharing platform, the company said on Friday.\nChew, who is based in Singapore and was named CFO of TikTok parent company ByteDance in March this year, will continue in that role.\nTikTok’s interim head Vanessa Pappas, based in Los Angeles, will be the new Chief Operating Officer.\nChew had served as Xiaomi’s chief financial officer from 2015 to 2020, and ran its international business for a year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":165073846,"gmtCreate":1624083524785,"gmtModify":1631888121071,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"What goes up will come down...","listText":"What goes up will come down...","text":"What goes up will come down...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/165073846","repostId":"1166679093","repostType":4,"repost":{"id":"1166679093","pubTimestamp":1624065234,"share":"https://www.laohu8.com/m/news/1166679093?lang=&edition=full","pubTime":"2021-06-19 09:13","market":"us","language":"en","title":"3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166679093","media":"fool","summary":"Meme stocks have been all the rage so far this year. That's understandable, with several of them del","content":"<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.</p>\n<p>However, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.</p>\n<p>AMC Entertainment</p>\n<p><b>AMC Entertainment</b>(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.</p>\n<p>The consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.</p>\n<p>But isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.</p>\n<p>However, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.</p>\n<p>Clover Health Investments</p>\n<p>Only a few days ago, it looked like&nbsp;<b>Clover Health Investments</b>(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.</p>\n<p>Since the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.</p>\n<p>Clover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.</p>\n<p>Still, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.</p>\n<p>Sundial Growers</p>\n<p>At one point earlier this year,&nbsp;<b>Sundial Growers</b>(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.</p>\n<p>Analysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.</p>\n<p>There certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.</p>\n<p>Sundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.</p>\n<p>However, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the&nbsp;<b>Nasdaq</b>&nbsp;stock exchange.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线","SNDL":"SNDL Inc.","CLOV":"Clover Health Corp"},"source_url":"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166679093","content_text":"Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.\nAMC Entertainment\nAMC Entertainment(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.\nThe consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.\nBut isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.\nHowever, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.\nClover Health Investments\nOnly a few days ago, it looked like Clover Health Investments(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.\nSince the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.\nClover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.\nStill, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.\nSundial Growers\nAt one point earlier this year, Sundial Growers(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.\nAnalysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.\nThere certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.\nSundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.\nHowever, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the Nasdaq stock exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":204,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":183966826,"gmtCreate":1623301106465,"gmtModify":1631884082634,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"New phenomenon and new ways of trading....we all need to adapt.change is the only thing constant... indeed.","listText":"New phenomenon and new ways of trading....we all need to adapt.change is the only thing constant... indeed.","text":"New phenomenon and new ways of trading....we all need to adapt.change is the only thing constant... indeed.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/183966826","repostId":"2142210925","repostType":4,"repost":{"id":"2142210925","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623289980,"share":"https://www.laohu8.com/m/news/2142210925?lang=&edition=full","pubTime":"2021-06-10 09:53","market":"us","language":"en","title":"This robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and Amazon","url":"https://stock-news.laohu8.com/highlight/detail?id=2142210925","media":"Dow Jones","summary":"Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the","content":"<p>Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the AMOM fund on June 2</p>\n<p>An exchange-traded fund driven by artificial intelligence booted Tesla and Amazon from its portfolio in June, instead choosing to load up on shares of companies including Qualcomm, Snap and GameStop.</p>\n<p>The Qraft AI-Enhanced U.S. Large Cap Momentum ETF, trading as AMOM <a href=\"https://laohu8.com/S/AMOM\">$(AMOM)$</a> on the New York Stock Exchange, removed major technology companies from its portfolio this month, as it shifted to favor retailers and other post-pandemic trades.</p>\n<p>Electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> represented two of the fund's three largest holdings in May, but were completely removed in the latest rebalancing on June 2, along with graphics microchip maker Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, which was its sixth-largest holding. The artificial-intelligence program controlling the fund believes these stocks will see price declines across the coming month.</p>\n<p>The standout among the stocks added in June was GameStop <a href=\"https://laohu8.com/S/GME\">$(GME)$</a>, the videogame retailer that epitomized the \"meme stock\" trading frenzy that began in late January.</p>\n<p>This was when a flock of investors, largely organized on social media platform Reddit, helped squeeze hedge funds' short positions on companies including GameStop, cinema chain AMC <a href=\"https://laohu8.com/S/AMC\">$(AMC)$</a>, and tech group BlackBerry (BB.T) earlier this year. The trading frenzy caused multibillion-dollar losses for hedge funds, unbelievable gains for individuals that timed it right, and ushered in a new era of internet-inspired trading.</p>\n<p>GameStop's stock price rose almost 10-fold from Jan. 15 to Jan. 27, from $35 per share to nearly $350. The stock is currently trading around $300 and makes up around 1% of AMOM. And now the AI calling the shots thinks it will move even higher in June, and the shares have already gained more than 6% since the stock was added to the fund for the first time.</p>\n<p>\"Few fund managers would take the risk of adding a meme stock to their portfolios, but Qraft's AI model has no such prejudices,\" said Geeseok Oh, a managing director at Qraft and the head of its Asia-Pacific business.</p>\n<p>The top five stocks by portfolio weight added to AMOM in June include semiconductor group Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>, Big Tobacco company Philip Morris <a href=\"https://laohu8.com/S/PM\">$(PM)$</a>, social-media player Snap <a href=\"https://laohu8.com/S/SNAP\">$(SNAP)$</a>, medical technology specialists Edwards Lifesciences <a href=\"https://laohu8.com/S/EW\">$(EW)$</a>, and orthodontics group Align Technology <a href=\"https://laohu8.com/S/ALGN\">$(ALGN)$</a>.</p>\n<p>After the fund was rebalanced, AMOM's top five largest holdings by portfolio weight were tech giant <a href=\"https://laohu8.com/S/FB\">Facebook</a> (FB), retailers Walmart <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a> and Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, software company Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, and semiconductor manufacturing company Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>.</p>\n<p>\"This month, AMOM's portfolio appears to be shifting towards post-pandemic trades, a bit more diversified of a portfolio from the previous month's big tech-heavy strategy,\" said Oh.</p>\n<p>AMOM's decision to remove Tesla from its portfolio came after a bullish bet failed to pay off. The fund bought around $1.4 million worth of shares in the electric-vehicle company in May after avoiding the stock for months, and shares in Tesla fell 7% before the AI ditched it from the fund. This mistake with Tesla was a rare occurrence for the robot controlling AMOM, which otherwise has a strong record of predicting moves in the company's share price .</p>\n<p>AMOM has been listed in New York since May 2019, and has delivered total returns of 11% so far in 2021 and 53% in the past year -- outpacing its benchmark, the S&amp;P 500 Momentum index , which has climbed a comparable 26% in the past year.</p>\n<p>AMOM is an actively managed portfolio driven by artificial intelligence, tracking 50 large-cap U.S. stocks and reweighting its holdings each month. It is based on a momentum strategy, with the AI behind its stock picks capitalizing on the movements of existing market trends to inform the decision to add, remove, or reweight holdings. The artificial intelligence scans the market and uses its predictive power to analyze a wide set of patterns that show stock-market momentum.</p>\n<p>The fund is a product of Qraft, a Seoul, South Korea-based fintech group leveraging AI across its investment products, which include three other AI-picked versions of major indexes: a U.S. large cap index <a href=\"https://laohu8.com/S/QRFT\">$(QRFT)$</a>; a U.S. large cap dividend index <a href=\"https://laohu8.com/S/HDIV.UK\">$(HDIV.UK)$</a>; and a U.S. value index <a href=\"https://laohu8.com/S/NVQ\">$(NVQ)$</a>.</p>\n<p>The entrance of AI-run funds onto Wall Street promised a new high-tech future for investing, though it hasn't quite lived up to the hype yet. Theoretically, researchers have shown that AI investing strategies can beat the market by up to 40% on an annualized basis , when tested against historical data.</p>\n<p>But Vasant Dhar, a professor at New York University's Stern School of Business and the founder of machine-learning-based hedge fund SCT Capital Management, argued on MarketWatch in June 2020 that AI-run funds won't \"crack\" the code of the stock market.</p>\n<p>Advocating caution, Dhar said that it was difficult for funds underpinned by machine learning to maintain a sustainable edge over markets, which have \"a nonstationary and adversarial nature.\" He advised investors considering an AI system to ask tough questions, including how likely it is that the AI's \"edge\" will persist into the future, and what the inherent uncertainties and range of performance outcomes for the fund are.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>This robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and Amazon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThis robot-run fund thinks GameStop stock will soar in June, and predicts a fall for Tesla and Amazon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-10 09:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the AMOM fund on June 2</p>\n<p>An exchange-traded fund driven by artificial intelligence booted Tesla and Amazon from its portfolio in June, instead choosing to load up on shares of companies including Qualcomm, Snap and GameStop.</p>\n<p>The Qraft AI-Enhanced U.S. Large Cap Momentum ETF, trading as AMOM <a href=\"https://laohu8.com/S/AMOM\">$(AMOM)$</a> on the New York Stock Exchange, removed major technology companies from its portfolio this month, as it shifted to favor retailers and other post-pandemic trades.</p>\n<p>Electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> and online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> represented two of the fund's three largest holdings in May, but were completely removed in the latest rebalancing on June 2, along with graphics microchip maker Nvidia <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, which was its sixth-largest holding. The artificial-intelligence program controlling the fund believes these stocks will see price declines across the coming month.</p>\n<p>The standout among the stocks added in June was GameStop <a href=\"https://laohu8.com/S/GME\">$(GME)$</a>, the videogame retailer that epitomized the \"meme stock\" trading frenzy that began in late January.</p>\n<p>This was when a flock of investors, largely organized on social media platform Reddit, helped squeeze hedge funds' short positions on companies including GameStop, cinema chain AMC <a href=\"https://laohu8.com/S/AMC\">$(AMC)$</a>, and tech group BlackBerry (BB.T) earlier this year. The trading frenzy caused multibillion-dollar losses for hedge funds, unbelievable gains for individuals that timed it right, and ushered in a new era of internet-inspired trading.</p>\n<p>GameStop's stock price rose almost 10-fold from Jan. 15 to Jan. 27, from $35 per share to nearly $350. The stock is currently trading around $300 and makes up around 1% of AMOM. And now the AI calling the shots thinks it will move even higher in June, and the shares have already gained more than 6% since the stock was added to the fund for the first time.</p>\n<p>\"Few fund managers would take the risk of adding a meme stock to their portfolios, but Qraft's AI model has no such prejudices,\" said Geeseok Oh, a managing director at Qraft and the head of its Asia-Pacific business.</p>\n<p>The top five stocks by portfolio weight added to AMOM in June include semiconductor group Qualcomm <a href=\"https://laohu8.com/S/QCOM\">$(QCOM)$</a>, Big Tobacco company Philip Morris <a href=\"https://laohu8.com/S/PM\">$(PM)$</a>, social-media player Snap <a href=\"https://laohu8.com/S/SNAP\">$(SNAP)$</a>, medical technology specialists Edwards Lifesciences <a href=\"https://laohu8.com/S/EW\">$(EW)$</a>, and orthodontics group Align Technology <a href=\"https://laohu8.com/S/ALGN\">$(ALGN)$</a>.</p>\n<p>After the fund was rebalanced, AMOM's top five largest holdings by portfolio weight were tech giant <a href=\"https://laohu8.com/S/FB\">Facebook</a> (FB), retailers Walmart <a href=\"https://laohu8.com/S/WMT\">$(WMT)$</a> and Home Depot <a href=\"https://laohu8.com/S/HD\">$(HD)$</a>, software company Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, and semiconductor manufacturing company Texas Instruments <a href=\"https://laohu8.com/S/TXN\">$(TXN)$</a>.</p>\n<p>\"This month, AMOM's portfolio appears to be shifting towards post-pandemic trades, a bit more diversified of a portfolio from the previous month's big tech-heavy strategy,\" said Oh.</p>\n<p>AMOM's decision to remove Tesla from its portfolio came after a bullish bet failed to pay off. The fund bought around $1.4 million worth of shares in the electric-vehicle company in May after avoiding the stock for months, and shares in Tesla fell 7% before the AI ditched it from the fund. This mistake with Tesla was a rare occurrence for the robot controlling AMOM, which otherwise has a strong record of predicting moves in the company's share price .</p>\n<p>AMOM has been listed in New York since May 2019, and has delivered total returns of 11% so far in 2021 and 53% in the past year -- outpacing its benchmark, the S&amp;P 500 Momentum index , which has climbed a comparable 26% in the past year.</p>\n<p>AMOM is an actively managed portfolio driven by artificial intelligence, tracking 50 large-cap U.S. stocks and reweighting its holdings each month. It is based on a momentum strategy, with the AI behind its stock picks capitalizing on the movements of existing market trends to inform the decision to add, remove, or reweight holdings. The artificial intelligence scans the market and uses its predictive power to analyze a wide set of patterns that show stock-market momentum.</p>\n<p>The fund is a product of Qraft, a Seoul, South Korea-based fintech group leveraging AI across its investment products, which include three other AI-picked versions of major indexes: a U.S. large cap index <a href=\"https://laohu8.com/S/QRFT\">$(QRFT)$</a>; a U.S. large cap dividend index <a href=\"https://laohu8.com/S/HDIV.UK\">$(HDIV.UK)$</a>; and a U.S. value index <a href=\"https://laohu8.com/S/NVQ\">$(NVQ)$</a>.</p>\n<p>The entrance of AI-run funds onto Wall Street promised a new high-tech future for investing, though it hasn't quite lived up to the hype yet. Theoretically, researchers have shown that AI investing strategies can beat the market by up to 40% on an annualized basis , when tested against historical data.</p>\n<p>But Vasant Dhar, a professor at New York University's Stern School of Business and the founder of machine-learning-based hedge fund SCT Capital Management, argued on MarketWatch in June 2020 that AI-run funds won't \"crack\" the code of the stock market.</p>\n<p>Advocating caution, Dhar said that it was difficult for funds underpinned by machine learning to maintain a sustainable edge over markets, which have \"a nonstationary and adversarial nature.\" He advised investors considering an AI system to ask tough questions, including how likely it is that the AI's \"edge\" will persist into the future, and what the inherent uncertainties and range of performance outcomes for the fund are.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMOM":"QRAFT AI-Enhanced U.S. Large Cap Momentum ETF","TXN":"德州仪器","EW":"爱德华兹","TSLA":"特斯拉","PM":"菲利普莫里斯","QCOM":"高通","QNETCN":"纳斯达克中美互联网老虎指数","NVDA":"英伟达","AMZN":"亚马逊","GME":"游戏驿站","ALGN":"艾利科技","WMT":"沃尔玛","09086":"华夏纳指-U","SNAP":"Snap Inc","HD":"家得宝","ADBE":"Adobe","03086":"华夏纳指"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142210925","content_text":"Shares in GameStop have already climbed since an artificial-intelligence trading bot added it to the AMOM fund on June 2\nAn exchange-traded fund driven by artificial intelligence booted Tesla and Amazon from its portfolio in June, instead choosing to load up on shares of companies including Qualcomm, Snap and GameStop.\nThe Qraft AI-Enhanced U.S. Large Cap Momentum ETF, trading as AMOM $(AMOM)$ on the New York Stock Exchange, removed major technology companies from its portfolio this month, as it shifted to favor retailers and other post-pandemic trades.\nElectric-car maker Tesla $(TSLA)$ and online retailer Amazon $(AMZN)$ represented two of the fund's three largest holdings in May, but were completely removed in the latest rebalancing on June 2, along with graphics microchip maker Nvidia $(NVDA)$, which was its sixth-largest holding. The artificial-intelligence program controlling the fund believes these stocks will see price declines across the coming month.\nThe standout among the stocks added in June was GameStop $(GME)$, the videogame retailer that epitomized the \"meme stock\" trading frenzy that began in late January.\nThis was when a flock of investors, largely organized on social media platform Reddit, helped squeeze hedge funds' short positions on companies including GameStop, cinema chain AMC $(AMC)$, and tech group BlackBerry (BB.T) earlier this year. The trading frenzy caused multibillion-dollar losses for hedge funds, unbelievable gains for individuals that timed it right, and ushered in a new era of internet-inspired trading.\nGameStop's stock price rose almost 10-fold from Jan. 15 to Jan. 27, from $35 per share to nearly $350. The stock is currently trading around $300 and makes up around 1% of AMOM. And now the AI calling the shots thinks it will move even higher in June, and the shares have already gained more than 6% since the stock was added to the fund for the first time.\n\"Few fund managers would take the risk of adding a meme stock to their portfolios, but Qraft's AI model has no such prejudices,\" said Geeseok Oh, a managing director at Qraft and the head of its Asia-Pacific business.\nThe top five stocks by portfolio weight added to AMOM in June include semiconductor group Qualcomm $(QCOM)$, Big Tobacco company Philip Morris $(PM)$, social-media player Snap $(SNAP)$, medical technology specialists Edwards Lifesciences $(EW)$, and orthodontics group Align Technology $(ALGN)$.\nAfter the fund was rebalanced, AMOM's top five largest holdings by portfolio weight were tech giant Facebook (FB), retailers Walmart $(WMT)$ and Home Depot $(HD)$, software company Adobe $(ADBE)$, and semiconductor manufacturing company Texas Instruments $(TXN)$.\n\"This month, AMOM's portfolio appears to be shifting towards post-pandemic trades, a bit more diversified of a portfolio from the previous month's big tech-heavy strategy,\" said Oh.\nAMOM's decision to remove Tesla from its portfolio came after a bullish bet failed to pay off. The fund bought around $1.4 million worth of shares in the electric-vehicle company in May after avoiding the stock for months, and shares in Tesla fell 7% before the AI ditched it from the fund. This mistake with Tesla was a rare occurrence for the robot controlling AMOM, which otherwise has a strong record of predicting moves in the company's share price .\nAMOM has been listed in New York since May 2019, and has delivered total returns of 11% so far in 2021 and 53% in the past year -- outpacing its benchmark, the S&P 500 Momentum index , which has climbed a comparable 26% in the past year.\nAMOM is an actively managed portfolio driven by artificial intelligence, tracking 50 large-cap U.S. stocks and reweighting its holdings each month. It is based on a momentum strategy, with the AI behind its stock picks capitalizing on the movements of existing market trends to inform the decision to add, remove, or reweight holdings. The artificial intelligence scans the market and uses its predictive power to analyze a wide set of patterns that show stock-market momentum.\nThe fund is a product of Qraft, a Seoul, South Korea-based fintech group leveraging AI across its investment products, which include three other AI-picked versions of major indexes: a U.S. large cap index $(QRFT)$; a U.S. large cap dividend index $(HDIV.UK)$; and a U.S. value index $(NVQ)$.\nThe entrance of AI-run funds onto Wall Street promised a new high-tech future for investing, though it hasn't quite lived up to the hype yet. Theoretically, researchers have shown that AI investing strategies can beat the market by up to 40% on an annualized basis , when tested against historical data.\nBut Vasant Dhar, a professor at New York University's Stern School of Business and the founder of machine-learning-based hedge fund SCT Capital Management, argued on MarketWatch in June 2020 that AI-run funds won't \"crack\" the code of the stock market.\nAdvocating caution, Dhar said that it was difficult for funds underpinned by machine learning to maintain a sustainable edge over markets, which have \"a nonstationary and adversarial nature.\" He advised investors considering an AI system to ask tough questions, including how likely it is that the AI's \"edge\" will persist into the future, and what the inherent uncertainties and range of performance outcomes for the fund are.","news_type":1},"isVote":1,"tweetType":1,"viewCount":88,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":189280302,"gmtCreate":1623275624206,"gmtModify":1631890212514,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Will pay close attention to them....","listText":"Will pay close attention to them....","text":"Will pay close attention to them....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/189280302","repostId":"1141925795","repostType":4,"repost":{"id":"1141925795","pubTimestamp":1623253683,"share":"https://www.laohu8.com/m/news/1141925795?lang=&edition=full","pubTime":"2021-06-09 23:48","market":"us","language":"en","title":"UBS says buy these cheap stocks with pricing power amid higher inflation","url":"https://stock-news.laohu8.com/highlight/detail?id=1141925795","media":"cnbc","summary":"Inflation is expected to increase throughout the summer as the economy continues to rebound while st","content":"<div>\n<p>Inflation is expected to increase throughout the summer as the economy continues to rebound while still experiencing supply constraints.\nBut that looks to be a temporary phenomenon that’ll put demand-...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/09/ubs-says-buy-these-cheap-stocks-with-pricing-power-amid-higher-inflation.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UBS says buy these cheap stocks with pricing power amid higher inflation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUBS says buy these cheap stocks with pricing power amid higher inflation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-09 23:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/09/ubs-says-buy-these-cheap-stocks-with-pricing-power-amid-higher-inflation.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Inflation is expected to increase throughout the summer as the economy continues to rebound while still experiencing supply constraints.\nBut that looks to be a temporary phenomenon that’ll put demand-...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/09/ubs-says-buy-these-cheap-stocks-with-pricing-power-amid-higher-inflation.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"KO":"可口可乐","EL":"雅诗兰黛","VNO":"沃那多房信","IBM":"IBM","IDXX":"爱德士实验室","CRM":"赛富时","EXPE":"Expedia","ORLY":"奥莱利","EFX":"艾可菲","AZO":"汽车地带"},"source_url":"https://www.cnbc.com/2021/06/09/ubs-says-buy-these-cheap-stocks-with-pricing-power-amid-higher-inflation.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1141925795","content_text":"Inflation is expected to increase throughout the summer as the economy continues to rebound while still experiencing supply constraints.\nBut that looks to be a temporary phenomenon that’ll put demand-driven stocks with higher pricing power at an advantage, according to a Wednesday report by UBS.\nStocks with strong pricing power, or the effect that a change in product pricing has on demand for that product, tend to outperform during high inflation periods. UBS screened several large cap companies – as they tend to beat small cap companies in inflationary periods – with the highest pricing power and margin momentum relative to their sector.\n“A number of factors make the strong vs weak pricing power trade attractive now,” the report said. “It’s working across most sectors, it’s relatively cheap, has better pricing trends and much lower margin expectations for Q2.”\nExpediais on its list of consumer discretionary stocks with pricing power as the U.S. begins to relax international travel bans and restrictions.IBMandSalesforceare among the IT stocks, especially as companies prepare for a hybrid approach to the future of work after the pandemic.\nBeauty companyEstée Lauderhas one of the highest pricing power scores, which is based on mostly markup as well as EBIT margin volatility, EBIT margin skew and market share, calculated by UBS. Other analysts have also pointed to the stock as onepoised to outperformthis summer with the economy reopening and mask mandates easing.\nThe list includes companies across communications, consumer staples and discretionary, health, industrials, IT, materials and real estate stocks. Financial, energy and utility stocks were excluded.\n“The market is pricing in a 40% chance of inflation exceeding 3% over the next 5 years,” UBS said in its report. “However, we expect inflation pressures to moderate towards the end of the year as supply conditions ease and pent-up demand ebbs, which should allow S&P 500 margins to continue to expand.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":132369026,"gmtCreate":1622072606565,"gmtModify":1631892448449,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Positive report.....cheers","listText":"Positive report.....cheers","text":"Positive report.....cheers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/132369026","repostId":"1198109956","repostType":4,"repost":{"id":"1198109956","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622072280,"share":"https://www.laohu8.com/m/news/1198109956?lang=&edition=full","pubTime":"2021-05-27 07:38","market":"us","language":"en","title":"Nvidia EPS beats by $0.38, beats on revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=1198109956","media":"Tiger Newspress","summary":" Nvidia today reported record revenue for the first quarter ended May 2, 2021, of $5.66 billion, up 84 percent from a year earlier and up 13 percent from the previous quarter, with record revenue from the company’s Gaming, Data Center and Professional Visualization platforms.Nvidia Q1 Non-GAAP EPS of $3.66beats by $0.38; GAAP EPS of $3.03beats by $0.51.Revenue of $5.66B beats by $250M.NVIDIA paid quarterly cash dividends of $99 million in the first quarter. It will pay its next quarterly cash di","content":"<p>(May&nbsp;27)&nbsp;Nvidia today reported record revenue for the first quarter ended May 2, 2021, of $5.66 billion, up 84 percent from a year earlier and up 13 percent from the previous quarter, with record revenue from the company’s Gaming, Data Center and Professional Visualization platforms.</p><ul><li>Nvidia&nbsp;Q1 Non-GAAP EPS of $3.66beats by $0.38; GAAP EPS of $3.03beats by $0.51.</li><li>Revenue of $5.66B (+83.8% Y/Y)beats by $250M.</li></ul><p><b>Outlook for the second quarter of fiscal 2022 is as follows:</b></p><ul><li>Revenue is expected to be $6.30 billion, plus or minus 2 percent&nbsp;vs. $5.48B consensus.</li><li>GAAP and non-GAAP gross margins are expected to be 64.6 percent and 66.5 percent, respectively, plus or minus 50 basis points.</li><li>GAAP and non-GAAP operating expenses are expected to be approximately $1.76 billion and $1.26 billion, respectively.</li><li>GAAP and non-GAAP other income and expense are both expected to be an expense of approximately $50 million.</li><li>GAAP and non-GAAP tax rates are both expected to be 10 percent, plus or minus 1 percent, excluding any discrete items. GAAP discrete items include excess tax benefits or deficiencies related to stock-based compensation, which are expected to generate variability on a quarter-by-quarter basis.</li></ul><p>Shares&nbsp;of&nbsp;Nvidia&nbsp;fell&nbsp;nearly&nbsp;1%&nbsp;in&nbsp;afterhour&nbsp;trading.</p><p><img src=\"https://static.tigerbbs.com/cc5b2493152883344459d99c9fa7aa82\" tg-width=\"662\" tg-height=\"466\" referrerpolicy=\"no-referrer\">“We had a fantastic quarter, with strong demand for our products driving record revenue,” saidJensen Huang, founder and CEO of NVIDIA.</p><p>“Our Data Center (VPN) business continues to expand, as the world’s industries take up NVIDIA AI to process computer vision, conversational AI, natural language understanding and recommender systems. NVIDIA RTX has reinvented computer graphics and is driving upgrades across the gaming and design markets. Our partners are launching the largest-ever wave of NVIDIA-powered laptops. Across industries, the adoption of NVIDIA computing platforms is accelerating.</p><p>“Mellanox, one year in, has exceeded our expectations and transformed NVIDIA into a data-center-scale computing company. We continue to make headway with our planned acquisition of Arm, which will accelerate innovation and growth for the Arm ecosystem. From gaming, cloud computing, AI, robotics, self-driving cars, to genomics and computational biology, NVIDIA continues to do impactful work to invent a better future,” he said.</p><p>NVIDIA paid quarterly cash dividends of $99 million in the first quarter. It will pay its next quarterly cash dividend of $0.16 per share on July 1, 2021, to all shareholders of record on June 10, 2021.</p><p>On May 21, 2021, the company’s board of directors declared a four-for-one split of NVIDIA’s common stock payable in the form of a stock dividend, with the additional shares expected to be distributed on July 19, 2021. The stock dividend is conditioned on obtaining stockholder approval at the company’s 2021 Annual Meeting of Stockholders on June 3, 2021, to increase the number of authorized shares of common stock from 2 billion to 4 billion.</p><p><b>Highlights</b></p><p>NVIDIA achieved progress since its previous earnings announcement in these areas:</p><p><b>Gaming</b></p><ul><li>First-quarter revenue was a record $2.76 billion, up 106 percent from a year earlier and up 11 percent from the previous quarter.</li><li>Broadened the wave of laptops powered by NVIDIA’s second-generation RTX graphics with the launch ofGeForce RTX™ 3060 Laptop GPU systemsstarting at $999, and the announcement ofGeForce®3050 Ti and 3050 Laptop GPU systemsstarting at $799 and aimed at gamers and creators.</li><li>AcceleratedRTX momentumwith now over 60 games, including<i>Call of Duty Modern Warfare,Crysis Remastered</i>and<i>Outriders.</i></li><li>Took steps to improve gamers’ access to GeForce GPUs byreducing the Ethereum hash rate on newly manufactured RTX 3080, 3070 and 3060 Ti graphics cards-- which carry a “Lite Hash Rate,” or “LHR,” identifier -- in addition toprevious steps to lower the RTX 3060’s hash rate.</li><li>Announced thatNVIDIA DLSS is available now in Unreal Engine 4and soon in theUnity game engine.</li><li>Announced thatNVIDIA Reflex, which reduces system latency, is now incorporated into<i>Call of Duty Warzone</i>,<i>Overwatch</i>and<i>Rainbow Six</i><i>: Siege</i>.</li><li>Announced thatGeForce NOW™, now in its second year, has over 10 million members in more than 70 countries and is approaching 1,000 games in its library.</li></ul><p><b>Data Center</b></p><ul><li>First-quarter revenue was a record $2.05 billion, up 79 percent from a year earlier and up 8 percent from the previous quarter.</li><li>Hosted its largest-everGPU Technology Conference, virtually, with more than 200,000 registrations from 195 countries, and an opening keynote with over 14 million views.</li><li>UnveiledNVIDIA Grace™, its first Arm-based data center CPU, designed for giant-scale AI and high performance computing, which will deliver 10x the performance of today’s fastest servers and power theworld’s most powerful AI-capable supercomputerat the Swiss National Supercomputing Centre.</li><li>Collaborated with Amazon Web Services to deployNVIDIA GPU inferencingthrough GPU-accelerated, AWS Graviton2-based Amazon EC2 instances, enabling GPU-accelerated games to run natively on AWS and allowing greater performance for Arm-based workloads.</li><li>Unveiled theNVIDIA®BlueField-3®DPU, the first data processing unit built for AI and accelerated computing, with support from VMware, Splunk, NetApp, Cloudflare and others.</li><li>Announced thenew NVIDIA DGX SuperPOD™, the first cloud-native, multi-tenant supercomputer, with customers in conversational AI, drug discovery, autonomous vehicles and more.</li><li>Announced that its AI inference platform, expanded withNVIDIA A30 and A10 GPUsfor mainstream servers, set records across every category in the latest release of the MLPerf benchmark for AI performance across a range of workloads.</li><li>Announced theNVIDIA AI Enterprise software suite for VMware vSphere, enabling scale-out, multi-node performance and compatibility for a range of applications and data science.</li><li>Introduced theNVIDIA Morpheus AIapplication framework to enable cybersecurity providers to instantly detect cyber breaches using AI and NVIDIA BlueField DPUs.</li><li>Announced availability ofNVIDIA Jarvis, a framework for interactive conversational AI, andNVIDIA Maxine™, a framework for real-time video-based experiences.</li><li>UnveiledNVIDIA TAO, a framework for accelerating the creation of enterprise AI applications.</li><li>Expanded its work supportingdrug development and discovery with NVIDIA Clara Discovery, announcing a partnership with Schrödinger to support the pharmaceutical industry with AI software to speed drug-discovery workflows.</li></ul><p><b>Professional Visualization</b></p><ul><li>First-quarter revenue was a record $372 million, up 21 percent both from a year earlier and the previous quarter.</li><li>Launched NVIDIA Omniverse™ Enterprisesoftware for real-time 3D design and collaboration, with BMW Group, Foster + Partners and WPP as early customers.</li><li>UnveiledNVIDIA RTX™ GPUsfor next-gen laptop and desktop workstations, including the NVIDIA RTX A4000 and A5000 for desktops and the A2000, A3000, A4000 and A5000 for laptops.</li><li>RevealedGANverse3D, an AI model for creating 3D object models from standard 2D images.</li></ul><p><b>Automotive</b></p><ul><li>First-quarter revenue was $154 million, down 1 percent from a year earlier and up 6 percent from the previous quarter.</li><li>Unveiled NVIDIA DRIVE Atlan™, an AI-enabled processor for autonomous vehicles with 1,000 TOPS and data-center-grade security, targeting automakers’ 2025 vehicles.</li><li>AnnouncedNVIDIA DRIVE Hyperion™ 8, the latest generation of a fully operational, open platform that reduces the time and cost to outfit vehicles with AI and surround sensors.</li><li>Announced thatNVIDIA DRIVE™ will be powering intelligent new energy vehiclesfrom SAIC R Auto, IM Motors, Faraday Future and VinFast, starting in 2022.</li><li>Revealed that Cruise is the latestrobotaxi company selecting NVIDIA DRIVE, following announcements by Amazon Zoox, DiDi (DIDI), Oxbotica, Pony.ai and AutoX.</li><li>Announced thatVolvo Cars will use NVIDIA DRIVE Orin™&nbsp;to power the autonomous driving computer in its next-generation cars, beginning with the XC90, to be revealed in 2022.</li><li>Announced that theNVIDIA DRIVE platformpowers MBUX Hyperscreen, the AI cockpit in Mercedes-Benz’s new EQS sedan.</li><li>Announced that TuSimple and Navistar will buildself-driving trucks powered by the NVIDIA DRIVE AGX™ platform, and the self-driving truck companyPlus will use NVIDIA DRIVE Orinfor its upcoming autonomous vehicle platform.</li></ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia EPS beats by $0.38, beats on revenue</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia EPS beats by $0.38, beats on revenue\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-27 07:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(May&nbsp;27)&nbsp;Nvidia today reported record revenue for the first quarter ended May 2, 2021, of $5.66 billion, up 84 percent from a year earlier and up 13 percent from the previous quarter, with record revenue from the company’s Gaming, Data Center and Professional Visualization platforms.</p><ul><li>Nvidia&nbsp;Q1 Non-GAAP EPS of $3.66beats by $0.38; GAAP EPS of $3.03beats by $0.51.</li><li>Revenue of $5.66B (+83.8% Y/Y)beats by $250M.</li></ul><p><b>Outlook for the second quarter of fiscal 2022 is as follows:</b></p><ul><li>Revenue is expected to be $6.30 billion, plus or minus 2 percent&nbsp;vs. $5.48B consensus.</li><li>GAAP and non-GAAP gross margins are expected to be 64.6 percent and 66.5 percent, respectively, plus or minus 50 basis points.</li><li>GAAP and non-GAAP operating expenses are expected to be approximately $1.76 billion and $1.26 billion, respectively.</li><li>GAAP and non-GAAP other income and expense are both expected to be an expense of approximately $50 million.</li><li>GAAP and non-GAAP tax rates are both expected to be 10 percent, plus or minus 1 percent, excluding any discrete items. GAAP discrete items include excess tax benefits or deficiencies related to stock-based compensation, which are expected to generate variability on a quarter-by-quarter basis.</li></ul><p>Shares&nbsp;of&nbsp;Nvidia&nbsp;fell&nbsp;nearly&nbsp;1%&nbsp;in&nbsp;afterhour&nbsp;trading.</p><p><img src=\"https://static.tigerbbs.com/cc5b2493152883344459d99c9fa7aa82\" tg-width=\"662\" tg-height=\"466\" referrerpolicy=\"no-referrer\">“We had a fantastic quarter, with strong demand for our products driving record revenue,” saidJensen Huang, founder and CEO of NVIDIA.</p><p>“Our Data Center (VPN) business continues to expand, as the world’s industries take up NVIDIA AI to process computer vision, conversational AI, natural language understanding and recommender systems. NVIDIA RTX has reinvented computer graphics and is driving upgrades across the gaming and design markets. Our partners are launching the largest-ever wave of NVIDIA-powered laptops. Across industries, the adoption of NVIDIA computing platforms is accelerating.</p><p>“Mellanox, one year in, has exceeded our expectations and transformed NVIDIA into a data-center-scale computing company. We continue to make headway with our planned acquisition of Arm, which will accelerate innovation and growth for the Arm ecosystem. From gaming, cloud computing, AI, robotics, self-driving cars, to genomics and computational biology, NVIDIA continues to do impactful work to invent a better future,” he said.</p><p>NVIDIA paid quarterly cash dividends of $99 million in the first quarter. It will pay its next quarterly cash dividend of $0.16 per share on July 1, 2021, to all shareholders of record on June 10, 2021.</p><p>On May 21, 2021, the company’s board of directors declared a four-for-one split of NVIDIA’s common stock payable in the form of a stock dividend, with the additional shares expected to be distributed on July 19, 2021. The stock dividend is conditioned on obtaining stockholder approval at the company’s 2021 Annual Meeting of Stockholders on June 3, 2021, to increase the number of authorized shares of common stock from 2 billion to 4 billion.</p><p><b>Highlights</b></p><p>NVIDIA achieved progress since its previous earnings announcement in these areas:</p><p><b>Gaming</b></p><ul><li>First-quarter revenue was a record $2.76 billion, up 106 percent from a year earlier and up 11 percent from the previous quarter.</li><li>Broadened the wave of laptops powered by NVIDIA’s second-generation RTX graphics with the launch ofGeForce RTX™ 3060 Laptop GPU systemsstarting at $999, and the announcement ofGeForce®3050 Ti and 3050 Laptop GPU systemsstarting at $799 and aimed at gamers and creators.</li><li>AcceleratedRTX momentumwith now over 60 games, including<i>Call of Duty Modern Warfare,Crysis Remastered</i>and<i>Outriders.</i></li><li>Took steps to improve gamers’ access to GeForce GPUs byreducing the Ethereum hash rate on newly manufactured RTX 3080, 3070 and 3060 Ti graphics cards-- which carry a “Lite Hash Rate,” or “LHR,” identifier -- in addition toprevious steps to lower the RTX 3060’s hash rate.</li><li>Announced thatNVIDIA DLSS is available now in Unreal Engine 4and soon in theUnity game engine.</li><li>Announced thatNVIDIA Reflex, which reduces system latency, is now incorporated into<i>Call of Duty Warzone</i>,<i>Overwatch</i>and<i>Rainbow Six</i><i>: Siege</i>.</li><li>Announced thatGeForce NOW™, now in its second year, has over 10 million members in more than 70 countries and is approaching 1,000 games in its library.</li></ul><p><b>Data Center</b></p><ul><li>First-quarter revenue was a record $2.05 billion, up 79 percent from a year earlier and up 8 percent from the previous quarter.</li><li>Hosted its largest-everGPU Technology Conference, virtually, with more than 200,000 registrations from 195 countries, and an opening keynote with over 14 million views.</li><li>UnveiledNVIDIA Grace™, its first Arm-based data center CPU, designed for giant-scale AI and high performance computing, which will deliver 10x the performance of today’s fastest servers and power theworld’s most powerful AI-capable supercomputerat the Swiss National Supercomputing Centre.</li><li>Collaborated with Amazon Web Services to deployNVIDIA GPU inferencingthrough GPU-accelerated, AWS Graviton2-based Amazon EC2 instances, enabling GPU-accelerated games to run natively on AWS and allowing greater performance for Arm-based workloads.</li><li>Unveiled theNVIDIA®BlueField-3®DPU, the first data processing unit built for AI and accelerated computing, with support from VMware, Splunk, NetApp, Cloudflare and others.</li><li>Announced thenew NVIDIA DGX SuperPOD™, the first cloud-native, multi-tenant supercomputer, with customers in conversational AI, drug discovery, autonomous vehicles and more.</li><li>Announced that its AI inference platform, expanded withNVIDIA A30 and A10 GPUsfor mainstream servers, set records across every category in the latest release of the MLPerf benchmark for AI performance across a range of workloads.</li><li>Announced theNVIDIA AI Enterprise software suite for VMware vSphere, enabling scale-out, multi-node performance and compatibility for a range of applications and data science.</li><li>Introduced theNVIDIA Morpheus AIapplication framework to enable cybersecurity providers to instantly detect cyber breaches using AI and NVIDIA BlueField DPUs.</li><li>Announced availability ofNVIDIA Jarvis, a framework for interactive conversational AI, andNVIDIA Maxine™, a framework for real-time video-based experiences.</li><li>UnveiledNVIDIA TAO, a framework for accelerating the creation of enterprise AI applications.</li><li>Expanded its work supportingdrug development and discovery with NVIDIA Clara Discovery, announcing a partnership with Schrödinger to support the pharmaceutical industry with AI software to speed drug-discovery workflows.</li></ul><p><b>Professional Visualization</b></p><ul><li>First-quarter revenue was a record $372 million, up 21 percent both from a year earlier and the previous quarter.</li><li>Launched NVIDIA Omniverse™ Enterprisesoftware for real-time 3D design and collaboration, with BMW Group, Foster + Partners and WPP as early customers.</li><li>UnveiledNVIDIA RTX™ GPUsfor next-gen laptop and desktop workstations, including the NVIDIA RTX A4000 and A5000 for desktops and the A2000, A3000, A4000 and A5000 for laptops.</li><li>RevealedGANverse3D, an AI model for creating 3D object models from standard 2D images.</li></ul><p><b>Automotive</b></p><ul><li>First-quarter revenue was $154 million, down 1 percent from a year earlier and up 6 percent from the previous quarter.</li><li>Unveiled NVIDIA DRIVE Atlan™, an AI-enabled processor for autonomous vehicles with 1,000 TOPS and data-center-grade security, targeting automakers’ 2025 vehicles.</li><li>AnnouncedNVIDIA DRIVE Hyperion™ 8, the latest generation of a fully operational, open platform that reduces the time and cost to outfit vehicles with AI and surround sensors.</li><li>Announced thatNVIDIA DRIVE™ will be powering intelligent new energy vehiclesfrom SAIC R Auto, IM Motors, Faraday Future and VinFast, starting in 2022.</li><li>Revealed that Cruise is the latestrobotaxi company selecting NVIDIA DRIVE, following announcements by Amazon Zoox, DiDi (DIDI), Oxbotica, Pony.ai and AutoX.</li><li>Announced thatVolvo Cars will use NVIDIA DRIVE Orin™&nbsp;to power the autonomous driving computer in its next-generation cars, beginning with the XC90, to be revealed in 2022.</li><li>Announced that theNVIDIA DRIVE platformpowers MBUX Hyperscreen, the AI cockpit in Mercedes-Benz’s new EQS sedan.</li><li>Announced that TuSimple and Navistar will buildself-driving trucks powered by the NVIDIA DRIVE AGX™ platform, and the self-driving truck companyPlus will use NVIDIA DRIVE Orinfor its upcoming autonomous vehicle platform.</li></ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198109956","content_text":"(May 27) Nvidia today reported record revenue for the first quarter ended May 2, 2021, of $5.66 billion, up 84 percent from a year earlier and up 13 percent from the previous quarter, with record revenue from the company’s Gaming, Data Center and Professional Visualization platforms.Nvidia Q1 Non-GAAP EPS of $3.66beats by $0.38; GAAP EPS of $3.03beats by $0.51.Revenue of $5.66B (+83.8% Y/Y)beats by $250M.Outlook for the second quarter of fiscal 2022 is as follows:Revenue is expected to be $6.30 billion, plus or minus 2 percent vs. $5.48B consensus.GAAP and non-GAAP gross margins are expected to be 64.6 percent and 66.5 percent, respectively, plus or minus 50 basis points.GAAP and non-GAAP operating expenses are expected to be approximately $1.76 billion and $1.26 billion, respectively.GAAP and non-GAAP other income and expense are both expected to be an expense of approximately $50 million.GAAP and non-GAAP tax rates are both expected to be 10 percent, plus or minus 1 percent, excluding any discrete items. GAAP discrete items include excess tax benefits or deficiencies related to stock-based compensation, which are expected to generate variability on a quarter-by-quarter basis.Shares of Nvidia fell nearly 1% in afterhour trading.“We had a fantastic quarter, with strong demand for our products driving record revenue,” saidJensen Huang, founder and CEO of NVIDIA.“Our Data Center (VPN) business continues to expand, as the world’s industries take up NVIDIA AI to process computer vision, conversational AI, natural language understanding and recommender systems. NVIDIA RTX has reinvented computer graphics and is driving upgrades across the gaming and design markets. Our partners are launching the largest-ever wave of NVIDIA-powered laptops. Across industries, the adoption of NVIDIA computing platforms is accelerating.“Mellanox, one year in, has exceeded our expectations and transformed NVIDIA into a data-center-scale computing company. We continue to make headway with our planned acquisition of Arm, which will accelerate innovation and growth for the Arm ecosystem. From gaming, cloud computing, AI, robotics, self-driving cars, to genomics and computational biology, NVIDIA continues to do impactful work to invent a better future,” he said.NVIDIA paid quarterly cash dividends of $99 million in the first quarter. It will pay its next quarterly cash dividend of $0.16 per share on July 1, 2021, to all shareholders of record on June 10, 2021.On May 21, 2021, the company’s board of directors declared a four-for-one split of NVIDIA’s common stock payable in the form of a stock dividend, with the additional shares expected to be distributed on July 19, 2021. The stock dividend is conditioned on obtaining stockholder approval at the company’s 2021 Annual Meeting of Stockholders on June 3, 2021, to increase the number of authorized shares of common stock from 2 billion to 4 billion.HighlightsNVIDIA achieved progress since its previous earnings announcement in these areas:GamingFirst-quarter revenue was a record $2.76 billion, up 106 percent from a year earlier and up 11 percent from the previous quarter.Broadened the wave of laptops powered by NVIDIA’s second-generation RTX graphics with the launch ofGeForce RTX™ 3060 Laptop GPU systemsstarting at $999, and the announcement ofGeForce®3050 Ti and 3050 Laptop GPU systemsstarting at $799 and aimed at gamers and creators.AcceleratedRTX momentumwith now over 60 games, includingCall of Duty Modern Warfare,Crysis RemasteredandOutriders.Took steps to improve gamers’ access to GeForce GPUs byreducing the Ethereum hash rate on newly manufactured RTX 3080, 3070 and 3060 Ti graphics cards-- which carry a “Lite Hash Rate,” or “LHR,” identifier -- in addition toprevious steps to lower the RTX 3060’s hash rate.Announced thatNVIDIA DLSS is available now in Unreal Engine 4and soon in theUnity game engine.Announced thatNVIDIA Reflex, which reduces system latency, is now incorporated intoCall of Duty Warzone,OverwatchandRainbow Six: Siege.Announced thatGeForce NOW™, now in its second year, has over 10 million members in more than 70 countries and is approaching 1,000 games in its library.Data CenterFirst-quarter revenue was a record $2.05 billion, up 79 percent from a year earlier and up 8 percent from the previous quarter.Hosted its largest-everGPU Technology Conference, virtually, with more than 200,000 registrations from 195 countries, and an opening keynote with over 14 million views.UnveiledNVIDIA Grace™, its first Arm-based data center CPU, designed for giant-scale AI and high performance computing, which will deliver 10x the performance of today’s fastest servers and power theworld’s most powerful AI-capable supercomputerat the Swiss National Supercomputing Centre.Collaborated with Amazon Web Services to deployNVIDIA GPU inferencingthrough GPU-accelerated, AWS Graviton2-based Amazon EC2 instances, enabling GPU-accelerated games to run natively on AWS and allowing greater performance for Arm-based workloads.Unveiled theNVIDIA®BlueField-3®DPU, the first data processing unit built for AI and accelerated computing, with support from VMware, Splunk, NetApp, Cloudflare and others.Announced thenew NVIDIA DGX SuperPOD™, the first cloud-native, multi-tenant supercomputer, with customers in conversational AI, drug discovery, autonomous vehicles and more.Announced that its AI inference platform, expanded withNVIDIA A30 and A10 GPUsfor mainstream servers, set records across every category in the latest release of the MLPerf benchmark for AI performance across a range of workloads.Announced theNVIDIA AI Enterprise software suite for VMware vSphere, enabling scale-out, multi-node performance and compatibility for a range of applications and data science.Introduced theNVIDIA Morpheus AIapplication framework to enable cybersecurity providers to instantly detect cyber breaches using AI and NVIDIA BlueField DPUs.Announced availability ofNVIDIA Jarvis, a framework for interactive conversational AI, andNVIDIA Maxine™, a framework for real-time video-based experiences.UnveiledNVIDIA TAO, a framework for accelerating the creation of enterprise AI applications.Expanded its work supportingdrug development and discovery with NVIDIA Clara Discovery, announcing a partnership with Schrödinger to support the pharmaceutical industry with AI software to speed drug-discovery workflows.Professional VisualizationFirst-quarter revenue was a record $372 million, up 21 percent both from a year earlier and the previous quarter.Launched NVIDIA Omniverse™ Enterprisesoftware for real-time 3D design and collaboration, with BMW Group, Foster + Partners and WPP as early customers.UnveiledNVIDIA RTX™ GPUsfor next-gen laptop and desktop workstations, including the NVIDIA RTX A4000 and A5000 for desktops and the A2000, A3000, A4000 and A5000 for laptops.RevealedGANverse3D, an AI model for creating 3D object models from standard 2D images.AutomotiveFirst-quarter revenue was $154 million, down 1 percent from a year earlier and up 6 percent from the previous quarter.Unveiled NVIDIA DRIVE Atlan™, an AI-enabled processor for autonomous vehicles with 1,000 TOPS and data-center-grade security, targeting automakers’ 2025 vehicles.AnnouncedNVIDIA DRIVE Hyperion™ 8, the latest generation of a fully operational, open platform that reduces the time and cost to outfit vehicles with AI and surround sensors.Announced thatNVIDIA DRIVE™ will be powering intelligent new energy vehiclesfrom SAIC R Auto, IM Motors, Faraday Future and VinFast, starting in 2022.Revealed that Cruise is the latestrobotaxi company selecting NVIDIA DRIVE, following announcements by Amazon Zoox, DiDi (DIDI), Oxbotica, Pony.ai and AutoX.Announced thatVolvo Cars will use NVIDIA DRIVE Orin™ to power the autonomous driving computer in its next-generation cars, beginning with the XC90, to be revealed in 2022.Announced that theNVIDIA DRIVE platformpowers MBUX Hyperscreen, the AI cockpit in Mercedes-Benz’s new EQS sedan.Announced that TuSimple and Navistar will buildself-driving trucks powered by the NVIDIA DRIVE AGX™ platform, and the self-driving truck companyPlus will use NVIDIA DRIVE Orinfor its upcoming autonomous vehicle platform.","news_type":1},"isVote":1,"tweetType":1,"viewCount":248,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":104199466,"gmtCreate":1620361154555,"gmtModify":1631892448454,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Sea is good, but already skyrocketed....","listText":"Sea is good, but already skyrocketed....","text":"Sea is good, but already skyrocketed....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/104199466","repostId":"2133520488","repostType":4,"repost":{"id":"2133520488","pubTimestamp":1620357500,"share":"https://www.laohu8.com/m/news/2133520488?lang=&edition=full","pubTime":"2021-05-07 11:18","market":"us","language":"en","title":"Forget Dogecoin: These Stocks Are Infinitely Smarter Buys","url":"https://stock-news.laohu8.com/highlight/detail?id=2133520488","media":"Motley Fool","summary":"With the Dogecoin bull thesis easily debunked, this trio of high-growth companies is a better way to put your money to work.","content":"<p>For more than a century, the stock market has been the undisputed greatest wealth creator on the planet. Even though certain assets or commodities, such as gold and housing, have had short periods when they've outperformed equities, stocks have delivered the greatest and most consistent long-term returns.</p><p>Then cryptocurrencies came along about a decade ago and completely turned this thesis on its head. <b>Bitcoin</b>, the largest digital currency in the world by market cap, could once be purchased for less than $1 per token. This past weekend, each Bitcoin would set you back around $58,000. That's an insane return in just over a decade.</p><p>Unfortunately, this mountain of momentum that's built up in the crypto space has also given rise to some truly awful digital currencies. <b>Dogecoin</b> (CRYPTO:DOGE) is the perfect example.<img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F624448%2Fsmartphone-invest-robinhood-stock-market-trade-profit-loss-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h2>The Dogecoin bull thesis can be easily debunked</h2><p>Peruse any of the popular social media boards (Reddit or <b><a href=\"https://laohu8.com/S/TWTR\">Twitter</a></b>), and you'll get no shortage of reasons why Dogecoin is the greatest possible crypto to buy now. Enthusiasts often cite its lower transaction fees relative to Bitcoin and <b>Ethereum</b> (the No. 1 and 2 in terms of crypto market cap), improving adoption by retailers, and its community as reasons for its current and future success. Unfortunately, every \"catalyst\" for Dogecoin can be very easily debunked.</p><p>For example, Dogecoin does indeed have lower transaction fees than Bitcoin and Ethereum, but they're far from the lowest. While we're on the subject of cherry-picking comparison data, <b>Nano</b>, <b>Ripple</b>, <b>Stellar</b>, <b>Dash</b>, and <b>Litecoin</b>&nbsp;are just some of the cryptos that offer lower transaction fees. Nano, Ripple, Stellar, and Dash also validate and settle transactions faster than Dogecoin. In an arena where the barrier to entry is virtually nonexistent, Dogecoin offers no true competitive advantage on fees or transaction speed.</p><p>As for adoption, online business directory Cryptwerk suggests that around 1,300 companies accept Dogecoin. Nearly all of these businesses are obscure, and Dogecoin has had eight years to develop a following. Managing to be accepted by 1,300 businesses when well over 500 million companies exist worldwide isn't exactly game-changing utility.</p><p>Lastly, the community aspect looks to be built on hype. Without anything tangible to drive Dogecoin's valuation, most \"hodlers\" are waiting on the edge of their seats hoping <b>Tesla</b>'s CEO Elon Musk will mention Dogecoin in a tweet or say its name on an upcoming episode of <i>Saturday Night Live</i>, which he's hosting on May 8. These aren't tangible catalysts. They're the signs of a pump-and-dump asset.</p><h2>This trio of stocks would be a much smarter way to put your money to work</h2><p>Instead of potentially throwing your money away on a digital currency that was created as a joke in 2013, consider putting it to work in the following trio of infinitely smarter stocks.<img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F624448%2Fretail-shopping-store-online-sale-smartphone-website-ecommerce-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\">Image source: Getty Images.</p><h2>Sea Limited</h2><p>If growth, growth, and more growth is your thing, you're going to love Singapore-based <b>Sea Limited</b> (NYSE:SE). Sea is a bit of a conglomerate in that it has three exceptionally fast-growing operating segments.</p><p>For the time being, the greatest driver of adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) is the company's digital entertainment division. This segment, which focuses on mobile gaming, had more than 610 million active users in the fourth quarter, 73.1 million of whom were paying customers. With people stuck in their homes in 2020 due to the pandemic, gaming was a form of release and entertainment. As a result, the company's paying customers grew by 120%.</p><p>Arguably the more important operating segment is e-commerce. Sea's online Shopee platform has consistently been the most popular e-commerce download in Southeast Asia. The combination of people staying home and desiring the convenience of ordering goods online has sent Shopee's growth trajectory into the stratosphere. The amount of gross merchandise value transacted on its network doubled last year to $35.4 billion, with gross orders rising 133% to 2.8 billion. With Shopee making inroads in South America as well, it has aspirations of becoming <b>Amazon</b>&nbsp;2.0.</p><p>Third, Sea offers digital financial services to largely underbanked countries and communities. Last year, it handled $7.8 billion in mobile-wallet payment volume and counted north of 23 million paying customers.</p><p>Sea could realistically quadruple its revenue in four years, which makes it a much smarter bet than Dogecoin.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F624448%2Fcannabis-leaf-marijuana-pot-weed-cash-profit-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\">Image source: Getty Images.</p><h2>Trulieve Cannabis</h2><p>U.S. marijuana stocks can also be a source of immense gains this decade. Even if President Joe Biden and his administration fail to pass any cannabis reforms at the federal level, state-level legalizations are providing more than enough growth potential for U.S. multistate operators. That's why <b>Trulieve Cannabis</b> (OTC:TCNNF) could run circles around Dogecoin.</p><p>What allows Trulieve Cannabis to stand out from an increasingly crowded field of marijuana companies is its laser focus on a single state. A little over two weeks ago, the company opened its 85th and 86th dispensaries nationwide. And 81 of these 86 retail locations are in the Sunshine State.</p><p>Instead of planting its flag in as many legalized markets as possible, Trulieve decided to saturate <a href=\"https://laohu8.com/S/AONE\">one</a> of the largest states by annual cannabis sales. By piling into Florida, it's been able to effectively build up its brand without having to break the bank with marketing costs. Trulieve ended 2020 with a 53% share of the state's dried cannabis market and a 49% share of its oils market. It's worth pointing out that oils are a much higher-margin product and less susceptible to oversupply than dried cannabis.</p><p>Furthermore, Trulieve was profitable long before its peers. It's generated a profit for 12 consecutive quarters and should be profitable on a recurring basis moving forward. Being cash flow positive is a big advantage when it comes to opening new locations and attempting to expand its successful Florida blueprint to other legalized states.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F624448%2Fcomputer-data-saas-application-monitoring-enterprise-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\">Image source: Getty Images.</p><h2>Palantir Technologies</h2><p>A third stock that's an infinitely smarter buy than the hyped-up cryptocurrency Dogecoin is data-mining company <b>Palantir Technologies</b> (NYSE:PLTR).</p><p>Palantir is what you might call a dual threat. It has a platform that's specifically focused on helping the federal government categorize and analyze data (Gotham), and offers data-mining analytics for businesses, too (Foundry). Gotham is primarily used for defense purposes and military missions, whereas Foundry helps businesses visualize their data to make their operations more efficient.</p><p>Last year, Gotham was Palantir's primarily driver. Big military contract wins helped propel full-year sales for the company higher by 45%. But over the long run, Foundry offers more potential. Palantir has only scratched the surface of its potential customer pool for Foundry, and ended 2020 with 24 customers in the Global 300. There's work to be done to gain additional enterprise customers, but there's also a long runway of double-digit growth opportunity.</p><p>The thing to understand about Palantir Technologies' artificial-intelligence-driven platforms is that there's simply nothing else like them. This may be a controversial company given its tie-ins with certain federal agencies, but it's destined to be a moneymaker and a business that can keep growing by 30% or more for the next five years. That makes it a good bet to outperform Dogecoin.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Forget Dogecoin: These Stocks Are Infinitely Smarter Buys</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nForget Dogecoin: These Stocks Are Infinitely Smarter Buys\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-07 11:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/06/forget-dogecoin-stocks-are-infinitely-smarter-buys/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a century, the stock market has been the undisputed greatest wealth creator on the planet. Even though certain assets or commodities, such as gold and housing, have had short periods ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/06/forget-dogecoin-stocks-are-infinitely-smarter-buys/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TCNNF":"Trulieve Cannabis Corporation","SE":"Sea Ltd","PLTR":"Palantir Technologies Inc."},"source_url":"https://www.fool.com/investing/2021/05/06/forget-dogecoin-stocks-are-infinitely-smarter-buys/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2133520488","content_text":"For more than a century, the stock market has been the undisputed greatest wealth creator on the planet. Even though certain assets or commodities, such as gold and housing, have had short periods when they've outperformed equities, stocks have delivered the greatest and most consistent long-term returns.Then cryptocurrencies came along about a decade ago and completely turned this thesis on its head. Bitcoin, the largest digital currency in the world by market cap, could once be purchased for less than $1 per token. This past weekend, each Bitcoin would set you back around $58,000. That's an insane return in just over a decade.Unfortunately, this mountain of momentum that's built up in the crypto space has also given rise to some truly awful digital currencies. Dogecoin (CRYPTO:DOGE) is the perfect example.Image source: Getty Images.The Dogecoin bull thesis can be easily debunkedPeruse any of the popular social media boards (Reddit or Twitter), and you'll get no shortage of reasons why Dogecoin is the greatest possible crypto to buy now. Enthusiasts often cite its lower transaction fees relative to Bitcoin and Ethereum (the No. 1 and 2 in terms of crypto market cap), improving adoption by retailers, and its community as reasons for its current and future success. Unfortunately, every \"catalyst\" for Dogecoin can be very easily debunked.For example, Dogecoin does indeed have lower transaction fees than Bitcoin and Ethereum, but they're far from the lowest. While we're on the subject of cherry-picking comparison data, Nano, Ripple, Stellar, Dash, and Litecoin are just some of the cryptos that offer lower transaction fees. Nano, Ripple, Stellar, and Dash also validate and settle transactions faster than Dogecoin. In an arena where the barrier to entry is virtually nonexistent, Dogecoin offers no true competitive advantage on fees or transaction speed.As for adoption, online business directory Cryptwerk suggests that around 1,300 companies accept Dogecoin. Nearly all of these businesses are obscure, and Dogecoin has had eight years to develop a following. Managing to be accepted by 1,300 businesses when well over 500 million companies exist worldwide isn't exactly game-changing utility.Lastly, the community aspect looks to be built on hype. Without anything tangible to drive Dogecoin's valuation, most \"hodlers\" are waiting on the edge of their seats hoping Tesla's CEO Elon Musk will mention Dogecoin in a tweet or say its name on an upcoming episode of Saturday Night Live, which he's hosting on May 8. These aren't tangible catalysts. They're the signs of a pump-and-dump asset.This trio of stocks would be a much smarter way to put your money to workInstead of potentially throwing your money away on a digital currency that was created as a joke in 2013, consider putting it to work in the following trio of infinitely smarter stocks.Image source: Getty Images.Sea LimitedIf growth, growth, and more growth is your thing, you're going to love Singapore-based Sea Limited (NYSE:SE). Sea is a bit of a conglomerate in that it has three exceptionally fast-growing operating segments.For the time being, the greatest driver of adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) is the company's digital entertainment division. This segment, which focuses on mobile gaming, had more than 610 million active users in the fourth quarter, 73.1 million of whom were paying customers. With people stuck in their homes in 2020 due to the pandemic, gaming was a form of release and entertainment. As a result, the company's paying customers grew by 120%.Arguably the more important operating segment is e-commerce. Sea's online Shopee platform has consistently been the most popular e-commerce download in Southeast Asia. The combination of people staying home and desiring the convenience of ordering goods online has sent Shopee's growth trajectory into the stratosphere. The amount of gross merchandise value transacted on its network doubled last year to $35.4 billion, with gross orders rising 133% to 2.8 billion. With Shopee making inroads in South America as well, it has aspirations of becoming Amazon 2.0.Third, Sea offers digital financial services to largely underbanked countries and communities. Last year, it handled $7.8 billion in mobile-wallet payment volume and counted north of 23 million paying customers.Sea could realistically quadruple its revenue in four years, which makes it a much smarter bet than Dogecoin.Image source: Getty Images.Trulieve CannabisU.S. marijuana stocks can also be a source of immense gains this decade. Even if President Joe Biden and his administration fail to pass any cannabis reforms at the federal level, state-level legalizations are providing more than enough growth potential for U.S. multistate operators. That's why Trulieve Cannabis (OTC:TCNNF) could run circles around Dogecoin.What allows Trulieve Cannabis to stand out from an increasingly crowded field of marijuana companies is its laser focus on a single state. A little over two weeks ago, the company opened its 85th and 86th dispensaries nationwide. And 81 of these 86 retail locations are in the Sunshine State.Instead of planting its flag in as many legalized markets as possible, Trulieve decided to saturate one of the largest states by annual cannabis sales. By piling into Florida, it's been able to effectively build up its brand without having to break the bank with marketing costs. Trulieve ended 2020 with a 53% share of the state's dried cannabis market and a 49% share of its oils market. It's worth pointing out that oils are a much higher-margin product and less susceptible to oversupply than dried cannabis.Furthermore, Trulieve was profitable long before its peers. It's generated a profit for 12 consecutive quarters and should be profitable on a recurring basis moving forward. Being cash flow positive is a big advantage when it comes to opening new locations and attempting to expand its successful Florida blueprint to other legalized states.Image source: Getty Images.Palantir TechnologiesA third stock that's an infinitely smarter buy than the hyped-up cryptocurrency Dogecoin is data-mining company Palantir Technologies (NYSE:PLTR).Palantir is what you might call a dual threat. It has a platform that's specifically focused on helping the federal government categorize and analyze data (Gotham), and offers data-mining analytics for businesses, too (Foundry). Gotham is primarily used for defense purposes and military missions, whereas Foundry helps businesses visualize their data to make their operations more efficient.Last year, Gotham was Palantir's primarily driver. Big military contract wins helped propel full-year sales for the company higher by 45%. But over the long run, Foundry offers more potential. Palantir has only scratched the surface of its potential customer pool for Foundry, and ended 2020 with 24 customers in the Global 300. There's work to be done to gain additional enterprise customers, but there's also a long runway of double-digit growth opportunity.The thing to understand about Palantir Technologies' artificial-intelligence-driven platforms is that there's simply nothing else like them. This may be a controversial company given its tie-ins with certain federal agencies, but it's destined to be a moneymaker and a business that can keep growing by 30% or more for the next five years. That makes it a good bet to outperform Dogecoin.","news_type":1},"isVote":1,"tweetType":1,"viewCount":74,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":123088916,"gmtCreate":1624403655035,"gmtModify":1631888121034,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Turbulence time ahead....","listText":"Turbulence time ahead....","text":"Turbulence time ahead....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/123088916","repostId":"2145664330","repostType":4,"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":117098146,"gmtCreate":1623109160485,"gmtModify":1631890212525,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Wow....this is significant","listText":"Wow....this is significant","text":"Wow....this is significant","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/117098146","repostId":"2141453253","repostType":4,"repost":{"id":"2141453253","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1623096780,"share":"https://www.laohu8.com/m/news/2141453253?lang=&edition=full","pubTime":"2021-06-08 04:13","market":"us","language":"en","title":"Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK","url":"https://stock-news.laohu8.com/highlight/detail?id=2141453253","media":"Dow Jones","summary":"Shares rally to second -biggest one-day percentage gain since they went public 30 years agoShares of","content":"<p>Shares rally to second -biggest <a href=\"https://laohu8.com/S/AONE\">one</a>-day percentage gain since they went public 30 years ago</p><p>Shares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.</p><p>The stock <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> blasted $109.71, or 38.3% higher, to $395.85, the highest close since April 2015. The stock had been halted twice for volatility  during Monday's session, once at 10:44 a.m. Eastern and a second time at 1:37 p.m.</p><p>Trading volume spiked up to 17.7 million shares, compared with the full-day average over the past 30 days of about 1.0 million shares, according to FactSet.</p><p>Earlier Friday, the FDA approved Biogen's Aduhelm , also known as aducanumab, to treat Alzheimer's, the first drug to be approved that promises to actually slow the disease rather than just treat the symptoms.</p><p>Biogen investors were treated to the stock's biggest-ever <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day price gain, and second-biggest one-day percentage gain since it went public in September 1991. The stock had shot up $108.62, or 44.0%, on Nov. 4, 2020, after the FDA said there was \"substantial evidence\"</p><p>\"Currently available options only treat symptoms of the disease; this treatment option is the first therapy to target and affect the underlying disease process of Alzheimer's,\" said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research. \"As we have learned from the fight against cancer, the accelerated approval pathway can bring therapies to patients faster while spurring more research an innovation.\"</p><p>As the FDA described, accelerated approval can be based on the drug's effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients, with \"a required post-approval trial\" to verify the drug provides that expected clinical benefit.</p><p>Bernstein analyst Aaron Gal said approval under accelerated pathway is a distinction without a difference. \"The pathway allows for approval based on surrogate market, rather than completed efficacy endpoint data,\" Gal wrote in a note to clients. \"As long as Biogen does not challenge the use of the path, which they obviously would not, the approval holds.\"</p><p>Evercore ISI's Umer Raffat noted that the option of Accelerated Approval was not discussed by the FDA's advisory committee. And as the drug has \"clearly shown\" in all trials to substantially reduce amyloid beta plaques, the \"reduction in plaques is reasonably likely to result in clinical benefit.\"</p><p>Regarding labeling, Bernstein's Gal said it is \"almost shockingly broad,\" as the label just said Aduhelm is indicated for the treatment of Alzheimer's disease.</p><p>\"Thus, the approved population is broader than the tested population (mild-moderate Alzheimer's patients),\" Gal wrote. \"There is also no restriction on treatment duration suggesting that patients can stay on treatment until either all plaque is removed or the patient progresses.\"</p><p>Evercore's Raffat concurred, saying the label reads very very broad. He indicated that investors could be relieved, as there was some concern that the target population might be limited, and/or require very frequent monitoring.</p><p>Although pricing is still unknown, the Institute of Clinical and Economic Review (ICER) said that due to the relatively small overall health gains demonstrated in Phase 3 clinical trials, the drug should be price no higher than $8,400 a year, as MarketWatch's Jaimy Lee reported .</p><p>Some analysts say Biogen could price the drug higher than that, even though that might potentially trigger a regulatory response.</p><p>Evercore's Raffat said his financial estimates on Biogen include an estimate of $10,000, while Bernstein's Gal said the pricing could end up \"much higher,\" possibly as high as more than $30,000.</p><p>Gal said Biogen has a long history of pricing drugs in the \"specialty\" range, and is less likely to fear a backlash. \"Biogen would justify the price by arguing the total system impact would be modest upfront and that it will use the money to provide substantial services to [Alzheimer's disease] patients,\" Gal wrote.</p><p>Biogen and Eisai Inc., the U.S. subsidiary of Japan-based Eisai Co. Ltd. (4523.TO), announced after Aduhelm's approval programs intended to support access for all qualified patients, including those from traditionally underserved populations.</p><p>Eisai's U.S.-listed shares skyrocketed 68.9% in afternoon trading, on track for a record close and the biggest one-day gain since it started trading in the U.S. in December 1995.</p><p>\"We are committed to access and health equity as top priorities and will continue working with multiple stakeholders with the goal of helping patients who may benefit from treatment obtain care as quickly as possible,\" said Alisha Alaimo, president of Biogen U.S.</p><p>Biogen's stock has now run up 61.7% year to date, while SPDR Health Care Select Sector exchange-traded fund <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has gained 8.0% and the S&amp;P 500 index  has advanced 12.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen stock rockets to 6-year high after Alzheimer's drug gets FDA OK\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-06-08 04:13</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares rally to second -biggest <a href=\"https://laohu8.com/S/AONE\">one</a>-day percentage gain since they went public 30 years ago</p><p>Shares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.</p><p>The stock <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> blasted $109.71, or 38.3% higher, to $395.85, the highest close since April 2015. The stock had been halted twice for volatility  during Monday's session, once at 10:44 a.m. Eastern and a second time at 1:37 p.m.</p><p>Trading volume spiked up to 17.7 million shares, compared with the full-day average over the past 30 days of about 1.0 million shares, according to FactSet.</p><p>Earlier Friday, the FDA approved Biogen's Aduhelm , also known as aducanumab, to treat Alzheimer's, the first drug to be approved that promises to actually slow the disease rather than just treat the symptoms.</p><p>Biogen investors were treated to the stock's biggest-ever <a href=\"https://laohu8.com/S/AONE.U\">one</a>-day price gain, and second-biggest one-day percentage gain since it went public in September 1991. The stock had shot up $108.62, or 44.0%, on Nov. 4, 2020, after the FDA said there was \"substantial evidence\"</p><p>\"Currently available options only treat symptoms of the disease; this treatment option is the first therapy to target and affect the underlying disease process of Alzheimer's,\" said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research. \"As we have learned from the fight against cancer, the accelerated approval pathway can bring therapies to patients faster while spurring more research an innovation.\"</p><p>As the FDA described, accelerated approval can be based on the drug's effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients, with \"a required post-approval trial\" to verify the drug provides that expected clinical benefit.</p><p>Bernstein analyst Aaron Gal said approval under accelerated pathway is a distinction without a difference. \"The pathway allows for approval based on surrogate market, rather than completed efficacy endpoint data,\" Gal wrote in a note to clients. \"As long as Biogen does not challenge the use of the path, which they obviously would not, the approval holds.\"</p><p>Evercore ISI's Umer Raffat noted that the option of Accelerated Approval was not discussed by the FDA's advisory committee. And as the drug has \"clearly shown\" in all trials to substantially reduce amyloid beta plaques, the \"reduction in plaques is reasonably likely to result in clinical benefit.\"</p><p>Regarding labeling, Bernstein's Gal said it is \"almost shockingly broad,\" as the label just said Aduhelm is indicated for the treatment of Alzheimer's disease.</p><p>\"Thus, the approved population is broader than the tested population (mild-moderate Alzheimer's patients),\" Gal wrote. \"There is also no restriction on treatment duration suggesting that patients can stay on treatment until either all plaque is removed or the patient progresses.\"</p><p>Evercore's Raffat concurred, saying the label reads very very broad. He indicated that investors could be relieved, as there was some concern that the target population might be limited, and/or require very frequent monitoring.</p><p>Although pricing is still unknown, the Institute of Clinical and Economic Review (ICER) said that due to the relatively small overall health gains demonstrated in Phase 3 clinical trials, the drug should be price no higher than $8,400 a year, as MarketWatch's Jaimy Lee reported .</p><p>Some analysts say Biogen could price the drug higher than that, even though that might potentially trigger a regulatory response.</p><p>Evercore's Raffat said his financial estimates on Biogen include an estimate of $10,000, while Bernstein's Gal said the pricing could end up \"much higher,\" possibly as high as more than $30,000.</p><p>Gal said Biogen has a long history of pricing drugs in the \"specialty\" range, and is less likely to fear a backlash. \"Biogen would justify the price by arguing the total system impact would be modest upfront and that it will use the money to provide substantial services to [Alzheimer's disease] patients,\" Gal wrote.</p><p>Biogen and Eisai Inc., the U.S. subsidiary of Japan-based Eisai Co. Ltd. (4523.TO), announced after Aduhelm's approval programs intended to support access for all qualified patients, including those from traditionally underserved populations.</p><p>Eisai's U.S.-listed shares skyrocketed 68.9% in afternoon trading, on track for a record close and the biggest one-day gain since it started trading in the U.S. in December 1995.</p><p>\"We are committed to access and health equity as top priorities and will continue working with multiple stakeholders with the goal of helping patients who may benefit from treatment obtain care as quickly as possible,\" said Alisha Alaimo, president of Biogen U.S.</p><p>Biogen's stock has now run up 61.7% year to date, while SPDR Health Care Select Sector exchange-traded fund <a href=\"https://laohu8.com/S/XLV\">$(XLV)$</a> has gained 8.0% and the S&amp;P 500 index  has advanced 12.5%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BIIB":"渤健公司"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2141453253","content_text":"Shares rally to second -biggest one-day percentage gain since they went public 30 years agoShares of Biogen Inc. rocketed to a six-year high in volatile trading Monday, as Wall Street analysts cheered the U.S. Food and Drug Administration's broad labeling that came with the approval of the biotechnology company's Alzheimer's drug.The stock $(BIIB)$ blasted $109.71, or 38.3% higher, to $395.85, the highest close since April 2015. The stock had been halted twice for volatility  during Monday's session, once at 10:44 a.m. Eastern and a second time at 1:37 p.m.Trading volume spiked up to 17.7 million shares, compared with the full-day average over the past 30 days of about 1.0 million shares, according to FactSet.Earlier Friday, the FDA approved Biogen's Aduhelm , also known as aducanumab, to treat Alzheimer's, the first drug to be approved that promises to actually slow the disease rather than just treat the symptoms.Biogen investors were treated to the stock's biggest-ever one-day price gain, and second-biggest one-day percentage gain since it went public in September 1991. The stock had shot up $108.62, or 44.0%, on Nov. 4, 2020, after the FDA said there was \"substantial evidence\"\"Currently available options only treat symptoms of the disease; this treatment option is the first therapy to target and affect the underlying disease process of Alzheimer's,\" said Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research. \"As we have learned from the fight against cancer, the accelerated approval pathway can bring therapies to patients faster while spurring more research an innovation.\"As the FDA described, accelerated approval can be based on the drug's effect on a surrogate endpoint that is reasonably likely to predict a clinical benefit to patients, with \"a required post-approval trial\" to verify the drug provides that expected clinical benefit.Bernstein analyst Aaron Gal said approval under accelerated pathway is a distinction without a difference. \"The pathway allows for approval based on surrogate market, rather than completed efficacy endpoint data,\" Gal wrote in a note to clients. \"As long as Biogen does not challenge the use of the path, which they obviously would not, the approval holds.\"Evercore ISI's Umer Raffat noted that the option of Accelerated Approval was not discussed by the FDA's advisory committee. And as the drug has \"clearly shown\" in all trials to substantially reduce amyloid beta plaques, the \"reduction in plaques is reasonably likely to result in clinical benefit.\"Regarding labeling, Bernstein's Gal said it is \"almost shockingly broad,\" as the label just said Aduhelm is indicated for the treatment of Alzheimer's disease.\"Thus, the approved population is broader than the tested population (mild-moderate Alzheimer's patients),\" Gal wrote. \"There is also no restriction on treatment duration suggesting that patients can stay on treatment until either all plaque is removed or the patient progresses.\"Evercore's Raffat concurred, saying the label reads very very broad. He indicated that investors could be relieved, as there was some concern that the target population might be limited, and/or require very frequent monitoring.Although pricing is still unknown, the Institute of Clinical and Economic Review (ICER) said that due to the relatively small overall health gains demonstrated in Phase 3 clinical trials, the drug should be price no higher than $8,400 a year, as MarketWatch's Jaimy Lee reported .Some analysts say Biogen could price the drug higher than that, even though that might potentially trigger a regulatory response.Evercore's Raffat said his financial estimates on Biogen include an estimate of $10,000, while Bernstein's Gal said the pricing could end up \"much higher,\" possibly as high as more than $30,000.Gal said Biogen has a long history of pricing drugs in the \"specialty\" range, and is less likely to fear a backlash. \"Biogen would justify the price by arguing the total system impact would be modest upfront and that it will use the money to provide substantial services to [Alzheimer's disease] patients,\" Gal wrote.Biogen and Eisai Inc., the U.S. subsidiary of Japan-based Eisai Co. Ltd. (4523.TO), announced after Aduhelm's approval programs intended to support access for all qualified patients, including those from traditionally underserved populations.Eisai's U.S.-listed shares skyrocketed 68.9% in afternoon trading, on track for a record close and the biggest one-day gain since it started trading in the U.S. in December 1995.\"We are committed to access and health equity as top priorities and will continue working with multiple stakeholders with the goal of helping patients who may benefit from treatment obtain care as quickly as possible,\" said Alisha Alaimo, president of Biogen U.S.Biogen's stock has now run up 61.7% year to date, while SPDR Health Care Select Sector exchange-traded fund $(XLV)$ has gained 8.0% and the S&P 500 index  has advanced 12.5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":110832513,"gmtCreate":1622436859532,"gmtModify":1631892448435,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"To put SEA in this list is a huge surpriise to me.&nbsp; Dont get me wrong, i am a true fan of SEA and thus am optimistic on its growth trajectory. Hmmmm....to grow it into world top 10, I still think it is a bold prediction. Cheers","listText":"To put SEA in this list is a huge surpriise to me.&nbsp; Dont get me wrong, i am a true fan of SEA and thus am optimistic on its growth trajectory. Hmmmm....to grow it into world top 10, I still think it is a bold prediction. Cheers","text":"To put SEA in this list is a huge surpriise to me. Dont get me wrong, i am a true fan of SEA and thus am optimistic on its growth trajectory. Hmmmm....to grow it into world top 10, I still think it is a bold prediction. Cheers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/110832513","repostId":"2139487733","repostType":4,"repost":{"id":"2139487733","pubTimestamp":1622432435,"share":"https://www.laohu8.com/m/news/2139487733?lang=&edition=full","pubTime":"2021-05-31 11:40","market":"us","language":"en","title":"Prediction: These Will Be the 10 Largest Stocks by 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2139487733","media":"Motley Fool","summary":"Change is inevitable. The biggest stocks in the world by market cap will undoubtedly look a bit different in 14 years.","content":"<p>If there's one constant on Wall Street, it's that nothing remains constant for long. The combination of technological innovation, competitive advantages, acquisitions, and other tangible and intangible factors has a tendency to shake-up the world's largest companies on a regular basis.</p><p>For example, in 2004, <b>General Electric</b>, <b>ExxonMobil</b>, <b>Pfizer</b>, <b>Citigroup</b>, <b>Walmart</b>, <b>BP</b>, <b>AIG</b>, <b>Intel</b>, and <b>Bank of America</b> were nine of the 10 largest publicly traded companies by market cap. None are still in the top 10 just 17 years later. In fact, AIG isn't even in the top 250 anymore.</p><p>What might the top 10 look like in 2035? Frankly, we don't know. But given a number of proliferating high-growth trends, it won't stop me from making a prediction. In 14 years, these are likely to be the world's 10 largest publicly traded companies, presented in no particular order.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Fhourglass-coins-cash-bills-money-invest-rich-retirement-compound-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\">Image source: Getty Images.</p><h2>Amazon</h2><p>Unless e-commerce giant <b>Amazon.com</b> (NASDAQ:AMZN) decides to spin off its leading cloud infrastructure segment, Amazon Web Services (AWS), I consider it to have the best chance of being the largest company by market cap in 2035. Amazon currently controls more than 40% of all online sales in the U.S., and it's signed up 200 million people to Prime worldwide. The fees it collects from Prime memberships help to ensure it can undercut brick-and-mortar retailers on price.</p><p>As for AWS, it grew sales by 30% in 2020 (i.e., during the worst economic downturn in decades). AWS has a current run-rate of $54 billion in annual sales, meaning it alone could fetch a valuation north of $600 billion and still be valued cheaply within the cloud space. Because AWS generates considerably higher margins than retail, it's Amazon's key to a cash flow explosion in the years to come.<img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Fcloud-computing-data-server-storage-email-blockchain-saas-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h2>Microsoft</h2><p>Despite a myriad of change since 1999, tech stock <b>Microsoft</b> (NASDAQ:MSFT) is the only company to remain in the top 10 by market cap in 1999, 2004, 2009, 2014, 2019, and currently. Thus, it's a safe bet to suggest it'll hang onto a top-10 spot over the coming 14 years.</p><p>Although Microsoft is still generating plenty of cash flow from its legacy software and Windows operating system, the cloud is its future. Cloud infrastructure service Azure, along with enterprise and consumer cloud products across all of its core brands (Office, Dynamics, and Windows), can fuel sustainable double-digit or high single-digit growth for a long time to come.</p><p>Plus, Microsoft is loaded with cash, meaning it can use acquisitions as a means to boost its growth prospects and remain competitive.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Faapl-iphone-xr.PNG&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"463\" referrerpolicy=\"no-referrer\"></p><p>Image source: Apple.</p><h2>Apple</h2><p>Speaking of cash cows, I believe <b>Apple</b> (NASDAQ:AAPL) remains safely in the top 10, even if its growth rate were to taper a bit. Keep in mind that Apple generated nearly $100 billion in operating cash flow over the trailing 12 months, which means the company has an abundant cash pile to buy back its stock, pay dividends, reinvest in innovation, and make the occasional acquisition to bolster its product portfolio.</p><p>In the years to come, Tim Cook will continue to oversee Apple's transition to a services company. Subscription services boast higher margins than most products Apple sells, and will help reduce the revenue lumpiness associated with tech replacement cycles.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Fstudents-surfing-the-internet-studying-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h2><a href=\"https://laohu8.com/S/FB\">Facebook</a></h2><p>The social media space has proved especially fickle over the past 15 years, so there's certainly the risk <b>Facebook</b> (NASDAQ:FB) won't be <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the 10 largest companies by 2035. It could also be broken up by regulators, which would potentially remove it from consideration.</p><p>However, I chose to keep Facebook in the top 10 for two simple reasons. First, it had 44% of the world's population visit one of its owned assets in the first quarter. This makes it unlikely that any social media company will unseat it in the eyes of advertisers anytime soon.</p><p>Second, Facebook has only monetized two of its four prized assets (its namesake site and Instagram). When it decides to meaningfully monetize WhatsApp and Facebook Messenger, it'll enjoy a massive multiyear growth spurt.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Flaptop-internet-search-smartphone-work-from-home-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h2>Alphabet</h2><p>As with Facebook, ad-driven operating models come with risks. Thankfully, <b>Alphabet</b> (NASDAQ:GOOGL)(NASDAQ:GOOG) has ancillary operations and history on its side.</p><p>In terms of ancillary businesses, streaming content provider YouTube has grown into a top-three social media destination, and cloud infrastructure service Google Cloud now has an annual run-rate of more than $16 billion. Eventually, Cloud is going to do for Alphabet what AWS has done (and will continue to do) for Amazon.</p><p>Meanwhile, Alphabet's core business -- its Google internet search engine -- should benefit from long periods of economic expansion and the company's insane global share of internet search, which has ranged from 91% to 93% for two years.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Fairbnb1.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>Image source: Airbnb.</p><h2>Airbnb</h2><p>Perhaps the first big surprise is that I expect stay-and-hosting company <b>Airbnb</b> (NASDAQ:ABNB) to work its way into the top 10. That's because Airbnb is disrupting both the hotel stay side of the industry as well as the travel side of the equation.</p><p>At the moment, Airbnb has 4 million hosts worldwide. This is just a fraction of what the platform is capable of handling given the more than 130 million residences in the U.S. and around 1 billion residences worldwide.</p><p>Airbnb has also been pushing its Experiences platform -- i.e., adventures led by local experts. Nothing can stop Airbnb from entrenching itself further in vacation experiences. We're witnessing the early innings of true leisure industry disruption.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Fsquare-card-terminal.png&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"520\" referrerpolicy=\"no-referrer\"></p><p>Image source: Square.</p><h2>Square</h2><p>Fintech stock <b>Square</b> (NYSE:SQ) also has a very real opportunity to surpass <b><a href=\"https://laohu8.com/S/PYPL\">PayPal</a></b>&nbsp;over the next 14 years and work its way into the top 10.</p><p>Although Square should see steady growth from its seller ecosystem, the company's primary driver will be peer-to-peer digital payments platform Cash App. In three years, Cash App's monthly active user count has more than quintupled to 36 million. It's been a more popular download than PayPal's Venmo, and Square has been generating $41 in gross profit per user, compared to less than $5 in acquisition costs per user.</p><p>Square also completed the charter process to operate its own bank in March. This gives the company a full gamut of financial services it can offer in the high-margin digital banking space.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Fcredit-card-credit-score-debt-consumption-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"531\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h2><a href=\"https://laohu8.com/S/V\">Visa</a></h2><p>As of May 25, payment processing giant <b>Visa</b> (NYSE:V) was clinging the No. 10 spot with a $487 billion market cap, $3 billion ahead of <b>JPMorgan Chase</b>. I believe in 14 years it'll still be clinging to a top-10 spot and likely pushing above a $1 trillion valuation.</p><p>Visa is a cyclical business, which is a simple way of saying that it does really well when the U.S. and global economy are expanding and it struggles a bit when recession arise. However, this is a numbers game Visa is well-prepared to play. Periods of expansion last significantly longer than contractions. What's more, Visa isn't a lender, which means it's not required to set aside cash for delinquent loans when recession strike. Thus why it bounces back so quickly from economic contractions.</p><p>With a majority of the world's transactions still conducted in cash, Visa's growth runway extends decades into the future.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2F17191589198_aac39e29d5_k.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p><p>A jubilant Warren Buffett, Berkshire Hathaway CEO. Image source: The Motley Fool.</p><h2>Berkshire Hathaway</h2><p>In 14 years, it's unlikely that Warren Buffett and Charlie Munger are going to be running <b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) or dictating its investments. Thankfully, Buffett has laid out a winning game plan for his successors that should result in continued growth.</p><p>Similar to the Visa growth thesis (Visa is one of Berkshire's four-dozen holdings), most of Buffett's investment portfolio is tied up in cyclical businesses. The Oracle of Omaha has always thrived on playing the numbers game and betting on multiyear periods of economic expansion. He also loves a good dividend stock, which is why <b>Coca-Cola</b>&nbsp;and <b>American <a href=\"https://laohu8.com/S/EXPR\">Express</a></b>&nbsp;have been so valuable.</p><p>The wildcard here will be investment lieutenants Todd Combs and Ted Weschler. If they maintain Buffett's long-term approach and avoid trying to time the market, Berkshire Hathaway should be one of the 10 largest stocks come 2035.</p><p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F628448%2Fretail-shopping-store-online-sale-smartphone-website-ecommerce-getty.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p><p>Image source: Getty Images.</p><h2>Sea Limited</h2><p>A final surprise that could find its way into the top 10 is Singapore-based <b>Sea Limited</b> (NYSE:SE). A veritable no-name a couple of years ago, Sea has three extremely fast-growing businesses that could all help it reach a trillion-dollar valuation by 2035.</p><p>While mobile gaming is its primary generator of positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for the time being, it's e-commerce platform Shopee that'll be Sea's core sales and profit driver over the long run. \"But what about Amazon?\" you ask? Don't fret. Sea is primarily focused on emerging markets where the middle class is still taking shape. Sea and Amazon can thrive in their own separate niches.</p><p>Sea also has a nascent mobile wallet segment that could provide financial solutions to largely underbanked regions of Southeastern Asia. It has all the tools needed to be one of the world's largest companies.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Prediction: These Will Be the 10 Largest Stocks by 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPrediction: These Will Be the 10 Largest Stocks by 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-31 11:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/30/prediction-these-will-be-10-largest-stocks-by-2035/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If there's one constant on Wall Street, it's that nothing remains constant for long. The combination of technological innovation, competitive advantages, acquisitions, and other tangible and ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/30/prediction-these-will-be-10-largest-stocks-by-2035/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"V":"Visa","MSFT":"微软","AAPL":"苹果","AMZN":"亚马逊","BRK.B":"伯克希尔B","GOOG":"谷歌","SQ":"Block","QNETCN":"纳斯达克中美互联网老虎指数","GOOGL":"谷歌A","09086":"华夏纳指-U","03086":"华夏纳指","BRK.A":"伯克希尔"},"source_url":"https://www.fool.com/investing/2021/05/30/prediction-these-will-be-10-largest-stocks-by-2035/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2139487733","content_text":"If there's one constant on Wall Street, it's that nothing remains constant for long. The combination of technological innovation, competitive advantages, acquisitions, and other tangible and intangible factors has a tendency to shake-up the world's largest companies on a regular basis.For example, in 2004, General Electric, ExxonMobil, Pfizer, Citigroup, Walmart, BP, AIG, Intel, and Bank of America were nine of the 10 largest publicly traded companies by market cap. None are still in the top 10 just 17 years later. In fact, AIG isn't even in the top 250 anymore.What might the top 10 look like in 2035? Frankly, we don't know. But given a number of proliferating high-growth trends, it won't stop me from making a prediction. In 14 years, these are likely to be the world's 10 largest publicly traded companies, presented in no particular order.Image source: Getty Images.AmazonUnless e-commerce giant Amazon.com (NASDAQ:AMZN) decides to spin off its leading cloud infrastructure segment, Amazon Web Services (AWS), I consider it to have the best chance of being the largest company by market cap in 2035. Amazon currently controls more than 40% of all online sales in the U.S., and it's signed up 200 million people to Prime worldwide. The fees it collects from Prime memberships help to ensure it can undercut brick-and-mortar retailers on price.As for AWS, it grew sales by 30% in 2020 (i.e., during the worst economic downturn in decades). AWS has a current run-rate of $54 billion in annual sales, meaning it alone could fetch a valuation north of $600 billion and still be valued cheaply within the cloud space. Because AWS generates considerably higher margins than retail, it's Amazon's key to a cash flow explosion in the years to come.Image source: Getty Images.MicrosoftDespite a myriad of change since 1999, tech stock Microsoft (NASDAQ:MSFT) is the only company to remain in the top 10 by market cap in 1999, 2004, 2009, 2014, 2019, and currently. Thus, it's a safe bet to suggest it'll hang onto a top-10 spot over the coming 14 years.Although Microsoft is still generating plenty of cash flow from its legacy software and Windows operating system, the cloud is its future. Cloud infrastructure service Azure, along with enterprise and consumer cloud products across all of its core brands (Office, Dynamics, and Windows), can fuel sustainable double-digit or high single-digit growth for a long time to come.Plus, Microsoft is loaded with cash, meaning it can use acquisitions as a means to boost its growth prospects and remain competitive.Image source: Apple.AppleSpeaking of cash cows, I believe Apple (NASDAQ:AAPL) remains safely in the top 10, even if its growth rate were to taper a bit. Keep in mind that Apple generated nearly $100 billion in operating cash flow over the trailing 12 months, which means the company has an abundant cash pile to buy back its stock, pay dividends, reinvest in innovation, and make the occasional acquisition to bolster its product portfolio.In the years to come, Tim Cook will continue to oversee Apple's transition to a services company. Subscription services boast higher margins than most products Apple sells, and will help reduce the revenue lumpiness associated with tech replacement cycles.Image source: Getty Images.FacebookThe social media space has proved especially fickle over the past 15 years, so there's certainly the risk Facebook (NASDAQ:FB) won't be one of the 10 largest companies by 2035. It could also be broken up by regulators, which would potentially remove it from consideration.However, I chose to keep Facebook in the top 10 for two simple reasons. First, it had 44% of the world's population visit one of its owned assets in the first quarter. This makes it unlikely that any social media company will unseat it in the eyes of advertisers anytime soon.Second, Facebook has only monetized two of its four prized assets (its namesake site and Instagram). When it decides to meaningfully monetize WhatsApp and Facebook Messenger, it'll enjoy a massive multiyear growth spurt.Image source: Getty Images.AlphabetAs with Facebook, ad-driven operating models come with risks. Thankfully, Alphabet (NASDAQ:GOOGL)(NASDAQ:GOOG) has ancillary operations and history on its side.In terms of ancillary businesses, streaming content provider YouTube has grown into a top-three social media destination, and cloud infrastructure service Google Cloud now has an annual run-rate of more than $16 billion. Eventually, Cloud is going to do for Alphabet what AWS has done (and will continue to do) for Amazon.Meanwhile, Alphabet's core business -- its Google internet search engine -- should benefit from long periods of economic expansion and the company's insane global share of internet search, which has ranged from 91% to 93% for two years.Image source: Airbnb.AirbnbPerhaps the first big surprise is that I expect stay-and-hosting company Airbnb (NASDAQ:ABNB) to work its way into the top 10. That's because Airbnb is disrupting both the hotel stay side of the industry as well as the travel side of the equation.At the moment, Airbnb has 4 million hosts worldwide. This is just a fraction of what the platform is capable of handling given the more than 130 million residences in the U.S. and around 1 billion residences worldwide.Airbnb has also been pushing its Experiences platform -- i.e., adventures led by local experts. Nothing can stop Airbnb from entrenching itself further in vacation experiences. We're witnessing the early innings of true leisure industry disruption.Image source: Square.SquareFintech stock Square (NYSE:SQ) also has a very real opportunity to surpass PayPal over the next 14 years and work its way into the top 10.Although Square should see steady growth from its seller ecosystem, the company's primary driver will be peer-to-peer digital payments platform Cash App. In three years, Cash App's monthly active user count has more than quintupled to 36 million. It's been a more popular download than PayPal's Venmo, and Square has been generating $41 in gross profit per user, compared to less than $5 in acquisition costs per user.Square also completed the charter process to operate its own bank in March. This gives the company a full gamut of financial services it can offer in the high-margin digital banking space.Image source: Getty Images.VisaAs of May 25, payment processing giant Visa (NYSE:V) was clinging the No. 10 spot with a $487 billion market cap, $3 billion ahead of JPMorgan Chase. I believe in 14 years it'll still be clinging to a top-10 spot and likely pushing above a $1 trillion valuation.Visa is a cyclical business, which is a simple way of saying that it does really well when the U.S. and global economy are expanding and it struggles a bit when recession arise. However, this is a numbers game Visa is well-prepared to play. Periods of expansion last significantly longer than contractions. What's more, Visa isn't a lender, which means it's not required to set aside cash for delinquent loans when recession strike. Thus why it bounces back so quickly from economic contractions.With a majority of the world's transactions still conducted in cash, Visa's growth runway extends decades into the future.A jubilant Warren Buffett, Berkshire Hathaway CEO. Image source: The Motley Fool.Berkshire HathawayIn 14 years, it's unlikely that Warren Buffett and Charlie Munger are going to be running Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) or dictating its investments. Thankfully, Buffett has laid out a winning game plan for his successors that should result in continued growth.Similar to the Visa growth thesis (Visa is one of Berkshire's four-dozen holdings), most of Buffett's investment portfolio is tied up in cyclical businesses. The Oracle of Omaha has always thrived on playing the numbers game and betting on multiyear periods of economic expansion. He also loves a good dividend stock, which is why Coca-Cola and American Express have been so valuable.The wildcard here will be investment lieutenants Todd Combs and Ted Weschler. If they maintain Buffett's long-term approach and avoid trying to time the market, Berkshire Hathaway should be one of the 10 largest stocks come 2035.Image source: Getty Images.Sea LimitedA final surprise that could find its way into the top 10 is Singapore-based Sea Limited (NYSE:SE). A veritable no-name a couple of years ago, Sea has three extremely fast-growing businesses that could all help it reach a trillion-dollar valuation by 2035.While mobile gaming is its primary generator of positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for the time being, it's e-commerce platform Shopee that'll be Sea's core sales and profit driver over the long run. \"But what about Amazon?\" you ask? Don't fret. Sea is primarily focused on emerging markets where the middle class is still taking shape. Sea and Amazon can thrive in their own separate niches.Sea also has a nascent mobile wallet segment that could provide financial solutions to largely underbanked regions of Southeastern Asia. It has all the tools needed to be one of the world's largest companies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":80,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":150927820,"gmtCreate":1624883915760,"gmtModify":1631888121010,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Gene editing is the biggest winner on today market....well done.","listText":"Gene editing is the biggest winner on today market....well done.","text":"Gene editing is the biggest winner on today market....well done.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/150927820","repostId":"1149431635","repostType":4,"repost":{"id":"1149431635","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624882571,"share":"https://www.laohu8.com/m/news/1149431635?lang=&edition=full","pubTime":"2021-06-28 20:16","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1149431635","media":"Tiger Newspress","summary":"U.S. stock futures traded mixed in early pre-market trade\n\n\nVirgin Galactic stock surged another 6% ","content":"<ul>\n <li>U.S. stock futures traded mixed in early pre-market trade</li>\n</ul>\n<ul>\n <li>Virgin Galactic stock surged another 6% in premarket trading</li>\n</ul>\n<p>Futures tracking the S&amp;P 500 paused at an all-time high on Monday as investors stayed away from making big bets ahead of data on the health of a U.S. labor market recovery and corporate earnings later in the week.</p>\n<p>At 8:05 a.m. ET, Dow e-minis were down 33 points, or 0.1% and S&amp;P 500 e-minis were up 2.5 points, or 0.06%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a1d78faa2e0d7f393f800bb396bc1082\" tg-width=\"1080\" tg-height=\"425\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Nasdaq 100 e-minis were up 43.75 points, or 0.31% as megacap companies including Microsoft, Amazon&nbsp;and Facebook Inc&nbsp;edged higher in premarket trading.</p>\n<p>Crypto stocks follow the rise of Bitcoin in premarket trading.Marathon Digital,Riot Blockchain,Canaan&nbsp;and&nbsp;SOS Limited&nbsp;climbed between 1.8% and 6%.</p>\n<p>Quarterly results from Micron Technology, ConocoPhillips&nbsp;and Walgreens&nbsp;are slated for this week. On the economic front, attention will be on consumer confidence data, a private jobs report and a crucial monthly nonfarm payrolls report.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic&nbsp;(SPCE)</b>– Virgin Galactic shares surged another 6% in the premarket after geting the green light from the FAA to fly passengers to space.Virgin Galactic shares soared 38.87% to $55.91&nbsp;on last&nbsp;Friday in the regular session. The company’s shares have returned 135.6% on a year-to-date basis.</p>\n<p><b>Boeing&nbsp;(BA)</b> – Boeingis not likely to receive certification&nbsp;for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket.</p>\n<p><b>Baidu&nbsp;(BIDU)</b>&nbsp;–&nbsp;U.S-listed shares of Chinese tech giant Baidu rose 1.2% after its smart electric vehicle venture with automaker Geely [RIC:RIC:GEELY.UL], Jidu Auto, hired Frank Wu, formerly at Cadillac, to lead its design studio.</p>\n<p><b>Tesla&nbsp;(TSLA)</b> – Tesla&nbsp;is virtually recalling nearly 300,000 cars&nbsp;to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in order to receive the update.</p>\n<p><b>Nvidia&nbsp;(NVDA) </b>– Nvidia received support for its planned $40 billion takeover of ARM from some of the U.K. chip maker’s major customers, according to a report in the Sunday Times. The public display of support comes from&nbsp;Broadcom(AVGO),Marvell(MRVL) and MediaTek.</p>\n<p><b>Intellia Therapeutics&nbsp;(NTLA)</b> – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner&nbsp;Regeneron(REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with&nbsp;CRISPR Therapeutics(CRSP) soaring 13.5% and&nbsp;Editas Medicine(EDIT) jumping 17.1%.</p>\n<p><b>Perion Network&nbsp;(PERI)</b> – The advertising technology company’s shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast.</p>\n<p><b>Johnson &amp; Johnson&nbsp;(JNJ) </b>– Johnson &amp; Johnson will pay $263 million&nbsp;to resolve opioid-related claims&nbsp;in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&amp;J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday.</p>\n<p><b>Biogen&nbsp;(BIIB)</b> – House lawmakers announced an inquiry into the process that approved Biogen’s Alzheimer’s treatment as well as its pricing. Biogen told Reuters it would cooperate with any inquiries it received from lawmakers.</p>\n<p><b>MetLife&nbsp;(MET)</b> – MetLife received an offer from Netherlands-based insurer NN Group for some of MetLife’s European businesses, though NN did not say which businesses were involved or how much it had offered.</p>\n<p><b>MicroStrategy&nbsp;(MSTR)</b> – The business analytics company’s stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin. MicroStrategy has several billion dollars of the virtual currency on its books.</p>\n<p><b>Ocwen Financial&nbsp;(OCN),JOANN&nbsp;(JOAN)</b> – Both stocks will be included in the small-cap Russell 2000 index as of today. Ocwen is a mortgage origination and servicing company, while JOANN is an arts and crafts retailer.</p>\n<p><b>NRG Energy&nbsp;(NRG)</b> – The energy provider’s stock was added to the Conviction Buy list at Goldman Sachs, which also increased its price target on the stock to $57 per share from $46. The stock closed at $38.49 per share Friday, and gained 1.8% in premarket trading.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-28 20:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>U.S. stock futures traded mixed in early pre-market trade</li>\n</ul>\n<ul>\n <li>Virgin Galactic stock surged another 6% in premarket trading</li>\n</ul>\n<p>Futures tracking the S&amp;P 500 paused at an all-time high on Monday as investors stayed away from making big bets ahead of data on the health of a U.S. labor market recovery and corporate earnings later in the week.</p>\n<p>At 8:05 a.m. ET, Dow e-minis were down 33 points, or 0.1% and S&amp;P 500 e-minis were up 2.5 points, or 0.06%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a1d78faa2e0d7f393f800bb396bc1082\" tg-width=\"1080\" tg-height=\"425\" referrerpolicy=\"no-referrer\"><span>*Source From Tiger Trade, EST 08:05</span></p>\n<p>Nasdaq 100 e-minis were up 43.75 points, or 0.31% as megacap companies including Microsoft, Amazon&nbsp;and Facebook Inc&nbsp;edged higher in premarket trading.</p>\n<p>Crypto stocks follow the rise of Bitcoin in premarket trading.Marathon Digital,Riot Blockchain,Canaan&nbsp;and&nbsp;SOS Limited&nbsp;climbed between 1.8% and 6%.</p>\n<p>Quarterly results from Micron Technology, ConocoPhillips&nbsp;and Walgreens&nbsp;are slated for this week. On the economic front, attention will be on consumer confidence data, a private jobs report and a crucial monthly nonfarm payrolls report.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Virgin Galactic&nbsp;(SPCE)</b>– Virgin Galactic shares surged another 6% in the premarket after geting the green light from the FAA to fly passengers to space.Virgin Galactic shares soared 38.87% to $55.91&nbsp;on last&nbsp;Friday in the regular session. The company’s shares have returned 135.6% on a year-to-date basis.</p>\n<p><b>Boeing&nbsp;(BA)</b> – Boeingis not likely to receive certification&nbsp;for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket.</p>\n<p><b>Baidu&nbsp;(BIDU)</b>&nbsp;–&nbsp;U.S-listed shares of Chinese tech giant Baidu rose 1.2% after its smart electric vehicle venture with automaker Geely [RIC:RIC:GEELY.UL], Jidu Auto, hired Frank Wu, formerly at Cadillac, to lead its design studio.</p>\n<p><b>Tesla&nbsp;(TSLA)</b> – Tesla&nbsp;is virtually recalling nearly 300,000 cars&nbsp;to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in order to receive the update.</p>\n<p><b>Nvidia&nbsp;(NVDA) </b>– Nvidia received support for its planned $40 billion takeover of ARM from some of the U.K. chip maker’s major customers, according to a report in the Sunday Times. The public display of support comes from&nbsp;Broadcom(AVGO),Marvell(MRVL) and MediaTek.</p>\n<p><b>Intellia Therapeutics&nbsp;(NTLA)</b> – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner&nbsp;Regeneron(REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with&nbsp;CRISPR Therapeutics(CRSP) soaring 13.5% and&nbsp;Editas Medicine(EDIT) jumping 17.1%.</p>\n<p><b>Perion Network&nbsp;(PERI)</b> – The advertising technology company’s shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast.</p>\n<p><b>Johnson &amp; Johnson&nbsp;(JNJ) </b>– Johnson &amp; Johnson will pay $263 million&nbsp;to resolve opioid-related claims&nbsp;in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&amp;J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday.</p>\n<p><b>Biogen&nbsp;(BIIB)</b> – House lawmakers announced an inquiry into the process that approved Biogen’s Alzheimer’s treatment as well as its pricing. Biogen told Reuters it would cooperate with any inquiries it received from lawmakers.</p>\n<p><b>MetLife&nbsp;(MET)</b> – MetLife received an offer from Netherlands-based insurer NN Group for some of MetLife’s European businesses, though NN did not say which businesses were involved or how much it had offered.</p>\n<p><b>MicroStrategy&nbsp;(MSTR)</b> – The business analytics company’s stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin. MicroStrategy has several billion dollars of the virtual currency on its books.</p>\n<p><b>Ocwen Financial&nbsp;(OCN),JOANN&nbsp;(JOAN)</b> – Both stocks will be included in the small-cap Russell 2000 index as of today. Ocwen is a mortgage origination and servicing company, while JOANN is an arts and crafts retailer.</p>\n<p><b>NRG Energy&nbsp;(NRG)</b> – The energy provider’s stock was added to the Conviction Buy list at Goldman Sachs, which also increased its price target on the stock to $57 per share from $46. The stock closed at $38.49 per share Friday, and gained 1.8% in premarket trading.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149431635","content_text":"U.S. stock futures traded mixed in early pre-market trade\n\n\nVirgin Galactic stock surged another 6% in premarket trading\n\nFutures tracking the S&P 500 paused at an all-time high on Monday as investors stayed away from making big bets ahead of data on the health of a U.S. labor market recovery and corporate earnings later in the week.\nAt 8:05 a.m. ET, Dow e-minis were down 33 points, or 0.1% and S&P 500 e-minis were up 2.5 points, or 0.06%.\n*Source From Tiger Trade, EST 08:05\nNasdaq 100 e-minis were up 43.75 points, or 0.31% as megacap companies including Microsoft, Amazon and Facebook Inc edged higher in premarket trading.\nCrypto stocks follow the rise of Bitcoin in premarket trading.Marathon Digital,Riot Blockchain,Canaan and SOS Limited climbed between 1.8% and 6%.\nQuarterly results from Micron Technology, ConocoPhillips and Walgreens are slated for this week. On the economic front, attention will be on consumer confidence data, a private jobs report and a crucial monthly nonfarm payrolls report.\nStocks making the biggest moves in the premarket:\nVirgin Galactic (SPCE)– Virgin Galactic shares surged another 6% in the premarket after geting the green light from the FAA to fly passengers to space.Virgin Galactic shares soared 38.87% to $55.91 on last Friday in the regular session. The company’s shares have returned 135.6% on a year-to-date basis.\nBoeing (BA) – Boeingis not likely to receive certification for its 777X long-range aircraft until mid-to-late 2023 at the earliest. That’s according to a letter from a Federal Aviation Administration official to Boeing that was obtained by CNBC, saying there were numerous technical issues that needed to be resolved. Boeing shares fell 1.2% in the premarket.\nBaidu (BIDU) – U.S-listed shares of Chinese tech giant Baidu rose 1.2% after its smart electric vehicle venture with automaker Geely [RIC:RIC:GEELY.UL], Jidu Auto, hired Frank Wu, formerly at Cadillac, to lead its design studio.\nTesla (TSLA) – Tesla is virtually recalling nearly 300,000 cars to implement a software update related to assisted driving. The owners will not actually have to return the vehicles in order to receive the update.\nNvidia (NVDA) – Nvidia received support for its planned $40 billion takeover of ARM from some of the U.K. chip maker’s major customers, according to a report in the Sunday Times. The public display of support comes from Broadcom(AVGO),Marvell(MRVL) and MediaTek.\nIntellia Therapeutics (NTLA) – Intellia shares surged 55.4% in the premarket after the Massachusetts-based company and partner Regeneron(REGN) announced positive results in a phase 1 study of a gene-editing treatment for a disease called transthyretin amyloidosis. Regeneron shares gained 1.6%. Two other companies involved with the same gene-editing technology also rallied in premarket trading, with CRISPR Therapeutics(CRSP) soaring 13.5% and Editas Medicine(EDIT) jumping 17.1%.\nPerion Network (PERI) – The advertising technology company’s shares surged 9.9% in the premarket after reporting upbeat second-quarter earnings and increasing its full-year forecast.\nJohnson & Johnson (JNJ) – Johnson & Johnson will pay $263 million to resolve opioid-related claims in a settlement involving both the state and Nassau and Suffolk Counties. The settlement – in which J&J does not admit or deny guilt – removes the company from an opioid trial set to begin Tuesday.\nBiogen (BIIB) – House lawmakers announced an inquiry into the process that approved Biogen’s Alzheimer’s treatment as well as its pricing. Biogen told Reuters it would cooperate with any inquiries it received from lawmakers.\nMetLife (MET) – MetLife received an offer from Netherlands-based insurer NN Group for some of MetLife’s European businesses, though NN did not say which businesses were involved or how much it had offered.\nMicroStrategy (MSTR) – The business analytics company’s stock gained 3.3% in premarket trading, continuing to trade in sync with bitcoin. MicroStrategy has several billion dollars of the virtual currency on its books.\nOcwen Financial (OCN),JOANN (JOAN) – Both stocks will be included in the small-cap Russell 2000 index as of today. Ocwen is a mortgage origination and servicing company, while JOANN is an arts and crafts retailer.\nNRG Energy (NRG) – The energy provider’s stock was added to the Conviction Buy list at Goldman Sachs, which also increased its price target on the stock to $57 per share from $46. The stock closed at $38.49 per share Friday, and gained 1.8% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":412,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":163032019,"gmtCreate":1623853005231,"gmtModify":1631890212449,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Cathie is confident on draftkings future....","listText":"Cathie is confident on draftkings future....","text":"Cathie is confident on draftkings future....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/163032019","repostId":"1100405031","repostType":4,"isVote":1,"tweetType":1,"viewCount":127,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":169512318,"gmtCreate":1623842610634,"gmtModify":1631890212463,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Sensitive time period....on fed policies.","listText":"Sensitive time period....on fed policies.","text":"Sensitive time period....on fed policies.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/169512318","repostId":"1185142374","repostType":4,"repost":{"id":"1185142374","pubTimestamp":1623811255,"share":"https://www.laohu8.com/m/news/1185142374?lang=&edition=full","pubTime":"2021-06-16 10:40","market":"us","language":"en","title":"The Fed Should Talk About Tapering. Here’s What Could Happen to the Stock Market.","url":"https://stock-news.laohu8.com/highlight/detail?id=1185142374","media":"Barrons","summary":"Investors expect the Federal Reserve to remain supportive of the economy and financial markets. But ","content":"<p>Investors expect the Federal Reserve to remain supportive of the economy and financial markets. But the central bank has limited margin for error, and any miscues on messaging could be costly to the stock market.</p>\n<p>Markets do not expect the Fed to make any sudden or drastic changes to its current easy-money policy. The 10-year Treasury bond’s yield has fallen to 1.51% from 1.64% a month ago, even as inflation has run hotter than expected. The Nasdaq 100, an index of large capitalization and fast-growing technology companies,is up more than 5% in the past month. Growth stocks see a significant valuation booster when long-dated bond yields remain low, as growth companies expect growing profits on a particularly long-term basis. But while&nbsp;investors expect the Fed to soon reduce the size of its bond-buying program, which would raise bond prices and lower their yields, most don’t think the Fed will do so immediately or drastically.</p>\n<p>“It’s pretty clear that the market expects Fed Chair Powell to strongly reiterate his stances,” writes Chris Senyek, chief investment strategist at Wolfe Research.</p>\n<p>Now, the Fed could stoke a harsh move downwards in tech stocks if it doesn’t choose its words wisely. With the Nasdaq 100 hovering just below a new all-time high set on June 14—accompanied with a 10-year Treasury bond yield that’s well below its 2021 peak of 1.75%—tech stocks are vulnerable to a downward jolt if the Fed misspeaks. Senyek notes that the Fed may indeed be more ready to taper—or reduce the size of its bond-buying program—than some appreciate. He cites the&nbsp;recently hot inflation. To be sure, most market participants see&nbsp;inflation as transitory, a result of a natural year-over-year bounce from low prices during last year’s lockdown. Even so, if the Fed speaks in a way that indicates it will begin tapering before the end of the year—which is the expected timing—stocks could fall sharply.</p>\n<p>“With both stocks and bonds currently ‘priced for perfection,’ the slightest miscommunication could spark a sharp selloff,” says Senyek, who cites the Nasdsaq 100’s recent rise.</p>\n<p>Watch to see if the Fed is about to begin tapering, or is merely considering the move in the coming quarters.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Fed Should Talk About Tapering. Here’s What Could Happen to the Stock Market.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Fed Should Talk About Tapering. Here’s What Could Happen to the Stock Market.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-16 10:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/the-fed-tapering-stock-market-51623777984?mod=RTA><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors expect the Federal Reserve to remain supportive of the economy and financial markets. But the central bank has limited margin for error, and any miscues on messaging could be costly to the ...</p>\n\n<a href=\"https://www.barrons.com/articles/the-fed-tapering-stock-market-51623777984?mod=RTA\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"source_url":"https://www.barrons.com/articles/the-fed-tapering-stock-market-51623777984?mod=RTA","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185142374","content_text":"Investors expect the Federal Reserve to remain supportive of the economy and financial markets. But the central bank has limited margin for error, and any miscues on messaging could be costly to the stock market.\nMarkets do not expect the Fed to make any sudden or drastic changes to its current easy-money policy. The 10-year Treasury bond’s yield has fallen to 1.51% from 1.64% a month ago, even as inflation has run hotter than expected. The Nasdaq 100, an index of large capitalization and fast-growing technology companies,is up more than 5% in the past month. Growth stocks see a significant valuation booster when long-dated bond yields remain low, as growth companies expect growing profits on a particularly long-term basis. But while investors expect the Fed to soon reduce the size of its bond-buying program, which would raise bond prices and lower their yields, most don’t think the Fed will do so immediately or drastically.\n“It’s pretty clear that the market expects Fed Chair Powell to strongly reiterate his stances,” writes Chris Senyek, chief investment strategist at Wolfe Research.\nNow, the Fed could stoke a harsh move downwards in tech stocks if it doesn’t choose its words wisely. With the Nasdaq 100 hovering just below a new all-time high set on June 14—accompanied with a 10-year Treasury bond yield that’s well below its 2021 peak of 1.75%—tech stocks are vulnerable to a downward jolt if the Fed misspeaks. Senyek notes that the Fed may indeed be more ready to taper—or reduce the size of its bond-buying program—than some appreciate. He cites the recently hot inflation. To be sure, most market participants see inflation as transitory, a result of a natural year-over-year bounce from low prices during last year’s lockdown. Even so, if the Fed speaks in a way that indicates it will begin tapering before the end of the year—which is the expected timing—stocks could fall sharply.\n“With both stocks and bonds currently ‘priced for perfection,’ the slightest miscommunication could spark a sharp selloff,” says Senyek, who cites the Nasdsaq 100’s recent rise.\nWatch to see if the Fed is about to begin tapering, or is merely considering the move in the coming quarters.","news_type":1},"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136537472,"gmtCreate":1622027223296,"gmtModify":1631892448449,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Good Q1 report card....cheers","listText":"Good Q1 report card....cheers","text":"Good Q1 report card....cheers","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/136537472","repostId":"1115191257","repostType":4,"repost":{"id":"1115191257","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1622025558,"share":"https://www.laohu8.com/m/news/1115191257?lang=&edition=full","pubTime":"2021-05-26 18:39","market":"us","language":"en","title":"China's Pinduoduo beats quarterly revenue estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1115191257","media":"Tiger Newspress","summary":"Chinese e-commerce platform Pinduoduo Inc's quarterly revenue beat Wall Street estimates on Wednesda","content":"<p>Chinese e-commerce platform Pinduoduo Inc's quarterly revenue beat Wall Street estimates on Wednesday, driven by steady demand for online shopping following the COVID-19 pandemic.</p><p>Total revenue more than tripled to 22.17 billion yuan ($3.47 billion)in the first quarter, boosted by Pinduoduo's online marketing services revenue. Analysts on average had expected revenue of 20.2 billion yuan, according to IBES data from Refinitiv.</p><p>The interactive buying platform's net loss attributable to shareholders narrowed to 2.91 billion yuan in the quarter ended March 31, from 4.12 billion yuan a year earlier.</p><p>Active buyers on Pinduoduo in the 12-month period ended March rose 31% to about 824 million, outpacing Alibaba's 811 million.</p><p>Pinduoduo&nbsp;stock&nbsp;surged more than 3% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/d78d44a7114b62db59be95f65e93e84e\" tg-width=\"1302\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><b>First Quarter 2021 Highlights</b></p><ul><li><b>Total revenues</b>&nbsp;in the quarter were&nbsp;RMB22,167.1 million&nbsp;(US$13,383.4 million), an increase of 239% from&nbsp;RMB6,541.1 millionin the same quarter of 2020.</li><li><b>Average monthly active users</b>&nbsp;in the quarter was 724.6 million, an increase of 49% from 487.4 million in the same quarter of 2020.</li><li><b>Active buyers</b>&nbsp;in the twelve-month period endedMarch 31, 2021was 823.8 million, an increase of 31% from 628.1 million in the twelve-month period endedMarch 31, 2020.</li><li><b>Operating loss</b>&nbsp;in the quarter was&nbsp;RMB4,147.0 million(US$633.0 million), compared with operating loss of&nbsp;RMB4,397.2 millionin the same quarter of 2020.<b>Non-GAAP4&nbsp;operating loss</b>&nbsp;in the quarter wasRMB&nbsp;3,174.1 million(US$484.5 million), compared with operating loss ofRMB3,587.9 millionin the same quarter of 2020.</li><li><b>Net loss attributable to ordinary shareholders</b>&nbsp;in the quarter was&nbsp;RMB2,905.4 million(US$ 443.5 million), compared with&nbsp;RMB4,119.3 millionin the same quarter of 2020.<b>Non-GAAP net loss attributable to ordinary shareholders</b>&nbsp;in the quarter was&nbsp;RMB1,890.3 million(US$288.5 million), compared withRMB3,169.6 millionin the same quarter of 2020.</li></ul><p>“Our growing scale gives us both greater capacity and responsibility to live up to our mission to ‘benefit all’,” said Mr.Lei Chen, Chairman and Chief Executive Officer ofPinduoduo. “We envisionPinduoduoas a platform that not only facilitates the trading of goods and services but also serves as a conduit for turning ideas into solutions to everyday problems.”</p><p>“We remain laser-focused on serving our users and anticipating what they need, and doing so in a way that is respectful of the community and environment,” added Mr.David Liu, Vice President of Strategy. “We will continue to engage our users, merchants and partners in improving all aspects of our services.”</p><p>“We continued to deliver strong results in the first quarter and remain disciplined,” said Mr.Tony Ma, Vice President of Finance. “Our total revenues, excluding contribution from merchandise sales, for the first quarter 2021 increased 161% from the prior year, while our non-GAAP operating and net losses narrowed at the same time.”</p><p><b>First Quarter 2021 Unaudited Financial Results</b></p><p><b>Total revenues</b>wereRMB22,167.1 million(US$3,383.4 million), an increase of 239% fromRMB6,541.1 millionin the same quarter of 2020. The increase was primarily due to an increase in revenues from online marketing services and contribution from merchandise sales.</p><ul><li><b>Revenues from online marketing services and others</b>wereRMB14,111.5 million(US$2,153.8 million), an increase of 157% fromRMB5,492.3 millionin the same quarter of 2020.</li><li><b>Revenues from transaction services</b>wereRMB2,931.5 million(US$447.4 million), an increase of 180% fromRMB1,048.8 millionin the same quarter of 2020.</li><li><b>Revenues from merchandise sales</b>wereRMB5,124.1 million(US$782.1 million), an increase ofRMB5,124.1 millionfrom nil in the same quarter of 2020.</li></ul><p><b>Total costs of revenues</b>wereRMB10,746.1 million(US$1,640.2 million), an increase of 487% fromRMB1,830.2 millionin the same quarter of 2020. The increase was mainly due to costs attributable to merchandise sales, higher cost of payment processing fees, cloud services fees, and delivery and storage fees.</p><p><b>Total operating expenses</b>wereRMB15,568.0 million(US$2,376.1 million), compared withRMB9,108.0 millionin the same quarter of 2020.</p><ul><li><b>Sales and marketing expenses</b>wereRMB12,997.4 million(US$1,983.8 million), an increase of 78% fromRMB7,296.6 millionin the same quarter of 2020, mainly due to an increase in advertising expenses and promotion and coupon expenses.</li><li><b>General and administrative expenses</b>wereRMB351.9 million(US$53.7 million), an increase of 4% fromRMB338.3 millionin the same quarter of 2020.</li><li><b>Research and development expenses</b>wereRMB2,218.7 million(US$338.6 million), an increase of 51% fromRMB1,473.2 millionin the same quarter of 2020. The increase was primarily due to an increase in headcount and the recruitment of more experienced R&amp;D personnel and an increase in R&amp;D-related cloud services expenses.</li></ul><p><b>Operating loss</b>wasRMB4,147.0 million(US$633.0 million), compared with operating loss ofRMB4,397.2 millionin the same quarter of 2020.<b>Non-GAAP operating loss</b>wasRMB3,174.1 million(US$484.5 million), compared with operating loss ofRMB3,587.9 millionin the same quarter of 2020.</p><p><b>Net loss attributable to ordinary shareholders</b>wasRMB2,905.4 million(US$443.5 million), compared withRMB4,119.3 millionin the same quarter of 2020.<b>Non-GAAP net loss attributable to ordinary shareholders</b>wasRMB1,890.3 million(US$288.5 million), compared withRMB3,169.6 millionin the same quarter of 2020.</p><p><b>Basic and diluted net loss per ADS</b>wereRMB2.33(US$0.36), compared withRMB3.54in the same quarter of 2020.<b>Non-GAAP basic and diluted net loss per ADS</b>wereRMB1.52(US$0.23), compared withRMB2.73in the same quarter of 2020.</p><p><b>Net cash flow used in operating activities</b>wasRMB3,724.5 million(US$568.5 million), compared withRMB567.1 millionin the same quarter of 2020, primarily due to an increase in restricted cash outflow due to seasonality, offset by increase in online marketing services revenues.</p><p><b>Cash, cash equivalents and short-term investments</b>wereRMB83.4 billion(US$12.7 billion) as ofMarch 31, 2021, compared withRMB87.0 billionas ofDecember 31, 2020.</p><p><b>Recent Development</b></p><p>As ofApril 30, 2021,US$756.4 millionof the 0% convertible bonds due in 2024 have been converted into newly issued ADSs.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China's Pinduoduo beats quarterly revenue estimates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina's Pinduoduo beats quarterly revenue estimates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-05-26 18:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Chinese e-commerce platform Pinduoduo Inc's quarterly revenue beat Wall Street estimates on Wednesday, driven by steady demand for online shopping following the COVID-19 pandemic.</p><p>Total revenue more than tripled to 22.17 billion yuan ($3.47 billion)in the first quarter, boosted by Pinduoduo's online marketing services revenue. Analysts on average had expected revenue of 20.2 billion yuan, according to IBES data from Refinitiv.</p><p>The interactive buying platform's net loss attributable to shareholders narrowed to 2.91 billion yuan in the quarter ended March 31, from 4.12 billion yuan a year earlier.</p><p>Active buyers on Pinduoduo in the 12-month period ended March rose 31% to about 824 million, outpacing Alibaba's 811 million.</p><p>Pinduoduo&nbsp;stock&nbsp;surged more than 3% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/d78d44a7114b62db59be95f65e93e84e\" tg-width=\"1302\" tg-height=\"663\" referrerpolicy=\"no-referrer\"></p><p><b>First Quarter 2021 Highlights</b></p><ul><li><b>Total revenues</b>&nbsp;in the quarter were&nbsp;RMB22,167.1 million&nbsp;(US$13,383.4 million), an increase of 239% from&nbsp;RMB6,541.1 millionin the same quarter of 2020.</li><li><b>Average monthly active users</b>&nbsp;in the quarter was 724.6 million, an increase of 49% from 487.4 million in the same quarter of 2020.</li><li><b>Active buyers</b>&nbsp;in the twelve-month period endedMarch 31, 2021was 823.8 million, an increase of 31% from 628.1 million in the twelve-month period endedMarch 31, 2020.</li><li><b>Operating loss</b>&nbsp;in the quarter was&nbsp;RMB4,147.0 million(US$633.0 million), compared with operating loss of&nbsp;RMB4,397.2 millionin the same quarter of 2020.<b>Non-GAAP4&nbsp;operating loss</b>&nbsp;in the quarter wasRMB&nbsp;3,174.1 million(US$484.5 million), compared with operating loss ofRMB3,587.9 millionin the same quarter of 2020.</li><li><b>Net loss attributable to ordinary shareholders</b>&nbsp;in the quarter was&nbsp;RMB2,905.4 million(US$ 443.5 million), compared with&nbsp;RMB4,119.3 millionin the same quarter of 2020.<b>Non-GAAP net loss attributable to ordinary shareholders</b>&nbsp;in the quarter was&nbsp;RMB1,890.3 million(US$288.5 million), compared withRMB3,169.6 millionin the same quarter of 2020.</li></ul><p>“Our growing scale gives us both greater capacity and responsibility to live up to our mission to ‘benefit all’,” said Mr.Lei Chen, Chairman and Chief Executive Officer ofPinduoduo. “We envisionPinduoduoas a platform that not only facilitates the trading of goods and services but also serves as a conduit for turning ideas into solutions to everyday problems.”</p><p>“We remain laser-focused on serving our users and anticipating what they need, and doing so in a way that is respectful of the community and environment,” added Mr.David Liu, Vice President of Strategy. “We will continue to engage our users, merchants and partners in improving all aspects of our services.”</p><p>“We continued to deliver strong results in the first quarter and remain disciplined,” said Mr.Tony Ma, Vice President of Finance. “Our total revenues, excluding contribution from merchandise sales, for the first quarter 2021 increased 161% from the prior year, while our non-GAAP operating and net losses narrowed at the same time.”</p><p><b>First Quarter 2021 Unaudited Financial Results</b></p><p><b>Total revenues</b>wereRMB22,167.1 million(US$3,383.4 million), an increase of 239% fromRMB6,541.1 millionin the same quarter of 2020. The increase was primarily due to an increase in revenues from online marketing services and contribution from merchandise sales.</p><ul><li><b>Revenues from online marketing services and others</b>wereRMB14,111.5 million(US$2,153.8 million), an increase of 157% fromRMB5,492.3 millionin the same quarter of 2020.</li><li><b>Revenues from transaction services</b>wereRMB2,931.5 million(US$447.4 million), an increase of 180% fromRMB1,048.8 millionin the same quarter of 2020.</li><li><b>Revenues from merchandise sales</b>wereRMB5,124.1 million(US$782.1 million), an increase ofRMB5,124.1 millionfrom nil in the same quarter of 2020.</li></ul><p><b>Total costs of revenues</b>wereRMB10,746.1 million(US$1,640.2 million), an increase of 487% fromRMB1,830.2 millionin the same quarter of 2020. The increase was mainly due to costs attributable to merchandise sales, higher cost of payment processing fees, cloud services fees, and delivery and storage fees.</p><p><b>Total operating expenses</b>wereRMB15,568.0 million(US$2,376.1 million), compared withRMB9,108.0 millionin the same quarter of 2020.</p><ul><li><b>Sales and marketing expenses</b>wereRMB12,997.4 million(US$1,983.8 million), an increase of 78% fromRMB7,296.6 millionin the same quarter of 2020, mainly due to an increase in advertising expenses and promotion and coupon expenses.</li><li><b>General and administrative expenses</b>wereRMB351.9 million(US$53.7 million), an increase of 4% fromRMB338.3 millionin the same quarter of 2020.</li><li><b>Research and development expenses</b>wereRMB2,218.7 million(US$338.6 million), an increase of 51% fromRMB1,473.2 millionin the same quarter of 2020. The increase was primarily due to an increase in headcount and the recruitment of more experienced R&amp;D personnel and an increase in R&amp;D-related cloud services expenses.</li></ul><p><b>Operating loss</b>wasRMB4,147.0 million(US$633.0 million), compared with operating loss ofRMB4,397.2 millionin the same quarter of 2020.<b>Non-GAAP operating loss</b>wasRMB3,174.1 million(US$484.5 million), compared with operating loss ofRMB3,587.9 millionin the same quarter of 2020.</p><p><b>Net loss attributable to ordinary shareholders</b>wasRMB2,905.4 million(US$443.5 million), compared withRMB4,119.3 millionin the same quarter of 2020.<b>Non-GAAP net loss attributable to ordinary shareholders</b>wasRMB1,890.3 million(US$288.5 million), compared withRMB3,169.6 millionin the same quarter of 2020.</p><p><b>Basic and diluted net loss per ADS</b>wereRMB2.33(US$0.36), compared withRMB3.54in the same quarter of 2020.<b>Non-GAAP basic and diluted net loss per ADS</b>wereRMB1.52(US$0.23), compared withRMB2.73in the same quarter of 2020.</p><p><b>Net cash flow used in operating activities</b>wasRMB3,724.5 million(US$568.5 million), compared withRMB567.1 millionin the same quarter of 2020, primarily due to an increase in restricted cash outflow due to seasonality, offset by increase in online marketing services revenues.</p><p><b>Cash, cash equivalents and short-term investments</b>wereRMB83.4 billion(US$12.7 billion) as ofMarch 31, 2021, compared withRMB87.0 billionas ofDecember 31, 2020.</p><p><b>Recent Development</b></p><p>As ofApril 30, 2021,US$756.4 millionof the 0% convertible bonds due in 2024 have been converted into newly issued ADSs.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PDD":"拼多多"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1115191257","content_text":"Chinese e-commerce platform Pinduoduo Inc's quarterly revenue beat Wall Street estimates on Wednesday, driven by steady demand for online shopping following the COVID-19 pandemic.Total revenue more than tripled to 22.17 billion yuan ($3.47 billion)in the first quarter, boosted by Pinduoduo's online marketing services revenue. Analysts on average had expected revenue of 20.2 billion yuan, according to IBES data from Refinitiv.The interactive buying platform's net loss attributable to shareholders narrowed to 2.91 billion yuan in the quarter ended March 31, from 4.12 billion yuan a year earlier.Active buyers on Pinduoduo in the 12-month period ended March rose 31% to about 824 million, outpacing Alibaba's 811 million.Pinduoduo stock surged more than 3% in premarket trading.First Quarter 2021 HighlightsTotal revenues in the quarter were RMB22,167.1 million (US$13,383.4 million), an increase of 239% from RMB6,541.1 millionin the same quarter of 2020.Average monthly active users in the quarter was 724.6 million, an increase of 49% from 487.4 million in the same quarter of 2020.Active buyers in the twelve-month period endedMarch 31, 2021was 823.8 million, an increase of 31% from 628.1 million in the twelve-month period endedMarch 31, 2020.Operating loss in the quarter was RMB4,147.0 million(US$633.0 million), compared with operating loss of RMB4,397.2 millionin the same quarter of 2020.Non-GAAP4 operating loss in the quarter wasRMB 3,174.1 million(US$484.5 million), compared with operating loss ofRMB3,587.9 millionin the same quarter of 2020.Net loss attributable to ordinary shareholders in the quarter was RMB2,905.4 million(US$ 443.5 million), compared with RMB4,119.3 millionin the same quarter of 2020.Non-GAAP net loss attributable to ordinary shareholders in the quarter was RMB1,890.3 million(US$288.5 million), compared withRMB3,169.6 millionin the same quarter of 2020.“Our growing scale gives us both greater capacity and responsibility to live up to our mission to ‘benefit all’,” said Mr.Lei Chen, Chairman and Chief Executive Officer ofPinduoduo. “We envisionPinduoduoas a platform that not only facilitates the trading of goods and services but also serves as a conduit for turning ideas into solutions to everyday problems.”“We remain laser-focused on serving our users and anticipating what they need, and doing so in a way that is respectful of the community and environment,” added Mr.David Liu, Vice President of Strategy. “We will continue to engage our users, merchants and partners in improving all aspects of our services.”“We continued to deliver strong results in the first quarter and remain disciplined,” said Mr.Tony Ma, Vice President of Finance. “Our total revenues, excluding contribution from merchandise sales, for the first quarter 2021 increased 161% from the prior year, while our non-GAAP operating and net losses narrowed at the same time.”First Quarter 2021 Unaudited Financial ResultsTotal revenueswereRMB22,167.1 million(US$3,383.4 million), an increase of 239% fromRMB6,541.1 millionin the same quarter of 2020. The increase was primarily due to an increase in revenues from online marketing services and contribution from merchandise sales.Revenues from online marketing services and otherswereRMB14,111.5 million(US$2,153.8 million), an increase of 157% fromRMB5,492.3 millionin the same quarter of 2020.Revenues from transaction serviceswereRMB2,931.5 million(US$447.4 million), an increase of 180% fromRMB1,048.8 millionin the same quarter of 2020.Revenues from merchandise saleswereRMB5,124.1 million(US$782.1 million), an increase ofRMB5,124.1 millionfrom nil in the same quarter of 2020.Total costs of revenueswereRMB10,746.1 million(US$1,640.2 million), an increase of 487% fromRMB1,830.2 millionin the same quarter of 2020. The increase was mainly due to costs attributable to merchandise sales, higher cost of payment processing fees, cloud services fees, and delivery and storage fees.Total operating expenseswereRMB15,568.0 million(US$2,376.1 million), compared withRMB9,108.0 millionin the same quarter of 2020.Sales and marketing expenseswereRMB12,997.4 million(US$1,983.8 million), an increase of 78% fromRMB7,296.6 millionin the same quarter of 2020, mainly due to an increase in advertising expenses and promotion and coupon expenses.General and administrative expenseswereRMB351.9 million(US$53.7 million), an increase of 4% fromRMB338.3 millionin the same quarter of 2020.Research and development expenseswereRMB2,218.7 million(US$338.6 million), an increase of 51% fromRMB1,473.2 millionin the same quarter of 2020. The increase was primarily due to an increase in headcount and the recruitment of more experienced R&D personnel and an increase in R&D-related cloud services expenses.Operating losswasRMB4,147.0 million(US$633.0 million), compared with operating loss ofRMB4,397.2 millionin the same quarter of 2020.Non-GAAP operating losswasRMB3,174.1 million(US$484.5 million), compared with operating loss ofRMB3,587.9 millionin the same quarter of 2020.Net loss attributable to ordinary shareholderswasRMB2,905.4 million(US$443.5 million), compared withRMB4,119.3 millionin the same quarter of 2020.Non-GAAP net loss attributable to ordinary shareholderswasRMB1,890.3 million(US$288.5 million), compared withRMB3,169.6 millionin the same quarter of 2020.Basic and diluted net loss per ADSwereRMB2.33(US$0.36), compared withRMB3.54in the same quarter of 2020.Non-GAAP basic and diluted net loss per ADSwereRMB1.52(US$0.23), compared withRMB2.73in the same quarter of 2020.Net cash flow used in operating activitieswasRMB3,724.5 million(US$568.5 million), compared withRMB567.1 millionin the same quarter of 2020, primarily due to an increase in restricted cash outflow due to seasonality, offset by increase in online marketing services revenues.Cash, cash equivalents and short-term investmentswereRMB83.4 billion(US$12.7 billion) as ofMarch 31, 2021, compared withRMB87.0 billionas ofDecember 31, 2020.Recent DevelopmentAs ofApril 30, 2021,US$756.4 millionof the 0% convertible bonds due in 2024 have been converted into newly issued ADSs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108619402,"gmtCreate":1620017560006,"gmtModify":1631892448457,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"While....yes all big boys are growing, no denial. As for investment, the question is going in at how much and what kind of timing.....i am not saying we can not buy, but rather take a deliberated approach.","listText":"While....yes all big boys are growing, no denial. As for investment, the question is going in at how much and what kind of timing.....i am not saying we can not buy, but rather take a deliberated approach.","text":"While....yes all big boys are growing, no denial. As for investment, the question is going in at how much and what kind of timing.....i am not saying we can not buy, but rather take a deliberated approach.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/108619402","repostId":"1184469535","repostType":4,"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":167672128,"gmtCreate":1624267885964,"gmtModify":1631888121046,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"This is the nature of bio- tech company, high risk and high reward at the same time, FDA approval is the key.","listText":"This is the nature of bio- tech company, high risk and high reward at the same time, FDA approval is the key.","text":"This is the nature of bio- tech company, high risk and high reward at the same time, FDA approval is the key.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/167672128","repostId":"1184501396","repostType":4,"repost":{"id":"1184501396","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624267024,"share":"https://www.laohu8.com/m/news/1184501396?lang=&edition=full","pubTime":"2021-06-21 17:17","market":"us","language":"en","title":"Orphazyme rose more than 6% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1184501396","media":"Tiger Newspress","summary":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a c","content":"<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme rose more than 6% in premarket trading </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme rose more than 6% in premarket trading \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-21 17:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(June 21)&nbsp;Orphazyme rose more than 6% in premarket trading.&nbsp;</p>\n<p><img src=\"https://static.tigerbbs.com/a1e2eb27cc68ce74ddd21a64a64634cf\" tg-width=\"719\" tg-height=\"495\" referrerpolicy=\"no-referrer\"></p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Orphazyme</b>, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last&nbsp;Friday.</p>\n<p><b>So what</b></p>\n<p>The FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.</p>\n<p>Instead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.</p>\n<p>Many institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.</p>\n<p><b>Now what</b></p>\n<p>According to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.</p>\n<p>Some shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.</p>\n<p>Despite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.</p>\n<p></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184501396","content_text":"(June 21) Orphazyme rose more than 6% in premarket trading. \n\nWhat happened\nShares of Orphazyme, a clinical-stage biopharmaceutical company, got hammered after the Food and Drug Administration (FDA) refused to approve an application for the company's lead candidate. Investors are now uncertain when the biotech could have an approved product to sell, and pushed the stock 44.4% lower as of 12:12 p.m. EDT on last Friday.\nSo what\nThe FDA began reviewing an application for Orphazyme's lead candidate arimoclomol last September as a potential treatment for a rare but life-threatening disease called Neimann-Pick Disease Type-C (NPC). Earlier this month, shares of Orphazymeshot upmore than 200% in anticipation of a green light that never came.\nInstead of an approval decision for arimoclomol, the agency asked for more information in the form of a complete response letter (CRL). That came as a shock to heaps of investors who were new to the complex world of drug development and were expecting a massiveshort squeeze.\nMany institutional investors were betting against Orphazyme because its lead candidate failed to achieve the primary endpoint in the pivotal study underpinning the application. Arimoclomol also failed to improve patients' scores on a secondary endpoint specifically requested by the FDA.\nNow what\nAccording to Orphazyme, the company needs to further substantiate the validity of the primary endpoint that arimoclomol almost achieved. To satisfy the FDA, the company will most likely have to run a new pivotal study.\nSome shareholders remain hopeful that the European Medicines Agency will be less strict than the FDA. While the FDA's European colleague has been more lenient regarding treatments for rare diseases in the past, arimoclomol probably isn't moving forward until it produces some convincing clinical-trial results.\nDespite lacking a clear path forward, the Denmark-headquartered company still boasts a fairly large market cap in excess of $500 million at recent prices. Irrational expectations could keep it elevated, but this is way too high for anyclinical-stage biotechin Orphazyme's position.","news_type":1},"isVote":1,"tweetType":1,"viewCount":231,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166603163,"gmtCreate":1624004486352,"gmtModify":1631888121095,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Oh dear...this is bad news from FDA.","listText":"Oh dear...this is bad news from FDA.","text":"Oh dear...this is bad news from FDA.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/166603163","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://www.laohu8.com/m/news/1142916683?lang=&edition=full","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1},"isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":139346794,"gmtCreate":1621595900518,"gmtModify":1631885571175,"author":{"id":"3578427892019378","authorId":"3578427892019378","name":"Magnusfu","avatar":"https://static.tigerbbs.com/3d8051c863ddbbc465926cd5d33368f9","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3578427892019378","idStr":"3578427892019378"},"themes":[],"htmlText":"Coinbase and telsa are closely associated due to Elon buying a lot of bitcoin as part of company cash investment.&nbsp; Kathie still strongly believes that&nbsp;these 2 companies have huge long term potential for growth though....the action speaks louder than words.&nbsp;Square is a different story, as a payment gateway or platform.","listText":"Coinbase and telsa are closely associated due to Elon buying a lot of bitcoin as part of company cash investment.&nbsp; Kathie still strongly believes that&nbsp;these 2 companies have huge long term potential for growth though....the action speaks louder than words.&nbsp;Square is a different story, as a payment gateway or platform.","text":"Coinbase and telsa are closely associated due to Elon buying a lot of bitcoin as part of company cash investment. Kathie still strongly believes that these 2 companies have huge long term potential for growth though....the action speaks louder than words. Square is a different story, as a payment gateway or platform.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/139346794","repostId":"2136883978","repostType":4,"repost":{"id":"2136883978","pubTimestamp":1621582642,"share":"https://www.laohu8.com/m/news/2136883978?lang=&edition=full","pubTime":"2021-05-21 15:37","market":"us","language":"en","title":"Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=2136883978","media":"Motley Fool","summary":"Things are rough for the kind of growth stocks that the popular fund manager owns, but she's adding to some of her bigger losers now.","content":"<p>Wednesday's crypto crash and falling prices on former market darlings were a potent one-two combo to get Cathie Wood buying. The popular money manager took advantage of the market's dip to add to some of her biggest names across ARK Invest's widely followed exchange-traded funds (ETFs).</p><p><b>Coinbase</b> (NASDAQ:COIN), <b>Tesla</b>&nbsp;(NASDAQ:TSLA), and <b>Square</b> (NYSE:SQ) stand out among her purchases on Wednesday. She added more shares of the fast-growing companies to at least two of her six ETFs. Let's see why she may be on to something with all three stocks.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1cab57a9463345d4bd7292cdfbc52cb9\" tg-width=\"700\" tg-height=\"525\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p><h2>Coinbase</h2><p>Wood was defending the long-term potential of <b>Bitcoin </b>on Wednesday as the crypto crash was happening, so it's not a surprise to see her adding to Coinbase. The leading cryptocurrency marketplace naturally took a hit as the digital currencies it specializes in moved sharply lower. Adding insult to injury, the Coinbase site was down for chunks of time on Wednesday morning as traders were looking to either cash out or take advantage of the lower price points.</p><p>Coinbase stock would tumble 13% to bottom out at $208 -- an all-time low for a stock that has only been public for a month -- but recovered a little more than half of its intraday losses to close just 6% lower. The crypto market itself took a bigger hit, but that does make sense. The negative sentiment that started with Telsa CEO Elon Musk dissing Bitcoin a week ago is generating a spike in trading activity, and that's ultimately good for Coinbase. This will naturally become a bigger problem for Coinbase if crypto doesn't bounce back, but that could also be a mixed blessing if that keeps new competitors away or a trading fee price war from breaking out.</p><h2>Tesla</h2><p>Wood apparently didn't take Musk's rant on Bitcoin as an energy hog personally. Tesla is the largest holding across her combined ETFs, and she nabbed a bit more of the electric car maker for three of them on Wednesday.</p><p>Tesla stock enters Thursday trading 37% below the all-time high it hit in January. Tesla has become a popular short with so many automakers pushing out electric vehicles, but it seems a bit misguided. None of them will have the proprietary fleet of charging stations that is the equivalent of selling a traditional car and owning every gas station the driver will ever need. Tesla's getting a lot of heat because its \"Full Self Driving\" upgrade isn't exactly full self driving just yet, but what is now a $10,000 digital accessory for new buyers is still well ahead of the competition in the race for autonomous driving. The stock wasn't cheap after last year's run, but the recent sell-off seems overdone at this point given Tesla's pole position in electric vehicles and the aspirational nature of its brand.</p><h2>Square</h2><p>Finally, Wood put some more money into a company that knows all about moving money around. Square is a leading payment platform. It's also been an early pioneer in crypto, and that may explain why the shares opened 5% lower on Wednesday before making back more than half of the initial hit by the end of the trading day.</p><p>Square has been on a growth tear lately, with sharply accelerating year-over-year top-line growth for five consecutive quarters. Revenue soared 266% in its latest report, a big step up from the 41% growth it was posting six quarters ago. Bitcoin trading through Square's Cash App was a major contributor to the monster quarter, but there's a lot more going for the digital payments platform than just crypto.</p><p>Wood isn't afraid to buy on the dip if a company's bullish thesis remains strong. Right now it seems as if Coinbase, Tesla, and Square are still worth buying.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-21 15:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/20/cathie-wood-goes-bargain-hunting-3-stocks-she-just/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Wednesday's crypto crash and falling prices on former market darlings were a potent one-two combo to get Cathie Wood buying. The popular money manager took advantage of the market's dip to add to some...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/20/cathie-wood-goes-bargain-hunting-3-stocks-she-just/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","COIN":"Coinbase Global, Inc.","SQ":"Block","ARKF":"ARK Fintech Innovation ETF","TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/05/20/cathie-wood-goes-bargain-hunting-3-stocks-she-just/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2136883978","content_text":"Wednesday's crypto crash and falling prices on former market darlings were a potent one-two combo to get Cathie Wood buying. The popular money manager took advantage of the market's dip to add to some of her biggest names across ARK Invest's widely followed exchange-traded funds (ETFs).Coinbase (NASDAQ:COIN), Tesla (NASDAQ:TSLA), and Square (NYSE:SQ) stand out among her purchases on Wednesday. She added more shares of the fast-growing companies to at least two of her six ETFs. Let's see why she may be on to something with all three stocks.Image source: Getty Images.CoinbaseWood was defending the long-term potential of Bitcoin on Wednesday as the crypto crash was happening, so it's not a surprise to see her adding to Coinbase. The leading cryptocurrency marketplace naturally took a hit as the digital currencies it specializes in moved sharply lower. Adding insult to injury, the Coinbase site was down for chunks of time on Wednesday morning as traders were looking to either cash out or take advantage of the lower price points.Coinbase stock would tumble 13% to bottom out at $208 -- an all-time low for a stock that has only been public for a month -- but recovered a little more than half of its intraday losses to close just 6% lower. The crypto market itself took a bigger hit, but that does make sense. The negative sentiment that started with Telsa CEO Elon Musk dissing Bitcoin a week ago is generating a spike in trading activity, and that's ultimately good for Coinbase. This will naturally become a bigger problem for Coinbase if crypto doesn't bounce back, but that could also be a mixed blessing if that keeps new competitors away or a trading fee price war from breaking out.TeslaWood apparently didn't take Musk's rant on Bitcoin as an energy hog personally. Tesla is the largest holding across her combined ETFs, and she nabbed a bit more of the electric car maker for three of them on Wednesday.Tesla stock enters Thursday trading 37% below the all-time high it hit in January. Tesla has become a popular short with so many automakers pushing out electric vehicles, but it seems a bit misguided. None of them will have the proprietary fleet of charging stations that is the equivalent of selling a traditional car and owning every gas station the driver will ever need. Tesla's getting a lot of heat because its \"Full Self Driving\" upgrade isn't exactly full self driving just yet, but what is now a $10,000 digital accessory for new buyers is still well ahead of the competition in the race for autonomous driving. The stock wasn't cheap after last year's run, but the recent sell-off seems overdone at this point given Tesla's pole position in electric vehicles and the aspirational nature of its brand.SquareFinally, Wood put some more money into a company that knows all about moving money around. Square is a leading payment platform. It's also been an early pioneer in crypto, and that may explain why the shares opened 5% lower on Wednesday before making back more than half of the initial hit by the end of the trading day.Square has been on a growth tear lately, with sharply accelerating year-over-year top-line growth for five consecutive quarters. Revenue soared 266% in its latest report, a big step up from the 41% growth it was posting six quarters ago. Bitcoin trading through Square's Cash App was a major contributor to the monster quarter, but there's a lot more going for the digital payments platform than just crypto.Wood isn't afraid to buy on the dip if a company's bullish thesis remains strong. Right now it seems as if Coinbase, Tesla, and Square are still worth buying.","news_type":1},"isVote":1,"tweetType":1,"viewCount":593,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}